<SEC-DOCUMENT>0001140361-23-030980.txt : 20230622
<SEC-HEADER>0001140361-23-030980.hdr.sgml : 20230622
<ACCEPTANCE-DATETIME>20230622170211
ACCESSION NUMBER:		0001140361-23-030980
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20230622
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230622
DATE AS OF CHANGE:		20230622

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray Brands, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				824310622
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		231034055

	BUSINESS ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065
		BUSINESS PHONE:		519.322.8800

	MAIL ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tilray, Inc.
		DATE OF NAME CHANGE:	20180213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20009174x12_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:tlry="http://tilray.com/20230622" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_ebbcf9f95c5b48bcb762bd0e3ca8206b" contextRef="c20230622to20230622" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_5414f07889a342d89b02e41e41ebad99" contextRef="c20230622to20230622">0001731348</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_3ce1a4f16d594c87a5bbfb438f6f52b5" contextRef="c20230622to20230622">ON</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_8f0f3b4cd4c24449a64a6d136b3aae77" contextRef="c20230622to20230622">N8H 5L4</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="tlry-20230622.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230622to20230622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001731348</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-22</xbrli:startDate><xbrli:endDate>2023-06-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_69926e009d6a4281a6cfdeba4d77ad0b" contextRef="c20230622to20230622">8-K</ix:nonNumeric></div>

      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_3c1ae370cd5e42f6a738b9c95c447ae6" contextRef="c20230622to20230622" format="ixt:date-monthname-day-year-en">June 22, 2023</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
        </span><span style="font-size: 24pt; font-family: 'Times New Roman', Times, serif;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_f8c51d7124cf45cea14d1735f7f0130c" contextRef="c20230622to20230622">Tilray Brands, Inc.</ix:nonNumeric> <br />
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.31%; vertical-align: top;">
              <div style="text-align: center; margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_8b8ac2966ebe4421b21d205fd31219e1" contextRef="c20230622to20230622" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_3ff9e5b0329b430ab6822529d5502c19" contextRef="c20230622to20230622">001-38594</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.31%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_6c5b7d4b89d44bd7bef1102667bf2e09" contextRef="c20230622to20230622">82-4310622</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.31%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(State or other jurisdiction<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
                </span>of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Commission<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
                </span>File Number)</div>
            </td>

    <td style="width: 33.31%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(IRS Employer<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br />
                </span>Identification No.)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_521ff4e7a462457dab150ec61d04ebf5" contextRef="c20230622to20230622">265 Talbot Street West</ix:nonNumeric>,</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_7af743a6e813422f8b8171e3211dd952" contextRef="c20230622to20230622">Leamington</ix:nonNumeric>,
                <span style="-sec-ix-hidden:Fact_3ce1a4f16d594c87a5bbfb438f6f52b5">Canada</span></div>
            </td>

    <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 49.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_8f0f3b4cd4c24449a64a6d136b3aae77">N8H 5L4</span><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.5%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">(Address of principal executive offices)</div>
            </td>

    <td style="width: 1%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 49.5%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">(Zip code)</div>
              <div>&#160;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_73730a95e07f489cbe7ca7a9b02577f1" contextRef="c20230622to20230622">844</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_4cfc877fcb3e46b9bf58c93f40accb76" contextRef="c20230622to20230622">845-7291</ix:nonNumeric></span></div>

      <div><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">N<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ot Applicable</span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div>&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
        any of the following provisions (see General Instruction A.2. below):</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 4%; vertical-align: top;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_f5973f640cef471581dcb9e64dc3d2b3" contextRef="c20230622to20230622" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 96%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 4%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_27b27134518b4f979814da0999971daa" contextRef="c20230622to20230622" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 96%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 4%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_04b8b9de113848248d445f1293c087b6" contextRef="c20230622to20230622" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 96%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 4%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_1dbd010ca59443daa60ae01de4cd2946" contextRef="c20230622to20230622" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 96%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Trading Symbol(s)</div>
            </td>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; margin-left: 7.5pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
              <div>&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_07d73e947dc84f2198abd7c1f4b951e7" contextRef="c20230622to20230622">Common Stock, $0.0001 par value per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_facb318aeb77429fad7fc46ad015feaf" contextRef="c20230622to20230622">TLRY</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.33%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_05d11a1e617d4f31bd3c4acffdada45c" contextRef="c20230622to20230622" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
        of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter):</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dfb81aea7d1540a0a27511be6e1e1bf4" contextRef="c20230622to20230622" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
        with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;"> <br />
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;"> </span></div>
</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Introductory Note.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As previously disclosed in the Current Reports on Form 8-K filed by Tilray Brands, Inc., a Delaware corporation (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Tilray</span>&#8221;), with the Securities and Exchange Commission (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">SEC</span>&#8221;) on April 10, 2023, as amended on April 11, 2023, and June 2, 2023, Tilray entered into an Arrangement Agreement on April 10, 2023, as amended on June 1, 2023 (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Arrangement Agreement</span>&#8221;), with HEXO Corp., a corporation existing under the laws of the Province of Ontario (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO</span>&#8221;), pursuant to which Tilray agreed to acquire all of the issued and outstanding common shares of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO Shares</span>&#8221;) as well as all of the issued and outstanding preferred shares of HEXO pursuant to a plan of arrangement (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Plan of Arrangement</span>&#8221;) under the Business Corporations Act (Ontario) (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Arrangement</span>&#8221;). The Arrangement was consummated on June 22, 2023 (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Closing Date</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 1.01.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Entry into a Material Definitive Agreement</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Second Supplemental Warrant Indenture to the April 2019 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, 48North Cannabis Corp. (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">48North</span>&#8221;), Tilray and Computershare Trust Company of Canada, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">April



          2019 Warrant Agent</span>&#8221;), entered into the Second Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO April 2019 Second Supplemental
          Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO April 2019 Warrant Indenture</span>&#8221;), dated as of April 2, 2019,
        48North and the April 2019 Warrant Agent, as amended by the First Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO April 2019 First
          Supplemental Warrant Indenture</span>&#8221;), dated as of September 1, 2021, between 48North, HEXO and the April 2019 Warrant Agent, relating to common share purchase warrants of 48North (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">48North Warrants</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO April 2019 Second Supplemental Warrant Indenture, from and after the effective time of the Plan of Arrangement (the
        &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Effective Time</span>&#8221;), each 48North Warrant exercisable for HEXO Shares became exercisable for 0.00073549 of a share of common
        stock of Tilray, par value $0.0001 per share (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Common Stock</span>&#8221;), at an exercise price of C$1.72 (or an effective exercise price
        of C$2,338.58 per one whole share of Common Stock), which represents an increase in the exercise price in a corresponding proportion to give effect to the Common Exchange Ratio (as defined below). Each 48North Warrant expires at 5:00pm (Toronto
        time) on April 2, 2024. No fractional warrants will be issued and the 48North Warrants may only be exercised to acquire whole numbers of shares of Common Stock. Further, if at any time prior to the expiration date of the 48North Warrants, the
        volume weighted average trading price (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">VWAP</span>&#8221;) of the Common Stock on the Toronto Stock Exchange (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">TSX</span>&#8221;) equals or exceeds C$4,486.82 per share of Common Stock for 10 consecutive trading days, Tilray may, within 10 days of such
        event, deliver written notice to holders of 48North Warrants and the April 2019 Warrant Agent, supplemented by way of a press release issued by Tilray, accelerating the expiration date to the date that is 30 days following the date of such notice.
        In that event, any unexercised 48North Warrants would automatically expire at the end of the accelerated expiration date. As of the date hereof, approximately 8,093 shares of Common Stock are issuable pursuant to the exercise of the issued and
        outstanding 48North Warrants. The 48North Warrants are listed on the TSX under the symbol &#8220;HEXO.WT.A&#8221;.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Third Supplemental Warrant Indenture to the June 2020 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and Computershare Trust Company of Canada, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Zenabis June 2020 Warrant Agent</span>&#8221;), entered into the Third Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Third Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Warrant Indenture</span>&#8221;), dated as of June 25, 2020, between Zenabis Global Inc. (&#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Zenabis</span>&#8221;)











        and the Zenabis June 2020 Warrant Agent, as amended by the First Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 First
          Supplemental Warrant Indenture</span>&#8221;), dated as of June 1, 2021, between HEXO and the Zenabis June 2020 Warrant Agent and the Second Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Second Supplemental Warrant Indenture</span>&#8221;), dated as of October 31, 2022, between HEXO and the Zenabis June 2020 Warrant Agent, relating to certain common share purchase warrants
        of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Warrants</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO June 2020 Third Supplemental Warrant Indenture, from and after the Effective Date, each HEXO June 2020 Warrant
        exercisable for HEXO Shares became exercisable for 0.000550839 of a share of Common Stock at an exercise price of C$0.16 (or an effective exercise price of C$290.47 per one whole share of Common Stock), which represents an increase in the exercise
        price in a corresponding proportion to give effect to the Common Exchange Ratio. Each HEXO June 2020 Warrant expires at 5:00pm (Toronto time) on June 25, 2025. No fractional warrants will be issued and the HEXO June 2020 Warrants may only be
        exercised to acquire whole numbers of shares of Common Stock. Further, if at any time after the Arrangement Effective Date (as defined in the HEXO June 2020 Third Supplemental Warrant Indenture), the closing sale price of the Common Stock on the
        TSX exceeds C$580.93 per share for a period of 10 consecutive trading days, Tilray may, at its sole discretion, accelerate the expiration date of the HEXO June 2020 Warrants to a date that is 15 days following delivery of notice of such
        acceleration to holders of HEXO June 2020 Warrants and the Zenabis June 2020 Warrant Agent. As of the date hereof, approximately 99,642 shares of Common Stock are issuable pursuant to the exercise of the issued and outstanding HEXO June 2020
        Warrants.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Third Supplemental Warrant Indenture to the September 2020 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and Computershare Trust Company of Canada, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Zenabis September 2020 Warrant Agent</span>&#8221;), entered into the Third Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO September 2020 Third Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO September 2020 Warrant Indenture</span>&#8221;), dated as of September 23, 2020, between Zenabis and the Zenabis June 2020 Warrant Agent, as amended by the First Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO September 2020 First Supplemental Warrant Indenture</span>&#8221;), dated as of June 1, 2021, between HEXO and the Zenabis September 2020
        Warrant Agent and the Second Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Second Supplemental Warrant Indenture</span>&#8221;),
        dated as of October 31, 2022, between HEXO and the Zenabis September 2020 Warrant Agent, relating to certain common share purchase warrants of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO September 2020 Warrants</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO September 2020 Third Supplemental Warrant Indenture, from and after the Closing Date, each HEXO September 2020
        Warrant exercisable for HEXO Shares became exercisable for 0.000550839 of a share of Common Stock at an exercise price of C$0.10 (or an effective exercise price of C$181.54 per one whole share of Common Stock), which represents an increase in the
        exercise price in a corresponding proportion to give effect to the Common Exchange Ratio. Each HEXO September 2020 Warrant expires at 5:00pm (Toronto time) on September 23, 2025. No fractional warrants will be issued and the HEXO September 2020
        Warrants may only be exercised to acquire whole numbers of shares of Common Stock. Further, if at any time after the Arrangement Effective Date (as defined in the HEXO September 2020 Third Supplemental Warrant Indenture), the closing sale price of
        the Common Stock on the TSX exceeds C$363.08 per share for a period of 10 consecutive trading days, Tilray may, at its sole discretion, accelerate the expiration date of the HEXO June 2020 Warrants to a date that is 15 days following delivery of
        notice of such acceleration to holders of HEXO September 2020 Warrants and the Zenabis September 2020 Warrant Agent. As of the date hereof, approximately 38,201 shares of Common Stock are issuable pursuant to the exercise of the issued and
        outstanding HEXO September 2020 Warrants.</div>

      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Supplemental Warrant Indenture to the August 2021 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and TSX Trust Company, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">August 2021 Warrant Agent</span>&#8221;), entered into the Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO August 2021 Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO August 2021
          Warrant Indenture</span>&#8221;), dated as of August 24, 2021, between HEXO and the August 2021 Warrant Agent, relating to certain common share purchase warrants of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">August 2021 HEXO Warrants</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO August 2021 Supplemental Warrant Indenture, from and after the Effective Date, each August 2021 HEXO Warrant
        exercisable for HEXO Shares became exercisable for 0.4352 of a share of Common Stock at an exercise price of US$48.30 (or an effective exercise price of US$110.98 per one whole share of Common Stock), which represents an increase in the exercise
        price in a corresponding proportion to give effect to the Common Exchange Ratio. Each August 2021 HEXO Warrant expires at 5:00pm (Eastern time) on August 24, 2026. No fractional warrants will be issued and the August 2021 HEXO Warrants may only be
        exercised to acquire whole numbers of shares of Common Stock. As of the date hereof, approximately 762,844 shares of Common Stock are issuable pursuant to the exercise of the issued and outstanding August 2021 HEXO Warrants.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Supplemental Warrant Indenture to the June 2020 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and TSX Trust Company, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">June 2020 Warrant Agent</span>&#8221;), entered into the Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO June 2020 Warrant
          Indenture</span>&#8221;), dated as of June 5, 2020, between HEXO and the June 2020 Warrant Agent, relating to certain common share purchase warrants of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">June 2020 HEXO Warrants</span>&#8221;).</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO June 2020 Supplemental Warrant Indenture, from and after the Effective Time, each June 2020 HEXO Warrant exercisable
        for HEXO Shares became exercisable for 0.4352 of a share of Common Stock at an exercise price of US$56.00 (or an effective exercise price of US$128.68 per one whole share of Common Stock), which represents an increase in the exercise price in a
        corresponding proportion to give effect to the Common Exchange Ratio. Each June 2020 HEXO Warrant expires at 5:00pm (Eastern time) on June 30, 2023. No fractional warrants will be issued and the June 2020 HEXO Warrants may only be exercised to
        acquire whole numbers of shares of Common Stock. As of the date hereof, approximately 30,460 shares of Common Stock are issuable pursuant to the exercise of the issued and outstanding June 2020 HEXO Warrants.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Supplemental Warrant Indenture to the May 2020 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and TSX Trust Company, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">May 2020 Warrant Agent</span>&#8221;), entered into the Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO May 2020 Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO May Warrant
          Indenture</span>&#8221;), dated as of May 21, 2020, between HEXO and the May 2020 Warrant Agent, relating to certain common share purchase warrants of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">May 2020 HEXO Warrants</span>&#8221;).<br />
      </div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO May 2020 Supplemental Warrant Indenture, from and after the Closing Date, each May 2020 HEXO Warrant exercisable for
        HEXO Shares became exercisable for 0.4352 of a share of Common Stock at an exercise price of C$58.80 (or an effective exercise price of C$135.11 per one whole share of Common Stock), which represents an increase in the exercise price in a
        corresponding proportion to give effect to the Common Exchange Ratio. Each May 2020 HEXO Warrant expires at 5:00pm (Eastern time) on May 21, 2025. No fractional warrants will be issued and the May 2020 HEXO Warrants may only be exercised to acquire
        whole numbers of shares of Common Stock. As of the date hereof, approximately 235,999 shares of Common Stock are issuable pursuant to the exercise of the issued and outstanding May 2020 HEXO Warrants.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Supplemental Warrant Indenture to the April 2020 Warrant Indenture</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On the Closing Date, HEXO, Tilray and TSX Trust Company, as warrant agent (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">April 2020 Warrant Agent</span>&#8221;), entered into the Supplemental Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO April 2020 Supplemental Warrant Indenture</span>&#8221;) to the Warrant Indenture (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO April 2020
          Warrant Indenture</span>&#8221;), dated as of April 13, 2020, between HEXO and the April 2020 Warrant Agent, relating to certain common share purchase warrants of HEXO (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">April 2020 HEXO Warrants</span>&#8221;).</div>

      <div><br /></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the HEXO April 2020 Supplemental Warrant Indenture, from and after the Closing Date, each April 2020 HEXO Warrant exercisable
        for HEXO Shares became exercisable for 0.4352 of a share of Common Stock at an exercise price of C$53.76 (or an effective exercise price of C$123.53 per one whole share of Common Stock), which represents an increase in the exercise price in a
        corresponding proportion to give effect to the Common Exchange Ratio. Each April 2020 HEXO Warrant expires at 5:00pm (Eastern time) on April 13, 2025. No fractional warrants will be issued and the April 2020 HEXO Warrants may only be exercised to
        acquire whole numbers of shares of Common Stock. As of the date hereof, approximately 367,746 shares of Common Stock are issuable pursuant to the exercise of the issued and outstanding April 2020 HEXO Warrants.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing descriptions of the warrant indentures are not complete and are qualified in their entirety by reference to the full text
        of such warrant indentures, copies of which are filed as Exhibits 4.1 through 4.19 hereto, and incorporated herein by reference.</div>

      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 2.01.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Completion of Acquisition or Disposition of Assets.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information provided in the Introductory Note is incorporated by reference herein.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under the terms of the Arrangement Agreement and the Plan of Arrangement, on June 22, 2023, each HEXO Share outstanding immediately prior
        to the Effective Time (other than shares held by Tilray and HEXO dissenting shareholders) was transferred to Tilray in exchange for 0.4352&#160;of a share of Common Stock (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Common Exchange Ratio</span>&#8221;).&#160; Each preferred share of HEXO outstanding immediately prior to the Effective Time was transferred to Tilray in exchange for 0.7805 of a share of Common Stock. In the
        aggregate, HEXO shareholders received 39,710,845 shares of Common Stock (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Consideration Shares</span>&#8221;). The Arrangement was
        intended to qualify as a reorganization for U.S. federal income tax purposes.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In addition, at the Effective Time, (i) all HEXO equity awards granted under HEXO&#8217;s equity compensation plans (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO Plans</span>&#8221;) that were outstanding as of the Effective Time were either, depending on the type of equity award, (a) assumed and
        adjusted to represent a right to acquire Common Stock, with the number of shares underlying such awards and the exercise prices of such awards adjusted based on the Common Exchange Ratio, or (b) exchanged for a cash payment, and (ii) all of the
        warrants to acquire HEXO Shares that were outstanding as of the Effective Time were adjusted to reflect the terms of the Arrangement, account for the Common Exchange Ratio and represent a right to acquire shares of Common Stock in place of HEXO
        Shares.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Treatment of HEXO Convertible Securities</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the Arrangement, at the Effective Time, (i) each outstanding option to purchase HEXO Shares, whether vested or unvested,
        issued pursuant to the HEXO Plans (each, a &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO Option</span>&#8221;), to the extent not exercised as of the Effective Date (as defined
        in the Arrangement Agreement), was adjusted pursuant to the Arrangement (each, an &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Adjusted Option</span>&#8221;) to represent a right to
        purchase a number of shares of Common Stock equal to the product of the Common Exchange Ratio multiplied by the number of HEXO Shares issuable on exercise of such HEXO Option immediately prior to the Effective Time, for an exercise price per share
        of Common Stock equal to the exercise price per share of such HEXO Option immediately prior to the Effective Time divided by the Common Exchange Ratio; (ii) each restricted share unit, whether vested or unvested, issued pursuant to the HEXO Plans
        (each, a &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO RSU</span>&#8221;), to the extent not exercised as of the Effective Date, was exchanged for a cash payment equal to the
        number of HEXO RSUs credited to such holder multiplied by $1.25 (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Payout Value</span>&#8221;) and was immediately thereafter cancelled
        and terminated; and (iii) each deferred share unit issued pursuant to the HEXO Plans (each, a &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">HEXO DSU</span>&#8221;), to the extent not
        exercised as of the Effective Date, was exchanged for a cash payment equal to the number of HEXO DSUs credited to such holder multiplied by the Payout Value. The HEXO Options shall continue to be governed by the applicable HEXO Plan pursuant to
        which the HEXO Options were initially granted. The Adjusted Options are convertible into aggregate of 1,283,985 shares of Common Stock. The exercise prices for the Adjusted Options range from C$3.63 to C$1,093.75.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Treatment of HEXO Warrants</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the Arrangement, at the Effective Time, each holder of a Company Warrant (as defined in the Arrangement Agreement), to the
        extent such Company Warrant had not expired as of the Effective Time and the holder of such Company Warrant had not exercised such Company Warrant as of the Effective Date, became entitled to acquire and receive, upon the exercise of such Company
        Warrant and payment of the applicable exercise price, the number of shares of Common Stock that would have been issued or paid to such holder if it had exercised such Company Warrant immediately prior to the Effective Time. The Company Warrants
        are, however, subject to adjustment in accordance with the terms of the applicable warrant indentures and warrant certificates. In addition, each Company Warrant, if applicable, will continue to be governed by and subject to the terms of the
        applicable warrant indenture or applicable warrant certificate.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing summary description of the completion of the Arrangement does not purport to be complete and is qualified in its entirety
        by reference to the terms of (i) the Arrangement Agreement, which was filed as Exhibit 10.1 to the Current Report on Form 8-K filed by Tilray with the SEC on April 10, 2023 and (ii) the Arrangement Agreement Amendment, which was filed as Exhibit
        10.2 to the Current Report on Form 8-K filed by Tilray with the SEC on June 2, 2023, and incorporated by reference into this Item 2.01.</div>

      <div><br />
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 3.01.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of the close of trading on June 22, 2023, HEXO, acting pursuant to authorization from its board of directors, voluntarily withdrew the
        listing of the HEXO Shares from the Nasdaq Stock Market.</div>

      <div><br />
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 3.02.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Unregistered Sales of Equity Securities.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information contained in Item 2.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 3.02. The
        Consideration Shares issued by Tilray in connection with the consummation of the Arrangement were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Securities Act</span>&#8221;), pursuant to Section 3(a)(10) of the Securities Act based on the final order of the Ontario Superior Court of Justice (Commercial List)
        issued on June 19, 2023, approving the Plan of Arrangement following a hearing by the court which considered, among other things, the fairness of the Arrangement to the persons affected.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The issuance of the shares of Common Stock underlying the Adjusted Options will be registered under the Securities Act under a Form S-8
        registration statement for the Company&#8217;s Amended and Restated 2018 Equity Incentive Plan.</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The issuance of the shares of Common Stock underlying of the Company Warrants will be registered under the Securities Act under a
        prospectus supplement related to the Form S-3 registration statement (File No. 333-267788) filed by the Company on October 7, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 3.03</span><span style="font-weight: bold;">.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Material Modification to Rights of Security Holders.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information set forth under Item 2.01 and Item 3.01, of this Current Report on Form 8-K is incorporated by reference into this Item
        3.03.</div>

      <div><br />
      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 8.01.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Other Events.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Press Release</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 22, 2023, Tilray issued a press release announcing the closing of the Arrangement. The press release is attached as Exhibit 99.1
        to this Current Report on Form 8-K.</div>

      <div><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Item 9.01.</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Financial Statements and Exhibits.</span></div>

      <div><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits.</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Number</div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 93%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Description</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1731348/000143774923009862/ex_498879.htm">2.1</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Arrangement Agreement, dated as of April 10, 2023, by and between Tilray Brands, Inc. and HEXO Corp. (incorporated by reference
                  to Exhibit 10.1 of Tilray&#8217;s Current Report on Form 8-K filed with the SEC on April 10, 2023).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1731348/000143774923016398/ex_528596.htm">2.2</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Arrangement Agreement Amendment, dated as of June 1, 2023, by and between Tilray Brands, Inc. and HEXO Corp. (incorporated by
                  reference to Exhibit 10.2 of Tilray&#8217;s Current Report on Form 8-K filed with the SEC on June 2, 2023).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-1.htm">4.1*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Second Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company
                  of Canada.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521268004/d199426dex991.htm">4.2</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">First Supplemental Warrant Indenture dated September 1 2021 among 48North Cannabis Corp., HEXO Corp. and Computershare Trust
                  Company of Canada (incorporated by reference to Exhibit 99.1 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on September 9, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521268004/d199426dex991.htm">4.3</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated April 2, 2019 between 48North Cannabis Corp. and Computershare Trust Company of Canada (incorporated by
                  reference to Exhibit 99.1 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on September 9, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-4.htm">4.4*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company
                  of Canada.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312522289884/d406976dex991.htm">4.5</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Second Supplemental Warrant Indenture dated October 31, 2022 between HEXO Corp. and Computershare Trust Company of Canada
                  (incorporated by reference to Exhibit 99.1 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on November 21, 2022).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521185406/d104852dex992.htm">4.6</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 1, 2021 among Zenabis Global Inc., HEXO Corp. and Computershare Trust Company of
                  Canada (incorporated by reference to Exhibit 99.2 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on June 8, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521185406/d104852dex992.htm">4.7</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated June 25, 2020 between Zenabis Global Inc. and Computershare Trust Company of Canada (incorporated by
                  reference to Exhibit 99.2 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on June 8, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-8.htm">4.8*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company
                  of Canada.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312522289884/d406976dex992.htm">4.9</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Second Supplemental Warrant Indenture dated October 31, 2022 between HEXO Corp. and Computershare Trust Company of Canada
                  (incorporated by reference to Exhibit 99.2 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on November 21, 2022).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521185406/d104852dex993.htm">4.10</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 1, 2021 among Zenabis Global Inc., HEXO Corp. and Computershare Trust Company of
                  Canada (incorporated by reference to Exhibit 99.3 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on June 8, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521185406/d104852dex993.htm">4.11</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated September 23, 2020 between Zenabis Global Inc. and Computershare Trust Company of Canada (incorporated
                  by reference to Exhibit 99.3 of HEXO&#8217;s Current Report on Form 6-K filed with the SEC on June 8, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-12.htm">4.12*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312521256514/d120567dex993.htm">4.13</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated August 24, 2021 between HEXO Corp. and TSX Trust Company (incorporated by reference to Exhibit 99.3 of
                  HEXO&#8217;s Current Report on Form 6-K filed with the SEC on August 26, 2021).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-14.htm">4.14*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312520191175/d88401dex994.htm">4.15</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated June 5, 2020 between HEXO Corp. and TSX Trust Company (incorporated by reference to Exhibit 99.4 of
                  HEXO&#8217;s Current Report on Form 6-K filed with the SEC on July 10, 2020).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-16.htm">4.16*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312520148809/d933945dex991.htm">4.17</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated May 21, 2020 between HEXO Corp. and TSX Trust Company (incorporated by reference to Exhibit 99.1 of
                  HEXO&#8217;s Current Report on Form 6-K filed with the SEC on May 21, 2020).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex4-18.htm">4.18*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1690947/000119312520105208/d915055dex991.htm">4.19</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Warrant Indenture dated April 13, 2020 between HEXO Corp. and TSX Trust Company (incorporated by reference to Exhibit 99.1 of
                  HEXO&#8217;s Current Report on Form 6-K filed with the SEC on April 13, 2020).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex5-1.htm">5.1*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Opinion of DLA Piper LLP (US).</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20009174x12_ex99-1.htm">99.1*</a></div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Press release dated June 22, 2023.</div>
                <div>&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
              </td>

    <td style="width: 2%; vertical-align: bottom;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>

    <td style="width: 93%; vertical-align: top;">
                <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">* Filed herewith.</div>

      </div>

      <div><br /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div><br />
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned thereunto duly authorized.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45.43%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 5.03%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="2" style="width: 49.54%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TILRAY, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45.43%; vertical-align: middle;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 5.03%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.09%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 46.45%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45.43%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: June 22, 2023</div>
            </td>

    <td style="width: 5.03%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.09%; vertical-align: top;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
            </td>

    <td style="width: 46.45%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ Mitchell Gendel</div>
            </td>

  </tr>

  <tr>

    <td style="width: 45.43%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 5.03%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.09%; vertical-align: middle;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 46.45%; vertical-align: bottom; border-top: #000000 2px solid;">
              <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Name:</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Mitchell











                  Gendel</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 45.43%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 5.03%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.09%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 46.45%; vertical-align: bottom;">
              <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Title:</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Global











                  General Counsel</span></div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ny20009174x12_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman,Times,serif;">
  <font style="font-family: Arial;"> </font><!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 0; margin-bottom: 0">
    <div style="font-size: 1pt; border-top: 4pt solid Black; width: 100%; font-family: Arial;">&#160;</div>
  </div>
  <font style="font-family: Arial;"> </font><!-- Field: /Rule-Page -->
  <p style="font: 10pt Arial; margin: 0pt 0px; text-align: right;"><b>Exhibit 4.1</b></p>
  <font style="font-family: Arial;"> </font>
  <p style="font: 10pt Arial; margin: 0pt 0px; text-align: center;"><font style="font-size: 10pt;">&#160;</font></p>
  <font style="font-family: Arial;"> <br>
  </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">48NORTH CANNABIS CORP.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt;">and</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">HEXO CORP.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt;">and</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">TILRAY BRANDS, INC.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt;">and</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">COMPUTERSHARE TRUST COMPANY OF CANADA</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">SECOND SUPPLEMENTAL WARRANT INDENTURE</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">Supplementing the Warrant Indenture Dated as of April 2, 2019</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">SECOND SUPPLEMENTAL WARRANT INDENTURE</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">THIS SECOND SUPPLEMENTAL WARRANT INDENTURE </font><font style="font-family: Arial;">made as of the 22nd day of June, 2023.</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">AMONG:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">48NORTH CANNABIS CORP</font><font style="font-family: Arial;">., a
      company existing under the laws of Canada</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt; font-weight: bold;">(&#8220;48North&#8221;)</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; text-indent: -18pt; margin-left: 108pt; font-family: Arial; font-size: 10pt;">- and <font style="font-size: 10pt;">-</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">HEXO CORP.</font><font style="font-family: Arial;">, a company existing
      under the laws of the Province of Ontario</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt; font-weight: bold;">(&#8220;HEXO&#8221;)</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; text-indent: -18pt; margin-left: 108pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;">-</font><font style="font-family: Arial;"> and <font style="font-size: 10pt;">-</font></font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">TILRAY BRANDS, INC.</font><font style="font-family: Arial;">, a
      corporation existing under the laws of the State of Delaware</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt; font-weight: bold;">(&#8220;Tilray&#8221;)</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">- and <font style="font-size: 10pt;">-</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">COMPUTERSHARE TRUST COMPANY OF CANADA</font><font style="font-family: Arial;">, a trust company existing under the laws of Canada</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt; font-weight: bold;">(the &#8220;Warrant Agent&#8221;)</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">WHEREAS, </font><font style="font-family: Arial;">48North entered
      into a warrant indenture dated as of April 2, 2019 with the Warrant Agent, as amended by the First Supplemental Indenture (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Indenture</font>&#8221;) providing for the issue of up to 10,569,880 common
      share purchase warrants of 48North (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrants</font>&#8221;), with each whole Warrant exercisable to acquire one (1) common share of 48North (each, a &#8220;<font style="font-size: 10pt; font-weight: bold;">48North


        Share</font>&#8221;) at an exercise price of C$1.72 per 48North Share at any time prior to 5:00 p.m. (Toronto time) on April 2, 2024;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS </font><font style="font-family: Arial;">on September
      1, 2021, 48North, HEXO and the Warrant Agent entered into a supplemental warrant indenture (the &#8220;<font style="font-size: 10pt; font-weight: bold;">First Supplemental Warrant Indenture</font>&#8221;) providing that upon exercise of the Warrants, a holder is
      entitled to receive, and shall accept in lieu of each 48North Share to which such holder was previously entitled upon exercise, 0.02366 of a common share in the capital of HEXO (each, a &#8220;<font style="font-size: 10pt; font-weight: bold;">HEXO Share</font>&#8221;);</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS, </font><font style="font-family: Arial;">effective as
      of 12:01 a.m. on June 22, 2023 (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Arrangement Effective Date</font>&#8221;), Tilray acquired all of the issued and outstanding HEXO Shares pursuant to a statutory plan of arrangement under the <font style="font-size: 10pt; font-style: italic;">Business Corporations Act </font>(Ontario) (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Plan of Arrangement</font>&#8221;), pursuant to which the holders of HEXO Shares received 0.4352 of a share
      of common stock in the capital of Tilray (each whole share, a &#8220;<font style="font-size: 10pt; font-weight: bold;">Common Share</font>&#8221;) for each HEXO Share held (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Tilray Share Consideration</font>&#8221;),


      subject to and in accordance with the Plan of Arrangement;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS, </font><font style="font-family: Arial;">the Plan of
      Arrangement constitutes a capital reorganization pursuant to the provisions of the Indenture (and in particular, Section 4.1(d) of the Indenture) such that, following the Arrangement Effective Date, upon exercise of the Warrants, a holder is entitled
      to receive, and shall accept in lieu of each HEXO Share to which such holder was previously entitled upon exercise, the Tilray Share Consideration;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS, </font><font style="font-family: Arial;">the
      provisions of the Indenture (and in particular Section 4.1(d) and Article 8 of the Indenture) provide that, upon the happening of a capital reorganization, a supplemental indenture setting forth the adjustments required as a result of the capital
      reorganization shall be entered into pursuant to the provisions of the Indenture;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS, </font><font style="font-family: Arial;">the parties
      hereto are therefore desirous of executing and delivering this second supplemental warrant indenture (this &#8220;<font style="font-size: 10pt; font-weight: bold;">Second Supplemental Warrant Indenture</font>&#8221;), which is a supplemental warrant indenture
      for the purposes of the Indenture;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS </font><font style="font-family: Arial;">Tilray has
      agreed to execute and deliver this Second Supplemental Warrant Indenture to, among other things, evidence its agreement to assume the Warrants and to deliver, upon valid exercise by a holder of the Warrants, the Tilray Share Consideration;</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">AND WHEREAS </font><font style="font-family: Arial;">the foregoing
      recitals are made as representations of 48North, Tilray and HEXO, and not by the Warrant Agent.</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">NOW THEREFORE, THIS SECOND SUPPLEMENTAL WARRANT INDENTURE WITNESSES
    </font><font style="font-family: Arial;">that for good and valuable consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged, it is hereby covenanted, agreed and declared as follows:</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">ARTICLE 1</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">INTERPRETATION</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc705950a51c34aaa9e5c981df9ead15f">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">1.1</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">To Be Read With Indenture</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">This Second Supplemental Warrant Indenture is supplemental to the Indenture and the Indenture shall henceforth be read in conjunction with this Second Supplemental
    Warrant Indenture and all provisions of the Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of the Indenture and of this Second
    Supplemental Warrant Indenture were contained in one instrument. Except as specifically amended by this Second Supplemental Warrant Indenture, all other terms and conditions of the Indenture shall remain in full force and unchanged.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">On and after the date hereof, each reference to the Indenture, as amended by this Second Supplemental Warrant Indenture, &#8220;<font style="font-size: 10pt; font-weight: bold;">this Warrant Indenture</font>&#8221;, &#8220;<font style="font-size: 10pt; font-weight: bold;">this Indenture</font>&#8221;, &#8220;<font style="font-size: 10pt; font-weight: bold;">herein</font>&#8221;, &#8220;<font style="font-size: 10pt; font-weight: bold;">hereby</font>&#8221;,
    and similar references, and each reference to the Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Indenture as amended hereby.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze2ce97ab7c9b42d291b4263fdc13add1">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">1.2</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Definitions</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">All terms which are defined in the Indenture and are used but not defined in this Second Supplemental Warrant Indenture shall have the meanings ascribed to them in
    the Indenture as such meanings may be amended or supplemented with respect to the Warrants by this Second Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the Indenture and the meaning given to
    the same term in this Second Supplemental Warrant Indenture, the meaning given to the term in this Second Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11ce4e5547c54114ae2b97bc82f4d43d">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">1.3</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Headings, etc.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The division of this Second Supplemental Warrant Indenture into articles, sections, subsections and paragraphs, and the insertion of headings are for convenience of
    reference only and shall not affect the construction or interpretation hereof. Unless the context otherwise requires, &#8220;<font style="font-size: 10pt; font-weight: bold;">this Second Supplemental Warrant Indenture&#8221;, &#8220;hereto&#8221;, &#8220;hereby&#8221;, &#8220;hereunder&#8221;,
      &#8220;hereof&#8221;, &#8220;herein</font>&#8221; and similar expressions refer to this Second Supplemental Warrant Indenture and not to any particular article, section, subsection, paragraph or other portion hereof, and include any and every instrument which amends this
    Second Supplemental Warrant Indenture or is supplemental or ancillary hereto or in implementation hereof.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">ARTICLE 2</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">AMENDMENTS TO INDENTURE</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za5c1242f55674b45b90fc866f6bfee0e">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">2.1</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Exchange Basis</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Each of 48North, HEXO, Tilray and the Warrant Agent hereby acknowledge and agree that, as and from the date hereof, in accordance with the terms of the Indenture
    and as a result of the Plan of Arrangement, any Warrantholder who exercises that holder&#8217;s right to receive HEXO Shares pursuant to the Warrant(s) shall be entitled to receive, and shall accept in lieu of the number of HEXO Shares to which such holder
    was previously entitled upon such exercise and for the same consideration, the Tilray Share Consideration, subject to adjustment in accordance with the terms of the Indenture (for greater certainty, following the Arrangement Effective Date, each
    Warrant will become exercisable for 0.00073549 of a Common Share). Tilray hereby covenants, acknowledges and agrees that, as and from the Arrangement Effective Date, Tilray shall make available or cause to be made available the Common Shares in
    accordance with and subject to the terms of the Indenture and this Supplemental Warrant Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80160fd4085347a088e930e1fa6893c0">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">2.2</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Express Assumption of Rights, Duties and Obligations</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z825023f3462245318f3d2839c62d54a7">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(a)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Tilray covenants, acknowledges and agrees that, as and from the date hereof, it is bound by the provisions of the Indenture and shall cause HEXO or 48North, as the case may be, to comply with all
            covenants and obligations contained in the Indenture to be performed by HEXO or 48North, as the case may be.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6613b5c8c3834b4087172931057cce86">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(b)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Each of 48North, Tilray and HEXO agree to do, execute and deliver all such further acts, instruments and documents as may be necessary to give effect to the transfer, assignment and assumption
            herein provided for.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z163799e44cc74f8dba29485f6fffcc55">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(c)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">HEXO covenants, acknowledges and agrees to promptly remit to Tilray the Exercise Price per Warrant validly exercised upon receipt of payment thereof (or, alternatively in lieu thereof at Tilray&#8217;s
            direction, to cause the Exercise Price per Warrant payable upon the valid exercise thereof to be paid or made payable directly to Tilray).</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaee73f0261e34c0ea8843f43fec5df25">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(d)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Notwithstanding any of the foregoing, the resignation, discharge, appointment, transfers, assignments and other agreements provided for herein will not be effective unless this Second Supplemental
            Warrant Indenture has been executed by all of the parties hereto, whether upon the original instrument, by facsimile or in counterparts, or any combination thereof, and unless all preconditions to such resignation, discharge, appointment,
            transfers, assignments and other agreements as may be set forth in the Indenture have been fulfilled.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9aff64b9b394429f98616322e91420b7">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(e)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Notwithstanding anything in the Indenture, 48North, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued following the Arrangement Effective Date without the prior
            written consent of Tilray.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb60dcd33c3374c969d8200308133a9ba">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">2.3</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Specific Amendments</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Effective as of the Arrangement Effective Date, the following specific amendments are made to the following provisions of the Indenture:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1e9c5472a214c1290a3ca750d0d3f74">

      <tr>
        <td style="width: 57.5pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(a)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">The following recital of the Indenture is hereby deleted in its entirety:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">&#8220;Each Warrant entitles the holder thereof to purchase, subject to acceleration and adjustment in certain events, 0.02366 of a Common Share (as defined below) at a
    price equal to the Exercise Price (as defined below) at any time prior to 5:00 p.m. (Toronto time) on April 2, 2024;&#8221;</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">and replaced with the following:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">&#8220;Each Warrant entitles the holder thereof to purchase, subject to acceleration and adjustment in certain events, 0.00073549 of a Common Share (as defined below) at
    a price equal to the Exercise Price (as defined below) at any time prior to 5:00 p.m. (Toronto time) on April 2, 2024;&#8221;</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z896ce0c976fc4484b1d7b0639adb7477">

      <tr>
        <td style="width: 57.5pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(b)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 1.1 of the Indenture is amended by:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ebbfce66996482b917e2399e83578c3">

      <tr>
        <td style="width: 90pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 31.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(1)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Adding the following definition of &#8220;<font style="font-size: 10pt; font-weight: bold;">Arrangement Effective Date</font>&#8221;: &#8220;<font style="font-size: 10pt; font-weight: bold;">Arrangement Effective
              Date</font>&#8221; means June 22, 2023.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb6967c352a064dfb9d4e5a0a7e31330b">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(2)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Deleting the definition of &#8220;<font style="font-size: 10pt; font-weight: bold;">Common Shares</font>&#8221; and replacing it with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 121.5pt; font-family: Arial; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-weight: bold;">Common Shares</font>&#8221; means, subject to Article 4, fully paid and non-assessable shares of common stock in the
    capital of Tilray Brands, Inc. as presently constituted.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfcaa157c07a247e88e520dd1e199fcdb">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(3)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Deleting the definition of &#8220;<font style="font-size: 10pt; font-weight: bold;">Exercise Price</font>&#8221; and replacing it with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 121.5pt; font-family: Arial; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-weight: bold;">Exercise Price</font>&#8221; at any time means the price at which 0.00073549 of a Common Share may be purchased by
    the exercise of a whole Warrant, which at the Arrangement Effective Date is $1.72, payable in immediately available Canadian funds, subject to adjustment in accordance with the provisions of Article 4 hereof.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z20d5a847665e4ba8bee02ce319c15a25">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(4)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Adding the following definition of <font style="font-size: 10pt; font-weight: bold;">&#8220;Plan of Arrangement&#8221;:</font></div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 121.5pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">&#8220;Plan of Arrangement&#8221; </font><font style="font-family: Arial;">means


      the plan of arrangement attached hereto as Schedule &#8220;D&#8221;, as amended, modified or supplemented from time to time in accordance with the terms thereof.</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z738acb58f0be4f67aad3151664927b09">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(5)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Adding the following definition of &#8220;<font style="font-size: 10pt; font-weight: bold;">Tilray</font>&#8221;:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 121.5pt; font-family: Arial; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-weight: bold;">Tilray</font>&#8221; means Tilray Brands, Inc., a company existing under the laws of Delaware.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za333bb0ff527428abc2be39dcd49fa2b">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(6)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Adding the following definition of <font style="font-size: 10pt; font-weight: bold;">&#8220;Tilray&#8217;s Transfer Agent&#8221;:</font></div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 121.5pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">&#8220;Tilray&#8217;s Transfer Agent&#8221; </font><font style="font-family: Arial;">means



      Pacific Stock Transfer Company and Odyssey Trust Company.</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbaba03e17484bd79d141d00ea4406c9">

      <tr>
        <td style="width: 89pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.5pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(7)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Deleting the definition of &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrants</font>&#8221; and replacing it with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 121.5pt; font-family: Arial; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-weight: bold;">Warrants</font>&#8221; means the Common Share purchase warrants created by and authorized by and issuable under this
    Indenture, each to be issued and Authenticated hereunder as a Certificated Warrant or Uncertificated Warrant, with each Warrant entitling the holder thereof to purchase 0.00073549 of a Common Share (subject to adjustment as herein provided) per Warrant
    at the Exercise Price prior to the Expiry Time; and</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb97c0ba7e9e048ab9de0c8535eb135ac">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(d)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.2(1) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Subject to the applicable conditions for exercise set out in Article 3 having been satisfied and subject to adjustment in accordance with Article 4, each Warrant
    shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire 0.00073549 of a Common Share upon payment of the Exercise Price in cash (being an effective Exercise Price of $2,338.58
    per Common Share).</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z50479c81adb543328ef7629b2780b673">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(e)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.2(2) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">No fractional Warrants shall be issued or otherwise provided for hereunder and Warrants may only be exercised in a sufficient number to acquire whole numbers of
    Common Shares. Any fractional Common Shares that Tilray may otherwise be required to issue upon exercise of Warrants pursuant to Section 3.1 shall be rounded down to the nearest whole number and no consideration shall be paid for any such fractional
    Common Shares. Any fractional Warrants shall be rounded down to the nearest whole number and no consideration shall be paid for any such fractional Warrant.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb9e4e4daeaff44b19b6e4ce14b8f3980">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(f)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.2(5) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">If, at any time prior to the Expiry Date, the volume weighted average trading price of the Common Shares on the TSX equals or exceeds $4,486.82 per Common Share for
    10 consecutive Trading Days, the Corporation may, within 10 days of the occurrence of such event, deliver written notice to the holders of Warrants and to the Warrant Agent, supplemented by way of a press release issued by the Corporation, accelerating
    the Expiry Date to the date that is 30 days following the date of such notice (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Accelerated Expiry Date</font>&#8221;). Any unexercised Warrants shall automatically expire at the end of the Accelerated
    Expiry Date.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z124c0b2b366f4a3ab996f3d09ed12def">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(g)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.3 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z797819b2509c4e95ac280965f117fcdc">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(h)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.9(2) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf9419185dabd4dea90b4a27f9d04e4bb">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(i)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 2.12(3) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Subject to the provisions of this Indenture and applicable law, the Warrantholder shall be entitled to the rights and privileges attaching to the Warrants, and the
    issue of Common Shares by Tilray upon the exercise of Warrants in accordance with the terms and conditions herein contained shall discharge all responsibilities of the Corporation, HEXO, Tilray and the Warrant Agent with respect to such Warrants and
    none of the Corporation, HEXO, Tilray and the Warrant Agent shall be bound to inquire into the title of any such holder.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za39e0fd497ae4771883308d2aad5de6c">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(j)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.1 of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Subject to the provisions hereof, each Registered Warrantholder may exercise the right conferred on such holder to subscribe for and purchase 0.00073549 of a Common
    Share for each Warrant after the Arrangement Effective Date and prior to the Expiry Time, subject to adjustment and acceleration, and in accordance with the conditions herein.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za16909d70ce74189947416b56a5769d1">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: normal;">(k)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.2(4) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">A beneficial holder of Uncertificated Warrants evidenced by a security entitlement in respect of Warrants in the book entry registration system who desires to
    exercise his or her Warrants must do so by causing a Book Entry Only Participant to deliver to the Depository on behalf of the entitlement holder, notice of the owner&#8217;s intention to exercise Warrants in a manner acceptable to the Depository. Forthwith
    upon receipt by the Depository of such notice, as well as payment for the aggregate Exercise Price, the Depository shall deliver to the Warrant Agent and Tilray&#8217;s Transfer Agent confirmation of its intention to exercise Warrants (&#8220;<font style="font-size: 10pt; font-weight: bold;">Confirmation</font>&#8221;) in a manner acceptable to the Warrant Agent and Tilray&#8217;s Transfer Agent, including by electronic means through the book entry registration system. An electronic exercise of the
    Warrants initiated by the Book Entry Only Participant through a book based registration system, including CDSX, shall constitute a representation to the Corporation, HEXO, Tilray, Tilray&#8217;s Transfer Agent and the Warrant Agent that the beneficial owner
    at the time of exercise of such Warrants: (i)(A) is not in the United States; (B) is not a U.S. Person and is not exercising such Warrants on behalf of a U.S. Person or a person in the United States; (C) did not acquire the Warrants in the United
    States or on behalf of, or for the account or benefit of, a U.S. Person or a person in the United States; (D) did not receive an offer to exercise the Warrants in the United States; (E) did not execute or deliver the notice of the owner&#8217;s intention to
    exercise such Warrants in the United States; and (F) has, in all other respects, complied with the terms of Regulation S under the U.S. Securities Act in connection with such exercise, or (ii) is a U.S. Purchaser exercising the Warrants for its own
    account and not for the benefit of any other person, and that the representations and warranties made by the U.S. Purchaser in the U.S. subscription letter delivered to the Corporation at the time of the original issuance of the Warrants remain true
    and correct. If the Book Entry Only Participant is not able to make or deliver the foregoing representation by initiating the electronic exercise of the Warrants, then (a) such Warrants shall be withdrawn from the book based registration system,
    including CDSX, by the Book Entry Only Participant; (b) an individually registered Warrant Certificate shall be issued by the Warrant Agent to such beneficial holder of the Uncertificated Warrants or Book Entry Only Participant and (c) the exercise
    procedures set forth in Section 3.2(1) shall be followed.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b97e37313564c0ebf3afdce6392d506">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(l)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.2(5) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Payment representing the aggregate Exercise Price must be provided to the appropriate office of the Book Entry Only Participant in a manner acceptable to it. A
    notice in form acceptable to the Book Entry Only Participant and payment from such beneficial holder should be provided to the Book Entry Only Participant sufficiently in advance so as to permit the Book Entry Only Participant to deliver notice and
    payment to the Depository and for the Depository in turn to deliver notice and payment to the Warrant Agent prior to the Expiry Time. The Depository will initiate the exercise by way of the Confirmation and forward the Exercise Price electronically to
    the Warrant Agent, and Tilray&#8217;s Transfer Agent will execute the exercise by issuing to the Depository through the book entry registration system the Common Shares to which the exercising Warrantholder is entitled pursuant to the exercise. Any expense
    associated with the exercise process will be for the account of the entitlement holder exercising the Warrants and/or the Book Entry Only Participant exercising the Warrants on its behalf.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9b7379b53f5845a4ac4c2e038357237f">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(m)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.2(7) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Any notice which the Depository determines to be incomplete, not in proper form or not duly executed shall for all purposes be void and of no effect and the
    exercise to which it relates shall be considered for all purposes not to have been exercised thereby. A failure by a Book Entry Only Participant to exercise or to give effect to the settlement thereof in accordance with the Warrantholder&#8217;s instructions
    will not give rise to any obligations or liability on the part of the Corporation, HEXO, Tilray, Tilray&#8217;s Transfer Agent or Warrant Agent to the Book Entry Only Participant or the Warrantholder.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za689a0db00ad452490095aff3e098864">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(n)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.3(3) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Common Shares issued upon the exercise of any Certificated Warrant which bears the legend set forth in Section 2.8(1), other than an exercise pursuant to Box A of
    the Exercise Notice attached as Schedule &#8220;B&#8221; hereto, shall be issued in certificated form and, upon such issuance, shall bear the following legend (the &#8220;<font style="font-size: 10pt; font-weight: bold;">U.S. Common Share Legend</font>&#8221;):</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">&#8220;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;<font style="font-size: 10pt; font-weight: bold;">U.S. SECURITIES ACT</font>&#8221;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF TILRAY BRANDS, INC. (THE &#8220;<font style="font-size: 10pt; font-weight: bold;">CORPORATION</font>&#8221;) THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT
    AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY (1) RULE 144 THEREUNDER, IF AVAILABLE, OR (2) RULE 144A THEREUNDER, IF AVAILABLE, AND, IN
    BOTH CASES, IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR (D) IN ANOTHER TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF (C)(1) OR (D) ABOVE, AFTER THE
    SELLER FURNISHES TO THE CORPORATION AND THE TRANSFER AGENT AN OPINION OF COUNSEL OF RECOGNIZED STANDING OR SUCH OTHER EVIDENCE IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT. DELIVERY OF THIS CERTIFICATE MAY NOT
    CONSTITUTE &#8220;GOOD DELIVERY&#8221; IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA.&#8221;</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">provided, that, if any such securities are being sold in accordance with the requirements of Rule 904 of Regulation S, and in compliance with local laws and
    regulations, the legend set forth above may be removed by the transferor providing an executed declaration to Tilray&#8217;s Transfer Agent and Tilray in the form set forth in Schedule &#8220;C&#8221; hereto (or as Tilray may prescribe from time to time);</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">notwithstanding the foregoing, the Tilray&#8217;s Transfer Agent may impose additional requirements for the removal of legends from securities sold in accordance with
    Rule 904 of Regulation S in the future; and</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">provided, further, that, if any such securities are being sold pursuant to Rule 144 under the U.S. Securities Act, if available, or in another transaction that does
    not require registration under the U.S. Securities Act or applicable state securities laws, the legend may be removed by delivery to Tilray and Tilray&#8217;s Transfer Agent of an opinion of counsel of recognized standing, in form and substance reasonably
    satisfactory to Tilray and Tilray&#8217;s Transfer Agent, to the effect that such legend is no longer required under applicable requirements of the U.S. Securities Act or state securities laws.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z538a170fb56740a590aba29747e5f09e">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(o)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.3(4) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7fe64dec71e349a696827f77bc101654">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(p)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.4 of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">If any of the Common Shares subscribed for are to be issued to a person or persons other than the Registered Warrantholder, the Registered Warrantholder shall
    execute the form of transfer and will comply with such reasonable requirements as the Warrant Agent may stipulate and will pay to the Corporation or the Warrant Agent on behalf of the Corporation all applicable transfer or similar taxes and Tilray will
    not be required to issue or deliver certificates evidencing Common Shares unless or until such Warrantholder shall have paid to the Corporation or the Warrant Agent on behalf of the Corporation the amount of such tax or shall have established to the
    satisfaction of the Corporation and the Warrant Agent that such tax has been paid or that no tax is due.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9095c50ef8ed41dfacdb8685506df5f5">

      <tr>
        <td style="width: 57.55pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.45pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(q)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.7(2) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Notwithstanding anything herein contained including any adjustment provided for in Article 4 hereof, Tilray shall not be required, upon the exercise of any
    Warrants, to issue fractions of Common Shares. Warrants may only be exercised in a sufficient number to acquire whole numbers of Common Shares. Any fractional Common Shares that Tilray may otherwise be required to issue upon exercise of Warrants
    pursuant to Section 3.1 shall be rounded down to the nearest whole number and the holder of such Warrants shall not be entitled to any compensation in respect of any fractional Common Shares which is not issued.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15b20e30b216444db3a67ffadb09c66a">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(r)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 3.10 of the Indenture is amended so that the reference to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdb7cb710f4d44a34b22d874f36ec458b">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(s)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.1(a) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc50fe632c05c4418aa8a7241ff699945">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(t)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.1(b) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f2af8076f884be091e117922385ed2f">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(u)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.1(c) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6f314550b3747bcb421ea61f2bca1f3">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(v)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.1(d) of the indenture is amended so that (1) the references to &#8220;the Corporation&#8221; therein (other than references to &#8220;the Corporation&#8221; for those phrases excepted in subparagraph (2) of
            this subsection) shall refer to &#8220;Tilray&#8221;, and (2) notwithstanding the foregoing subparagraph (1) of this subsection, (i) the reference to &#8220;the Corporation, its successor, or such purchasing body corporate&#8221; therein shall refer to &#8220;the
            Corporation, Tilray, their respective successors, or such purchasing body corporate&#8221;, (ii) the reference to &#8220;the Corporation and the Warrant Agent&#8221; therein shall refer to &#8220;the Corporation, Tilray and the Warrant Agent&#8221;, and (iii) the reference
            to &#8220;the Corporation, any successor to the Corporation or such purchasing body corporate&#8221; therein shall refer to &#8220;the Corporation, Tilray, any successor to the Corporation or Tilray, or such purchasing body corporate&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb5479309759c45cabe35bcdbde165570">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(w)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.1(e) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1bd52620e1c5498082726254dbba2447">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(x)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.3 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z770ea0c94e364245a3a59c4e38e0b0b1">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(y)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.4 of the Indenture is amended so that the first and second references to &#8220;the Corporation&#8221; therein shall refer to &#8220;the Corporation and Tilray&#8221; and the third reference to &#8220;the
            Corporation, the Warrant Agent, all holders and all other persons&#8221; therein shall refer to &#8220;the Corporation, Tilray, the Warrant Agent, all holders and all other persons&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z608c344a30654905b2a7032dc553c20d">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(z)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.5 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c831346cdc74038a44d16d24e186ceb">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(aa)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.6 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1542289dc2c545b2ad75f37e45bd62e4">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(bb)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.7 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc87ab8e16618421aa55f2602ff979c5a">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(cc)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.8 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z04af725c2c9f42acb624d8ab4c409088">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(dd)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.9 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z597b44c5384e426598ec7c4e71d32797">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(ee)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 4.10 of the Indenture is amended so that references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z192ac3ae9e0c4d88b96369727c335c99">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(ff)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 5.2 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as applicable&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ec416f1bc644bdc9324ae4e284ff00c">

      <tr>
        <td style="width: 57.6pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(gg)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 5.4 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation and Tilray, as applicable&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8aad5852e172488db507a3f498385a19">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(hh)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 5.5 of the Indenture is amended so that the last reference to &#8220;the Corporation&#8221; therein refers to &#8220;Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze2056f58701840cab9607ee1b8ff6ec6">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(ii)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 5.6 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation and Tilray, as applicable&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce9e0b5e442c4d4c963ee816ebe5c522">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(jj)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 6.2 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation and Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z89c149d1524647b8acfde252626e21cc">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(kk)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 6.3 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation and Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf11cb5ad7e044f5a18c62ebb01c9787">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(ll)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 8.1 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c012d3028074448a7fb51e686b6fccc">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(mm)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 8.2 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as the case may be&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze6720787d0d04219b7fff3d4648b2af6">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(nn)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 9.1 of the indenture is amended so that the reference to &#8220;The Corporation and the Warrant Agent&#8221; therein shall refer to &#8220;The Corporation, Tilray and the Warrant Agent&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38fc036a89524f4c9a82ea5d0a6e6a18">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(oo)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 9.3 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as applicable&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z22aa149e3c3d41b59fd05f7998c96be9">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(pp)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 9.7 of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation and Tilray&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za2a6da762c8648d69de1c5579cc678c1">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(qq)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 10.1(1) of the Indenture is amended so that the references to &#8220;the Corporation&#8221; therein refer to &#8220;the Corporation or Tilray, as applicable&#8221;.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf637898a23d84a4cb4db738956e2b2df">

      <tr>
        <td style="width: 54pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(rr)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">Section 10.1(1)(a) of the Indenture is deleted and replaced with the following:</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">&#8220;If to the Corporation or Tilray:</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Tilray Brands, Inc.</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">655 Madison Avenue</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">19th Floor</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">New York, New York 10065</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Attention: Mitchell Gendel</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Email: <font style="font-size: 10pt;"><u>mitchell.gendel@tilray.com</u></font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">With a copy (which will not constitute notice) to:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">DLA Piper (Canada) LLP</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Suite 6000, 1 First Canadian Place</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">PO Box 367, 100 King Street West</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Toronto, ON</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">M5X 1E2</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Attention: Russel Drew</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Email: <font style="font-size: 10pt;">russel.drew@dlapiper.com</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">If to Tilray&#8217;s Transfer Agent:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Pacific Stock Transfer Company</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">6725 Via Austi Pkwy, Suite 300</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Las Vegas, Nevada 89119</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Attention: Maria Torres</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Email: <font style="font-size: 10pt;">MTorres@pacificstocktransfer.com</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">and to:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Odyssey Trust Company</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">United Kingdom Building</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">350 &#8211; 409 Granville Street</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Vancouver BC V6C 1T2</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Attention: Paul Keyes</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 90pt; font-family: Arial; font-size: 10pt;">Email: PKeyes@OdysseyTrust.com</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z210a33e563754eb99f772bfb0ad939f2">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">2.4</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Form of Warrant</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The form of Warrant attached as Schedule &#8220;A&#8221; to the Indenture is hereby amended and from the date hereof is the form of Warrant attached as Schedule &#8220;A&#8221; to this
    Supplemental Warrant Indenture, and all Warrants issued after the date hereof shall be in such form. All Warrants issued and outstanding shall be deemed to include the amendments as per Schedule &#8220;A&#8221;.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">ARTICLE 3</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">MISCELLANEOUS</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf1e0a5b400a641edbeb1ae8a3760af7f">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">3.1</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Acceptance of Trust</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The Warrant Agent accepts the agencies in this Second Supplemental Warrant Indenture and agrees to carry out and discharge the same upon the terms and conditions
    set out in this Second Supplemental Warrant Indenture and in accordance with the Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z290de114a7cc480ba2aae9975623cb2c">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">3.2</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Confirmation of Indenture</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The Indenture as amended and supplemented by this Second Supplemental Warrant Indenture, is hereby confirmed and approved.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2ea271d9d4e34f5484c1c2abb869230d">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">3.3</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Governing Law</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">This Second Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of Ontario and the federal laws of
    Canada applicable therein and shall be binding upon the parties hereto and their respective successors and assigns.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8f02f1ba4935440dab7991b9ff7e140e">

      <tr>
        <td style="width: 53.95pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 36.05pt; vertical-align: top; font-family: Arial; font-size: 10pt; font-weight: bold;">3.4</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt; font-weight: bold;">Counterparts</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">This Second Supplemental Warrant Indenture may be executed in counterparts, each of which so executed shall be deemed to be an original, and each of such
    counterparts when taken together shall constitute one and the same instrument and notwithstanding their date of execution they shall be deemed to be dated as of the date hereof. Delivery of an executed copy of this Second Supplemental Warrant Indenture
    by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Indenture as of the date hereof.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-style: italic; font-weight: bold;">[Remainder of page intentionally left blank. Signature page follows.]</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">IN WITNESS WHEREOF </font><font style="font-family: Arial;">the
      parties hereto have executed this Second Supplemental Warrant Indenture under the hands of their proper signatories in that behalf.</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z44dba44e2d1644c8a7ea9b6482ec5c12">

      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="3" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">48NORTH CANNABIS CORP.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt;">/s/ Joelle Maurais</font></div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Name:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Joelle Maurais</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Title:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">President</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;">I have authority to bind the company</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="3" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">TILRAY BRANDS, INC.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">/s/ Mitchell Gendel</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Name:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Mitchell Gendel</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Title:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Global General Counsel</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;">I have authority to bind the company</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="3" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">HEXO CORP.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">/s/ Rob Godfrey</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Name:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Rob Godfrey</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Title:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Director</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;">I have authority to bind the company</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="3" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">COMPUTERSHARE TRUST COMPANY OF CANADA</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td colspan="2" rowspan="1" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">/s/ Brian Howarth</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Name:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Brian Howarth</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Title:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Manager, Corporate Trust</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;">I have authority to bind the company</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 41%; vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td colspan="2" rowspan="1" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">/s/ Alan Zhang</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Name:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Alan Zhang</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 6%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Title:</div>
        </td>
        <td style="width: 41%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Associate Trust Officer</div>
        </td>
      </tr>
      <tr>
        <td style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="1" style="vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-style: italic;">I have authority to bind the company</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">SCHEDULE &#8220;A&#8221;</div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">FORM OF WARRANT</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">THE WARRANTS EVIDENCED HEREBY ARE EXERCISABLE AT OR BEFORE 5:00 P.M. (TORONTO TIME) ON APRIL 2, 2024, AFTER WHICH TIME THE WARRANTS EVIDENCED HEREBY SHALL BE DEEMED
    TO BE VOID AND OF NO FURTHER FORCE OR EFFECT. CERTAIN ADJUSTMENTS HAVE BEEN MADE TO THIS FORM OF WARRANT TO REFLECT AND GIVE EFFECT TO THE PLAN OF ARRANGEMENT INVOLVING THE ACQUISITION OF ALL OF THE COMMON SHARES OF HEXO CORP. BY TILRAY BRANDS, INC.
    WITH AN EFFECTIVE DATE OF JUNE 22, 2023 (THE &#8220;<font style="font-size: 10pt; font-weight: bold;">ARRANGEMENT</font>&#8221;).</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">For all Warrants sold outside the United States and to &#8220;qualified institutional buyers&#8221; (as defined in Rule 144A under the United States Securities Act of 1933, as
    amended (the &#8220;<font style="font-size: 10pt; font-weight: bold;">U.S. Securities Act</font>&#8221;)); registered in the name of the Depository, then include the following legend:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">(<font style="font-size: 10pt; font-weight: bold;">INSERT IF BEING ISSUED TO CDS</font>) UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF CDS
    CLEARING AND DEPOSITORY SERVICES INC. (&#8220;<font style="font-size: 10pt; font-weight: bold;">CDS</font>&#8221;) TO 48NORTH CANNABIS CORP. (THE &#8220;<font style="font-size: 10pt; font-weight: bold;">ISSUER</font>&#8221;) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE
    OR PAYMENT, AND ANY CERTIFICATE ISSUED IN RESPECT THEREOF IS REGISTERED IN THE NAME OF CDS &amp; CO., OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS (AND ANY PAYMENT IS MADE TO CDS &amp; CO. OR TO SUCH OTHER ENTITY AS IS
    REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED HOLDER HEREOF, CDS &amp; CO., HAS A PROPERTY INTEREST IN THE SECURITIES REPRESENTED
    BY THIS CERTIFICATE HEREIN AND IT IS A VIOLATION OF ITS RIGHTS FOR ANOTHER PERSON TO HOLD, TRANSFER OR DEAL WITH THIS CERTIFICATE.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-style: italic;">For Warrants sold in the United States to U.S. &#8220;accredited
      investors&#8221; (within the meaning assigned in Rule 501(a) of Regulation D under the U.S. Securities Act) that are not also &#8220;qualified institutional buyers&#8221; </font><font style="font-family: Arial;">(as defined in Rule 144A under the U.S. Securities Act)<font style="font-size: 10pt; font-style: italic;">, include the following legend:</font></font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT
    OF 1933, AS AMENDED (THE &#8220;U.S. SECURITIES ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF 48NORTH CANNABIS CORP. (THE &#8220;CORPORATION&#8221;) THAT SUCH SECURITIES MAY
    BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) IN
    COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY (1) RULE 144 THEREUNDER, IF AVAILABLE, OR (2) RULE 144A THEREUNDER, IF AVAILABLE, AND, IN BOTH CASES, IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR (D)
    IN ANOTHER TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS AND, IN THE CASE OF (C)(1) OR (D) ABOVE, AFTER THE SELLER FURNISHES TO THE CORPORATION AND THE WARRANT AGENT AN OPINION OF
    COUNSEL OF RECOGNIZED STANDING OR SUCH OTHER EVIDENCE IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE &#8220;GOOD DELIVERY&#8221; IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN
    CANADA.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">POST-ARRANGEMENT WARRANT OF 48NORTH CANNABIS CORP.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt;">To acquire, upon and after the exercise thereof, Common Shares of</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt; font-weight: bold;">TILRAY BRANDS, INC.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: center; margin-left: 54pt; font-family: Arial; font-size: 10pt;">(incorporated pursuant to the laws of the State of Delaware)</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze9ead8621bb3458185a80ae5941f2ce5">

      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 25%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Warrant Certificate No. [&#9744;]</div>
        </td>
        <td style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Certificate for <u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;</u> <u>&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160; </u>Warrants, each entitling the holder thereof to acquire, post-
            Arrangement, 0.00073549 of a share of common stock in the capital of Tilray Brands, Inc. (subject to adjustment as provided for in the Warrant Indenture (as defined below))</div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 25%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 25%; vertical-align: top;">
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Arial;"><br>
            </font> </div>
        </td>
        <td style="vertical-align: top;">
          <div style="text-align: left; font-family: Wingdings; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;">CUSIP [</font><font style="color: rgb(32, 33, 36); font-family: Arial; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: nowrap; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#9985;&#9985;&#9985;</font><font style="font-size: 10pt; font-family: Arial;">]</font></div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 25%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 25%; vertical-align: top;">
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Arial;"><br>
            </font> </div>
        </td>
        <td style="vertical-align: top;">
          <div style="text-align: left; font-family: Wingdings; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial;">ISIN [</font><font style="color: rgb(32, 33, 36); font-family: Arial; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: nowrap; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#9985;&#9985;&#9985;</font><font style="font-size: 10pt; font-family: Arial;">]</font></div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;"><font style="font-size: 10pt; font-weight: bold;"> <br>
    </font></div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">THIS IS TO CERTIFY THAT</font><font style="font-family: Arial;">,
      for value received,</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="z05a4bcbb56a5454dac465554a0789279" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 54pt; padding-bottom: 2px;">
            <div style="font-family: Arial;">&#160;</div>
          </td>
          <td style="border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-family: Arial;">&#160;</div>
          </td>
        </tr>

    </table>
  </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">(the &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrantholder</font>&#8221;) is the registered holder of the number of common share purchase warrants (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrants</font>&#8221;) of 48North Cannabis Corp. (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Corporation</font>&#8221;) specified above, and is entitled, upon exercise of these Warrants upon and subject to
    the terms and conditions set forth herein and in the warrant indenture dated as of April 2, 2019 (which indenture, together with the first supplemental warrant indenture dated September 1, 2021 among HEXO Corp. (&#8220;<font style="font-size: 10pt; font-weight: bold;">HEXO</font>&#8221;), the Corporation and Computershare Trust Company of Canada, as Warrant Agent, the second supplemental warrant indenture dated June 22, 2023 among the Corporation,&#160; HEXO, Tilray Brands, Inc. (&#8220;<font style="font-size: 10pt; font-weight: bold;">Tilray</font>&#8221;) and the Warrant Agent and all other instruments supplemental or ancillary thereto is herein referred to as the &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrant Indenture</font>&#8221;), to purchase at any
    time before 5:00 p.m. (Toronto time) (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Expiry Time</font>&#8221;) on April 2, 2024 (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Expiry Date</font>), 0.00073549 of a share of common stock in the
    capital of Tilray (each whole share, a &#8220;<font style="font-size: 10pt; font-weight: bold;">Common Share</font>&#8221;), subject to adjustment in accordance with the terms of the Warrant Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Effective on June 22, 2023 (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Arrangement Effective Date</font>&#8221;), Tilray acquired all of the issued and
    outstanding common shares of HEXO. Tilray has entered into the second supplemental warrant indenture dated June 22, 2023 among the Corporation, HEXO, Tilray and Computershare Trust Company of Canada, as Warrant Agent, and it has assumed the obligations
    of the Corporation and HEXO under the Warrant Indenture and, accordingly, any Warrantholder who exercises a Warrant shall be entitled to receive, and shall accept in lieu of each common share in the capital of HEXO to which such holder was previously
    entitled and for the same consideration, 0.00073549 of a Common Share for the Exercise Price (as defined below), subject to adjustment in accordance with the terms of the Warrant Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">If, at any time prior to the Expiry Date, the volume weighted average trading price of the Common Shares on the TSX equals or exceeds $4,486.82 per Common Share for
    a period of at least 10 consecutive Trading Days, the Corporation shall be entitled, within 10 days of the occurrence of such event, to deliver a written notice to the Warrantholders and to the Warrant Agent, supplemented by way of a press release
    issued by the Corporation, accelerating the Expiry Date of the Warrants to the date that is 30 days following the date of such notice (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Accelerated Expiry Date</font>&#8221;). Any unexercised Warrants
    shall automatically expire at the end of the Accelerated Expiry Date.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: left; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The right to purchase Common Shares may only be exercised by the Warrantholder within the time set forth above by:</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z15345151bab94cafb3a6bf9c4bbd2de0">

      <tr>
        <td style="width: 89.1pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(a)</td>
        <td style="width: auto; vertical-align: top; text-align: left;">
          <div style="font-family: Arial; font-size: 10pt;">duly completing and executing the exercise form (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Exercise Form</font>&#8221;) attached hereto; and</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa276947096841e69a54d71b4bbc9e63">

      <tr>
        <td style="width: 89.1pt;"><font style="font-family: Arial;"><br>
          </font> </td>
        <td style="width: 32.4pt; vertical-align: top; font-family: Arial; font-size: 10pt;">(b)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="font-family: Arial; font-size: 10pt;">surrendering this warrant certificate (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Warrant Certificate</font>&#8221;), with the Exercise Form to the Warrant Agent at the principal office of
            the Warrant Agent, in the City of Vancouver or the City of Toronto, together with a certified cheque, bank draft or money order in the lawful money of Canada payable to or to the order of the Corporation in an amount equal to the purchase price
            of the Common Shares so subscribed for.</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The surrender of this Warrant Certificate, the duly completed Exercise Form and payment as provided above will be deemed to have been effected only on personal
    delivery thereof to, or if sent by mail or other means of transmission on actual receipt thereof by, the Warrant Agent at its principal office as set out above.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Subject to adjustment thereof in the events and in the manner set forth in the Warrant Indenture hereinafter referred to, the exercise price payable for 0.00073549
    of a Common Share upon the exercise of each Warrant shall be $1.72 (the &#8220;<font style="font-size: 10pt; font-weight: bold;">Exercise Price</font>&#8221;).</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Certificates for the Common Shares subscribed for will be mailed to the persons specified in the Exercise Form at their respective addresses specified therein or,
    if so specified in the Exercise Form, delivered to such persons at the office where this Warrant Certificate is surrendered. If fewer Common Shares are purchased than the number that can be purchased pursuant to this Warrant Certificate, the holder
    hereof will be entitled to receive without charge a new Warrant Certificate in respect of the balance of the Common Shares not so purchased. No fractional Common Shares will be issued upon exercise of any Warrant. Any fractional Warrants shall be
    rounded down to the nearest whole number and no consideration shall be paid for any such fractional Warrant.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">This Warrant Certificate evidences Warrants of the Corporation issued or issuable under the provisions of the Warrant Indenture to which Warrant Indenture reference
    is hereby made for particulars of the rights of the holders of Warrants, the Corporation and the Warrant Agent in respect thereof and the terms and conditions on which the Warrants are issued and held, all to the same effect as if the provisions of the
    Warrant Indenture were herein set forth, to all of which the holder, by acceptance hereof, assents. Capitalized terms used but not defined in the Warrant Certificate have the meanings ascribed thereto in the Warrant Indenture. The Corporation will
    furnish to the holder, on request and without charge, a copy of the Warrant Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">On presentation at the principal office of the Warrant Agent as set out above, subject to the provisions of the Warrant Indenture and on compliance with the
    reasonable requirements of the Warrant Agent, one or more Warrant Certificates may be exchanged for one or more Warrant Certificates entitling the holder thereof to purchase in the aggregate an equal number of Common Shares as are purchasable under the
    Warrant Certificate(s) so exchanged.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Neither the Warrants nor the Common Shares issuable upon exercise hereof have been or will be registered under the United States <font style="font-size: 10pt; font-style: italic;">Securities Act of 1933</font>, as amended (the &#8220;<font style="font-size: 10pt; font-weight: bold;">U.S. Securities Act</font>&#8221;), or U.S. state securities laws. Other than by an original U.S. purchaser that purchased the Warrants
    directly from the Corporation, these Warrants may not be exercised in the &#8220;United States&#8221; (as such term is defined in Regulation S under the U.S. Securities Act) or by or on behalf of, or for the account or benefit of, a &#8220;U.S. Person&#8221; (as such term is
    defined in Regulation S under the U.S. Securities Act) (a &#8220;<font style="font-size: 10pt; font-weight: bold;">U.S. Person</font>&#8221;) or a person in the United States unless the Warrants and the Common Shares issuable upon exercise of the Warrants have
    been registered under the U.S. Securities Act and the applicable state securities legislation or an exemption from such registration requirements is available.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The Warrant Indenture contains provisions for the adjustment of the Exercise Price payable for each Common Share upon the exercise of Warrants and the number of
    Common Shares issuable upon the exercise of Warrants in the events and in the manner set forth therein.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The Warrant Indenture also contains provisions making binding on all holders of Warrants outstanding thereunder resolutions passed at meetings of holders of
    Warrants held in accordance with the provisions of the Warrant Indenture and instruments in writing signed by Warrantholders of Warrants entitled to purchase a specific majority of the Common Shares that can be purchased pursuant to such Warrants.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Nothing contained in this Warrant Certificate, the Warrant Indenture or elsewhere shall be construed as conferring upon the holder hereof any right or interest
    whatsoever as a holder of Common Shares or any other right or interest except as herein and in the Warrant Indenture expressly provided. In the event of any discrepancy between anything contained in this Warrant Certificate and the terms and conditions
    of the Warrant Indenture, the terms and conditions of the Warrant Indenture shall govern.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">Warrants may only be transferred in compliance with the conditions of the Warrant Indenture on the register to be kept by the Warrant Agent in Vancouver British
    Columbia or Toronto, Ontario, or such other registrar as the Corporation, with the approval of the Warrant Agent, may appoint at such other place or places, if any, as may be designated. Such transfer shall occur, upon the surrender of this Warrant
    Certificate to the Warrant Agent or other registrar accompanied by a written instrument of transfer in form and execution satisfactory to the Warrant Agent or other registrar and upon compliance with the conditions prescribed in the Warrant Indenture
    and with such reasonable requirements as the Warrant Agent or other registrar may prescribe and upon the transfer being duly noted thereon by the Warrant Agent or other registrar. Time is of the essence hereof.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">This Warrant Certificate will not be valid for any purpose until it has been countersigned by or on behalf of the Warrant Agent from time to time under the Warrant
    Indenture.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: Arial; font-size: 10pt;">The parties hereto have declared that they have required that these presents and all other documents related hereto be in the English language. Les parties aux
    pr&#233;sentes d&#233;clarent qu&#8217;elles ont exig&#233; que la pr&#233;sente&#160; convention,&#160; de&#160; m&#234;me&#160; que&#160; tous&#160; les&#160; documents&#160; s&#8217;y&#160; rapportant,&#160; soient&#160; r&#233;dig&#233;s&#160; en&#160; anglais.</div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: Arial; font-weight: bold;">IN WITNESS WHEREOF </font><font style="font-family: Arial;">the
      Corporation has caused this Warrant Certificate to be duly executed as of:</font></div>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf5a15f2cf1514106a2b7e075638bd57d">

      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">48NORTH CANNABIS CORP.</div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; padding-bottom: 2px; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; padding-bottom: 2px; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td style="border-bottom: 1pt solid #000000; vertical-align: top;">
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Arial;"><br>
            </font> </div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Authorized Signatory</div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Countersigned and Registered by</div>
        </td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt; font-weight: bold;">COMPUTERSHARE TRUST COMPANY OF CANADA</div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td style="border-bottom: 1pt solid #000000; vertical-align: top;">
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Arial;"><br>
            </font> </div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Authorized Signatory</div>
        </td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="vertical-align: top; font-family: Arial;">&#160;</td>
      </tr>
      <tr>
        <td colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td style="width: 3%; vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">By:</div>
        </td>
        <td style="border-bottom: 1pt solid #000000; vertical-align: top;">
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Arial;"><br>
            </font> </div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" colspan="1" style="width: 54pt; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 40%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="width: 3%; vertical-align: top; font-family: Arial;">&#160;</td>
        <td rowspan="1" style="vertical-align: top;">
          <div style="text-align: left; font-family: Arial; font-size: 10pt;">Authorized Signatory</div>
        </td>
      </tr>

  </table>
  <font style="font-family: Arial;"> </font>
  <div><font style="font-family: Arial;"><br>
    </font> </div>
  <font style="font-family: Arial;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <font style="font-family: Arial;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>ny20009174x12_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><b>Exhibit 4.4</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>TILRAY BRANDS, INC.</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">and</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>HEXO CORP.</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">and</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>COMPUTERSHARE TRUST COMPANY OF CANADA </b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>THIRD SUPPLEMENTAL WARRANT INDENTURE </b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>Supplementing the Warrant Indenture Dated as of June 25, 2020 </b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>June 22, 2023</b></p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>THIRD SUPPLEMENTAL WARRANT INDENTURE</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b>THIS THIRD SUPPLEMENTAL WARRANT INDENTURE </b>made as of the 22nd day of <font style="color: rgb(0, 0, 0);">June</font>, 2023.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b>AMONG:</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><b>HEXO CORP.</b>, a corporation existing under the laws of the Province of Ontario</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">("<b>HEXO</b>")</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">- and -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><b>TILRAY BRANDS, INC.</b>, a corporation existing under the laws of the State of Delaware</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">(&#8220;<b>Tilray</b>&#8221;)</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">- and -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>COMPUTERSHARE TRUST COMPANY OF CANADA</b>, a trust company existing under the laws of Canada</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">(the &#8220;<b>Warrant Agent</b>&#8221;)</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>WHEREAS </b>Zenabis Global Inc. (&#8220;<b>Zenabis</b>&#8221;) entered into a warrant indenture dated as of June 25, 2020 (as amended by the First Supplemental Indenture and
    Second Supplemental Indenture, the &#8220;<b>Indenture</b>&#8221;) with the Warrant Agent providing for the issue of up to 181,290,456 common share purchase warrants (the &#8220;<b>Zenabis Warrants</b>&#8221;) with each whole Zenabis Warrant exercisable to acquire one common
    share of Zenabis (each, a &#8220;<b>Zenabis Share</b>&#8221;) at an exercise price of C$0.16 per Zenabis Share at any time prior to 5:00 p.m. (Toronto time) on June 25, 2025;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>effective June 1, 2021, the Warrant Agent and HEXO Corp. (&#8220;<b>HEXO</b>&#8221;) entered into a supplemental indenture setting forth the adjustments to the
    Indenture required as a result of the Plan of Arrangement whereby HEXO acquired all of the issued and outstanding Zenabis Shares (the &#8220;<b>First Supplemental Indenture</b>&#8221;);</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS</b> effective October 31, 2022, the Warrant Agent and HEXO entered into a second supplemental indenture to evidence the exchange (the &#8220;<b>Warrant
      Exchange</b>&#8221;) of former Zenabis Warrants for common share purchase warrants of HEXO (&#8220;<b>HEXO Warrants</b>&#8221;) and to give effect to the provisions of the reverse vesting order of the Superior Court of Qu&#233;bec dated October 24, 2022, as amended and
    restated on October 25, 2022 ordering and approving the Warrant Exchange (the &#8220;<b>Second Supplemental Indenture</b>&#8221;);</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>effective June 22, 2023 (the &#8220;<b>Arrangement Effective Date</b>&#8221;), Tilray acquired all of the issued and outstanding HEXO Shares pursuant to a
    court-ordered and approved statutory plan of arrangement under the <i>Business Corporations Act </i>(Ontario) (the &#8220;<b>Plan of Arrangement</b>&#8221;), pursuant to which the holders of HEXO Shares received 0.4352 of a share in the common stock of Tilray
    (each, a &#8220;<b>Tilray Share</b>&#8221;) for each HEXO Share held (the &#8220;<b>Tilray Share Consideration</b>&#8221;), subject to and in accordance with the Plan of Arrangement;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>the Plan of Arrangement constituted a capital reorganization pursuant to the provisions of the Indenture such that, following the Arrangement
    Effective Date, the HEXO Warrants not previously exercised remained outstanding securities of HEXO, but the Warrantholders became entitled, upon exercise of each HEXO Warrant, to receive in lieu of each HEXO Share to which such holder was previously
    entitled upon exercise, the Tilray Share Consideration;</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>NOW THEREFORE THIS THIRD SUPPLEMENTAL WARRANT INDENTURE WITNESSES </b>that for good and valuable consideration mutually given and received, the receipt and
    sufficiency of which are hereby acknowledged, it is hereby covenanted, agreed and declared as follows:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 1</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>INTERPRETATION</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.1</b></td>
        <td style="text-align: justify"><b>To Be Read With Indenture</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture is supplemental to the Indenture and the Indenture shall henceforth be read in conjunction with this Third Supplemental
    Warrant Indenture and all provisions of the Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of the Indenture and of this Third Supplemental
    Warrant Indenture were contained in one instrument. Except as specifically amended by this Third Supplemental Warrant Indenture, all other terms and conditions of the Indenture shall remain in full force and unchanged.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">On and after the date hereof, each reference to the Indenture, as amended by this Third Supplemental Warrant Indenture, &#8220;<b>this Third Supplemental Warrant Indenture</b>&#8221;,




    &#8220;<b>this Indenture</b>&#8221;, &#8220;<b>herein</b>&#8221;, &#8220;<b>hereby</b>&#8221;, and similar references, and each reference to the Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Indenture as amended
    hereby.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.2</b></td>
        <td style="text-align: justify"><b>Definitions</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">All terms which are defined in the Indenture and are used but not defined in this Third Supplemental Warrant Indenture shall have the meanings ascribed to them in the
    Indenture as such meanings may be amended or supplemented by this Third Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the Indenture and the meaning given to the same term in this Third
    Supplemental Warrant Indenture, the meaning given to the term in this Third Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.3</b></td>
        <td style="text-align: justify"><b>Headings, etc.</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The division of this Third Supplemental Warrant Indenture into articles, sections, subsections and paragraphs, and the insertion of headings are for convenience of
    reference only and shall not affect the construction or interpretation hereof. Unless the context otherwise requires, &#8220;<b>this Third Supplemental Warrant Indenture</b>&#8221;, &#8220;<b>hereto</b>&#8221;, &#8220;<b>hereby</b>&#8221;, &#8220;<b>hereof</b>&#8221;, &#8220;<b>herein</b>&#8221; and similar
    expressions refer to this Third Supplemental Warrant Indenture and not to any particular article, section, subsection, paragraph or other portion hereof, and include any and every instrument which amends this Third Supplemental Warrant Indenture or is
    supplemental or ancillary hereto or in implementation hereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 2</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>AMENDMENTS TO INDENTURE</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.1</b></td>
        <td style="text-align: justify"><b>Exchange Basis</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Each of HEXO, Tilray and the Warrant Agent hereby acknowledge and agree that, as and from the date hereof, in accordance with the terms of the Indenture and as a
    result of the Plan of Arrangement, any Warrantholder who exercises that holder's right to receive HEXO Shares pursuant to the Warrant(s) shall be entitled to receive, and shall accept in lieu of the number of HEXO Shares to which such holder was
    previously entitled upon such exercise and for the same consideration, the Tilray Share Consideration, subject to adjustment in accordance with the terms of the Indenture. Tilray hereby covenants, acknowledges and agrees that, as and from the
    Arrangement Effective Date, Tilray shall make available or cause to be made available the Tilray Shares in accordance with and subject to the terms of the Indenture and this Third Supplemental Warrant Indenture.</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.2</b></td>
        <td style="text-align: justify"><b>Express Assumption of Rights, Duties and Obligations</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(a)</td>
        <td style="text-align: justify">Tilray covenants, acknowledges and agrees that, as and from the date hereof, it is bound by the provisions of the Indenture and shall cause HEXO to comply with all covenants and obligations contained in the Indenture
          to be performed by HEXO.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(b)</td>
        <td style="text-align: justify">Each of Tilray and HEXO agree to do, execute and deliver all such further acts, instruments and documents as may be necessary to give effect to the transfer, assignment and assumption herein provided for.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(c)</td>
        <td style="text-align: justify">HEXO covenants, acknowledges and agrees to promptly remit to Tilray the Exercise Price per Warrant validly exercised upon receipt of payment thereof (or, alternatively in lieu thereof at Tilray&#8217;s direction, to cause
          the Exercise Price per Warrant validly exercised upon receipt of payment thereof to be made directly to Tilray).</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(d)</td>
        <td style="text-align: justify">Notwithstanding any of the foregoing, the resignation, discharge, appointment, transfers, assignments and other agreements provided for herein will not be effective unless this Third Supplemental Warrant Indenture
          has been executed by all of the parties hereto, whether upon the original instrument, by facsimile or in counterparts, or any combination thereof, and unless all preconditions to such resignation, discharge, appointment, transfers, assignments
          and other agreements as may be set forth in the Indenture have been fulfilled.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(e)</td>
        <td style="text-align: justify">Notwithstanding anything in the Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued following the Arrangement Effective Date without the prior written consent of Tilray.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.3</b></td>
        <td style="text-align: justify"><b>Specific Amendments</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Effective as of the Arrangement Effective Date, the following specific amendments are made to the following provisions of the Indenture:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(a)</td>
        <td>The recitals of the Indenture are hereby amended to delete in its entirety the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">"<b>AND WHEREAS </b>pursuant to this Indenture, each Warrant shall, subject to adjustment, entitle the holder thereof to acquire one (1) Common Share (each,
    a "<b>Warrant Share</b>") upon payment of the Exercise Price prior to the Expiry Time upon the terms and conditions herein set forth;"</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">and to instead replace it with the following:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">"<b>AND WHEREAS </b>pursuant to this Indenture, each Warrant shall, subject to adjustment, entitle the holder thereof to acquire 0.000550839<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> of a Common Share (each whole Common Share, a "<b>Warrant Share</b>") upon payment of the Exercise Price prior to the Expiry Time upon the terms and conditions herein set
    forth;"</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(b)</td>
        <td>Section 1.1 of the Indenture is amended by:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in; text-align: left">(1)</td>
        <td style="text-align: justify">Deleting the definition of &#8220;Acceleration Right&#8221; and replacing it with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#8220;<b>Acceleration Right</b>&#8221; means the right of Tilray Brands, Inc. to accelerate the Expiry Date to a date that is fifteen (15) days following delivery of the
    Acceleration Notice if, at any time after the Effective Date, the closing sale price of the Common Shares exceeds $580.93 per Common Share for a period of ten (10) consecutive Trading Days on the Exchange.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> NTD: Previous adjusted exchange ratio of 0.001265714 (following the 14:1
    consolidation) multiplied by the Tilray exchange ratio of 0.4352</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 4 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(2)</td>
        <td style="text-align: justify">Adding the following definition of "<b>Arrangement Effective Date</b>":</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif; margin-left: 1in">"<b>Arrangement Effective Date</b>" means June 22, 2023.</p>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(3)</td>
        <td style="text-align: justify">Deleting the definition of "<b>Common Shares</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Common Shares</b>" means, subject to Article 4, fully paid and non-assessable shares of common stock in the capital of Tilray Brands, Inc. as presently
    constituted.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(4)</td>
        <td>Deleting the definition of "<b>Exercise Price</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Exercise Price</b>" at any time means the price at which 0.000550839 of a Warrant Share may be purchased by the exercise of a whole Warrant, which at the
    Arrangement Effective Date is $0.16, payable in immediately available Canadian funds, subject to adjustment in accordance with the provisions of Section 4.1.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(5)</td>
        <td>Adding the following definition of &#8220;<b>Plan of Arrangement</b>&#8221;:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify"><b>&#8220;Plan of Arrangement&#8221; </b>means the plan of arrangement attached hereto as Exhibit A, as amended, modified or supplemented from time to time in accordance
    with the terms thereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(6)</td>
        <td>Adding the following definition of "<b>Tilray</b>":</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in">"<b>Tilray</b>" means Tilray Brands, Inc., a company existing under the laws of Delaware.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(7)</td>
        <td>Adding the following definition of <b>&#8220;Tilray&#8217;s Transfer Agent</b>&#8221;: <br>
          <br>
          &#8220;<b>Tilray&#8217;s Transfer Agent</b>&#8221; means Pacific Stock Transfer Company and Odyssey Trust Company.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.55in"></td>
        <td style="width: 0.5in">(8)</td>
        <td>Deleting the definition of "<b>Warrants</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Warrants</b>" means the Common Share purchase warrants created by and authorized by and issuable under this Indenture, to be issued and countersigned
    hereunder as a Warrant Certificate and/or Uncertificated Warrant held through the Book Entry Registration System on a no-certificate issued basis, entitling the holder or holders thereof to purchase up to 99,862 Warrant Shares (subject to adjustment as
    herein provided) at the Exercise Price prior to the Expiry Time and, where the context so requires, also means the warrants issued and Authenticated hereunder, whether by way of Warrant Certificate or Uncertificated Warrant;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">(c)</td>
        <td style="text-align: justify">Section 2.2(1) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Arial,Helvetica,sans-serif; margin: 0pt 0px 0pt 36pt; text-align: justify;">Subject to the applicable conditions for exercise set out in Article 3 having been satisfied and subject to adjustment in accordance with Section 4.1, each
    whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire 0.000550839 of a Warrant Share upon payment of the Exercise Price (being an effective Exercise Price of
    $290.47 per Common Share).</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 5 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">(d)</td>
        <td style="text-align: justify">Section 2.2(2) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No fractional Warrants shall be issued or otherwise provided for hereunder and Warrants may only be exercised in a sufficient number to acquire whole numbers
    of Warrant Shares. Any fractional Warrant Shares that Tilray may otherwise be required to issue upon exercise of Warrants pursuant to Section 3.1 shall be rounded down to the nearest whole number and no consideration shall be paid for any such
    fractional Warrant Shares. Any fractional Warrants shall be rounded down to the nearest whole number and no consideration shall be paid for any such fractional Warrant.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(e)</td>
        <td>Section 2.2(5) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If at any time after the Arrangement Effective Date, the closing sale price of the Common Shares exceeds $580.93 per Common Share for a period of ten (10)
    consecutive Trading Days on the Exchange, the Corporation shall be entitled, at the sole option of the Corporation, to exercise the Acceleration Right by delivering an Acceleration Notice to the Registered Warrantholders and the Warrant Agent. An
    Acceleration Notice shall be delivered to each Registered Warrantholder in the manner set out in Section 10.2.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(f)</td>
        <td style="text-align: justify">Section 2.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(g)</td>
        <td style="text-align: justify">Section 2.9(2) of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(h)</td>
        <td style="text-align: justify">Section 3.1 of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions hereof, each Registered Warrantholder may exercise the right conferred on such holder to subscribe for and purchase 0.000550839 of
    a Warrant Share for each Warrant after the Arrangement Effective Date and prior to the Expiry Time and in accordance with the conditions herein.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(i)</td>
        <td>Section 3.2(4) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A beneficial owner of Uncertificated Warrants evidenced by a security entitlement in respect of Warrants in the Book Entry Registration System who desires to
    exercise their Warrants must do so by causing a Book Entry Participant to deliver to the Depository on behalf of the entitlement holder, notice of the owner&#8217;s intention to exercise Warrants in a manner acceptable to the Depository. Forthwith upon
    receipt by the Depository of such notice, as well as payment for the aggregate Exercise Price, the Depository shall deliver to the Warrant Agent and Tilray&#8217;s Transfer Agent confirmation of its intention to exercise Warrants (a &#8220;<b>Confirmation</b>&#8221;) in
    a manner acceptable to the Warrant Agent and Tilray&#8217;s Transfer Agent, including by electronic means through a Book Entry Registration System. An electronic exercise of the Warrants initiated by the Book Entry Participant through a Book Entry
    Registration System, including CDSX, shall constitute a representation to the Corporation, Tilray, Tilray&#8217;s Transfer Agent and the Warrant Agent that the beneficial owner at the time of exercise of such Warrants either: (a) (i) is not in the United
    States, (ii) is not a U.S. Person and is not exercising such Warrants on behalf of a U.S. Person or a person in the United States, and (iii) did not execute or deliver the notice of the owner&#8217;s intention to exercise such Warrants in the United States;
    or (b) the exercise of such Warrant and issuance of the Warrant Shares does not require registration in the United States. If the Book Entry Participant is not able to make or deliver the foregoing representations by initiating the electronic exercise
    of the Warrants, then such Warrants shall be withdrawn from the Book Entry Registration System by the Book Entry Participant and an individually registered Warrant Certificate shall be issued by the Warrant Agent to such beneficial owner or Book Entry
    Participant and the exercise procedures set forth in Section 3.2(1) and Section 3.2(2) shall be followed.</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(j)</td>
        <td>Section 3.2(5) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Payment representing the aggregate Exercise Price must be provided to the appropriate office of the Book Entry Participant in a manner acceptable to it. A
    notice in form acceptable to the Book Entry Participant and payment from such beneficial holder should be provided to the Book Entry Participant sufficiently in advance so as to permit the Book Entry Participant to deliver notice and payment to the
    Depository and for the Depository in turn to deliver notice and payment to the Warrant Agent prior to the Expiry Time. The Depository will initiate the exercise by way of the Confirmation and forward the aggregate Exercise Price electronically to the
    Warrant Agent and Tilray&#8217;s Transfer Agent will execute the exercise by issuing to the Depository through the Book Entry Registration System the Warrant Shares to which the exercising Warrantholder is entitled pursuant to the exercise. Any expense
    associated with the exercise process will be for the account of the entitlement holder exercising the Warrants or the Book Entry Participant exercising the Warrants on its behalf.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(k)</td>
        <td>Section 3.4 of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If any of the Warrant Shares subscribed for are to be issued to a person or persons other than the Registered Warrantholder, the Registered Warrantholder
    shall execute the form of transfer and will comply with such reasonable requirements as the Warrant Agent may stipulate and will pay to the Corporation or the Warrant Agent on behalf of the Corporation, all applicable transfer or similar taxes and
    Tilray will not be required to issue or deliver certificates evidencing Warrant Shares unless or until such Warrantholder shall have paid to the Corporation, or the Warrant Agent on behalf of the Corporation, the amount of such tax or shall have
    established to the satisfaction of the Corporation and the Warrant Agent that such tax has been paid or that no tax is due.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(l)</td>
        <td>Section 3.7(2) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notwithstanding anything herein contained including any adjustment provided for in Section 4.1, Tilray shall not be required, upon the exercise of any
    Warrants, to issue fractions of Warrant Shares. Warrants may only be exercised in a sufficient number to acquire whole numbers of Warrant Shares. Any fractional Warrant Shares that Tilray may otherwise be required to issue upon exercise of Warrants
    pursuant to Section 3.1 shall be rounded down to the nearest whole number and the holder of such Warrants shall not be entitled to any compensation in respect of any fractional Warrant Shares which is not issued.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(m)</td>
        <td style="text-align: justify">Section 4.1(a) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(n)</td>
        <td style="text-align: justify">Section 4.1(b) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(o)</td>
        <td style="text-align: justify">Section 4.1(c) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(p)</td>
        <td style="text-align: justify">Section 4.1(d) of the indenture is amended so that the first four references to "the Corporation" therein refer to "Tilray", the reference to "the Corporation, its successor, or such purchasing body corporate"
          therein shall refer to "the Corporation, Tilray, its successor, or such purchasing body corporate", the reference to "the Corporation and the Warrant Agent" therein shall refer to "the Corporation, Tilray and the Warrant Agent", and the reference
          to "the Corporation, any successor to the Corporation or such purchasing body corporate" therein shall refer to "the Corporation, Tilray, any successor to Tilray, or such purchasing body corporate".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(q)</td>
        <td style="text-align: justify">Section 4.1(e) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 7 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(r)</td>
        <td style="text-align: justify">Section 4.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(s)</td>
        <td style="text-align: justify">Section 4.4 of the Indenture is amended so that the first reference to "the Corporation" therein shall refer to "the Corporation and Tilray" and the second reference to "the Corporation, the Warrant Agent, all
          holders and all other persons" therein shall refer to "the Corporation, Tilray, the Warrant Agent, all holders and all other persons".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(t)</td>
        <td style="text-align: justify">Section 4.5 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(u)</td>
        <td style="text-align: justify">Section 4.6 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(v)</td>
        <td style="text-align: justify">Section 4.7 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(w)</td>
        <td style="text-align: justify">Section 4.8 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(x)</td>
        <td style="text-align: justify">Section 4.9 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(y)</td>
        <td style="text-align: justify">Section 4.10 of the Indenture is amended so that references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(z)</td>
        <td style="text-align: justify">Section 5.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(aa)</td>
        <td style="text-align: justify">Section 5.5 of the Indenture is amended so that the last reference to "the Corporation" therein refers to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(bb)</td>
        <td style="text-align: justify">Section 5.6 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(cc)</td>
        <td style="text-align: justify">Section 6.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(dd)</td>
        <td style="text-align: justify">Section 6.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(ee)</td>
        <td style="text-align: justify">Section 8.1 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(ff)</td>
        <td style="text-align: justify">Section 8.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(gg)</td>
        <td style="text-align: justify">Section 9.1 of the indenture is amended so that the reference to "The Corporation and the Warrant Agent" therein shall refer to "The Corporation, Tilray and the Warrant Agent".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(hh)</td>
        <td style="text-align: justify">Section 9.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 8 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(ii)</td>
        <td>Section 9.7 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(jj)</td>
        <td>Section 10.1(1) of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(kk)</td>
        <td>Section 10.1(1)(a) of the Indenture is deleted and replaced with the following: </td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif; margin-left: 0.5in">"If to the Corporation or Tilray:</p>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Tilray Brands, Inc.<br>
    655 Madison Avenue<br>
    19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<br>
    New York, New York<br>
    10065<br>
    <br>
  </p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Mitchell Gendel<br>
    Email: <u>mitchell.gendel@tilray.com</u></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">With a copy (which will not constitute notice) to:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">DLA Piper (Canada) LLP<br>
    Suite 6000, 1 First Canadian Place<br>
    PO Box 367, 100 King Street West<br>
    Toronto, ON<br>
    M5X 1E2</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Russel Drew</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Email: russel.drew@dlapiper.com</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">If to Tilray&#8217;s Transfer Agent:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Pacific Stock Transfer Company</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">6725 Via Austi Pkwy, Suite 300</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Las Vegas, Nevada 89119</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Maria Torres</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Email: MTorres@pacificstocktransfer.com</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">and to:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Odyssey Trust Company</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">United Kingdom Building</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">350 &#8211; 409 Granville Street</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Vancouver BC V6C 1T2</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Paul Keyes</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Email: PKeyes@OdysseyTrust.com</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 3</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>MISCELLANEOUS</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.1</b></td>
        <td style="text-align: justify"><b>Acceptance of Trust</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Warrant Agent accepts the trusts in this Third Supplemental Warrant Indenture and agrees to carry out and discharge the same upon the terms and conditions set out in this Third
    Supplemental Warrant Indenture and in accordance with the Indenture.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.2</b></td>
        <td style="text-align: justify"><b>Confirmation of Indenture</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Indenture as amended and supplemented by this Third Supplemental Warrant Indenture, is hereby confirmed and approved.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.3</b></td>
        <td style="text-align: justify"><b>Governing Law</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of British Columbia and the federal laws of
    Canada applicable therein and shall be binding upon the parties hereto and their respective successors and assigns.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.4</b></td>
        <td style="text-align: justify"><b>Counterparts</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture may be executed in counterparts, each of which so executed shall be deemed to be an original, and each of such counterparts
    when taken together shall constitute one and the same instrument and notwithstanding their date of execution they shall be deemed to be dated as of the date hereof. Delivery of an executed copy of this Third Supplemental Warrant Indenture by electronic
    facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Indenture as of the date hereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>[<i>Signature page follows</i>]</b></p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b>IN WITNESS WHEREOF </b>the parties hereto have executed this Third Supplemental Warrant Indenture under the hands of their proper signatories in that behalf.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 4%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="width: 46%; border-bottom: Black 1pt solid">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Mitchell Gendel</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>COMPUTERSHARE TRUST COMPANY OF CANADA</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="border-bottom: Black 1pt solid">/s/ Brian Howarth<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Brian Howarth</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font> </td>
        <td style="border-bottom: 1pt solid #000000;" rowspan="1">/s/ Alan Zhang<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <div>Name: Alan Zhang</div>
          <div>Title:&#160;&#160; Associate Trust Officer<br>
          </div>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>HEXO CORP.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="border-bottom: Black 1pt solid">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Rob Godfrey</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>ny20009174x12_ex4-8.htm
<DESCRIPTION>EXHIBIT 4.8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><b>Exhibit 4.8</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>TILRAY BRANDS, INC.&#8206;</b><br>
    <br>
    and<br>
    <br>
    <b>HEXO CORP.</b><br>
    <br>
    and<br>
    <br>
    <b>COMPUTERSHARE TRUST COMPANY OF CANADA </b><br>
    <br>
    <b>THIRD SUPPLEMENTAL WARRANT INDENTURE </b><br>
    <br>
    <b>Supplementing the Warrant Indenture Dated as of September 23, 2020</b><br>
    <br>
    <b>June 22, 2023</b></p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>THIRD SUPPLEMENTAL WARRANT INDENTURE</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b>THIS THIRD SUPPLEMENTAL WARRANT INDENTURE </b>made as of the 22nd day of June, 2023.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b>AMONG:</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><b>HEXO CORP.</b>, a corporation existing under the laws of the Province of Ontario<br>
    (&#8220;<b>HEXO</b>&#8221;)</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">- and -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><b>TILRAY BRANDS, INC.</b>, a corporation existing under the laws of the State of Delaware</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">(&#8220;<b>TILRAY</b>&#8221;)</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">- and -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>COMPUTERSHARE TRUST COMPANY OF CANADA</b>, a trust company existing under the laws of Canada</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">(the &#8220;<b>Warrant Agent</b>&#8221;)</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>WHEREAS </b>Zenabis Global Inc. (&#8220;<b>Zenabis</b>&#8221;) entered into a warrant indenture dated as of September 23, 2020 (as amended by the First Supplemental Indenture
    and Second Supplemental Indenture, the &#8220;<b>Indenture</b>&#8221;) with the Warrant Agent providing for the issue of up to 89,317,747 common share purchase warrants (the &#8220;<b>Zenabis Warrants</b>&#8221;) with each whole Zenabis Warrant exercisable to acquire one
    common share of Zenabis (each, a &#8220;<b>Zenabis Share</b>&#8221;) at an exercise price of C$0.10 per Zenabis Share at any time prior to 5:00 p.m. (Toronto time) on September 23, 2025;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>effective June 1, 2021, the Warrant Agent and HEXO Corp. (&#8220;<b>HEXO</b>&#8221;) entered into a supplemental indenture setting forth the adjustments to the
    Indenture required as a result of the Plan of Arrangement whereby HEXO acquired all of the issued and outstanding Zenabis Shares (the &#8220;<b>First Supplemental Indenture</b>&#8221;);</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS</b> effective October 31, 2022, the Warrant Agent and HEXO entered into a second supplemental indenture to evidence the exchange (the &#8220;<b>Warrant
      Exchange</b>&#8221;) of former Zenabis Warrants for common share purchase warrants of HEXO (&#8220;<b>HEXO Warrants</b>&#8221;) and to give effect to the provisions of the reverse vesting order of the Superior Court of Qu&#233;bec dated October 24, 2022, as amended and
    restated on October 25, 2022, ordering and approving the Warrant Exchange (the &#8220;<b>Second Supplemental Indenture</b>&#8221;);</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>effective June 22, 2023 (the &#8220;<b>Arrangement Effective Date</b>&#8221;), Tilray acquired all of the issued and outstanding HEXO Shares pursuant to a
    court-ordered and approved statutory plan of arrangement under the <i>Business Corporations Act </i>(Ontario) (the &#8220;<b>Plan of Arrangement</b>&#8221;), pursuant to which the holders of HEXO Shares received 0.4352 of a share in the common stock of Tilray
    (each, a &#8220;<b>Tilray Share</b>&#8221;) for each HEXO Share held (the &#8220;<b>Tilray Share Consideration</b>&#8221;), subject to and in accordance with the Plan of Arrangement;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>AND WHEREAS </b>the Plan of Arrangement constituted a capital reorganization pursuant to the provisions of the Indenture such that, following the Arrangement
    Effective Date, the HEXO Warrants not previously exercised remained outstanding securities of HEXO, but the Warrantholders became entitled, upon exercise of each HEXO Warrant, to receive in lieu of each HEXO Share to which such holder was previously
    entitled upon exercise, the Tilray Share Consideration;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><b>NOW THEREFORE THIS THIRD SUPPLEMENTAL WARRANT INDENTURE WITNESSES </b>that for good and valuable consideration mutually given and received, the receipt and
    sufficiency of which are hereby acknowledged, it is hereby covenanted, agreed and declared as follows:</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 1</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>INTERPRETATION</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.1</b></td>
        <td style="text-align: justify"><b>To Be Read With Indenture</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture is supplemental to the Indenture and the Indenture shall henceforth be read in conjunction with this Third
    Supplemental Warrant Indenture and all provisions of the Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of the Indenture and of this Third
    Supplemental Warrant Indenture were contained in one instrument. Except as specifically amended by this Third Supplemental Warrant Indenture, all other terms and conditions of the Indenture shall remain in full force and unchanged.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">On and after the date hereof, each reference to the Indenture, as amended by this Third Supplemental Warrant Indenture, &#8220;<b>this Third Supplemental Warrant
      Indenture</b>&#8221;, &#8220;<b>this Indenture</b>&#8221;, &#8220;<b>herein</b>&#8221;, &#8220;<b>hereby</b>&#8221;, and similar references, and each reference to the Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Indenture
    as amended hereby.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.2</b></td>
        <td style="text-align: justify"><b>Definitions</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">All terms which are defined in the Indenture and are used but not defined in this Third Supplemental Warrant Indenture shall have the meanings ascribed to them
    in the Indenture as such meanings may be amended or supplemented by this Third Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the Indenture and the meaning given to the same term in this Third
    Supplemental Warrant Indenture, the meaning given to the term in this Third Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>1.3</b></td>
        <td style="text-align: justify"><b>Headings, etc.</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">The division of this Third Supplemental Warrant Indenture into articles, sections, subsections and paragraphs, and the insertion of headings are for
    convenience of reference only and shall not affect the construction or interpretation hereof. Unless the context otherwise requires, &#8220;<b>this Third Supplemental Warrant Indenture</b>&#8221;, &#8220;<b>hereto</b>&#8221;, &#8220;<b>hereby</b>&#8221;, &#8220;<b>hereof</b>&#8221;, &#8220;<b>herein</b>&#8221;
    and similar expressions refer to this Third Supplemental Warrant Indenture and not to any particular article, section, subsection, paragraph or other portion hereof, and include any and every instrument which amends this Third Supplemental Warrant
    Indenture or is supplemental or ancillary hereto or in implementation hereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0in 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 2</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>AMENDMENTS TO INDENTURE</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.1</b></td>
        <td style="text-align: justify"><b>Exchange Basis</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Each of HEXO, Tilray and the Warrant Agent hereby acknowledge and agree that, as and from the date hereof, in accordance with the terms of the Indenture and as a
    result of the Plan of Arrangement, any Warrantholder who exercises that holder's right to receive HEXO Shares pursuant to the Warrant(s) shall be entitled to receive, and shall accept in lieu of the number of HEXO Shares to which such holder was
    previously entitled upon such exercise and for the same consideration, the Tilray Share Consideration, subject to adjustment in accordance with the terms of the Indenture. Tilray hereby covenants, acknowledges and agrees that, as and from the
    Arrangement Effective Date, Tilray shall make available or cause to be made available the Tilray Shares in accordance with and subject to the terms of the Indenture and this Third Supplemental Warrant Indenture.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.2</b></td>
        <td style="text-align: justify"><b>Express Assumption of Rights, Duties and Obligations</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(a)</td>
        <td style="text-align: justify">Tilray covenants, acknowledges and agrees that, as and from the date hereof, it is bound by the provisions of the Indenture and shall cause HEXO to comply with all covenants and obligations contained in the Indenture
          to be performed by HEXO.</td>
      </tr>

  </table>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(b)</td>
        <td style="text-align: justify">Each of Tilray and HEXO agree to do, execute and deliver all such further acts, instruments and documents as may be necessary to give effect to the transfer, assignment and assumption herein provided for.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(c)</td>
        <td style="text-align: justify">HEXO covenants, acknowledges and agrees to promptly remit to Tilray the Exercise Price per Warrant validly exercised upon receipt of payment thereof (or, alternatively in lieu thereof at Tilray&#8217;s direction, to cause
          the Exercise Price per Warrant validly exercised upon receipt of payment thereof to be made directly to Tilray).</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(d)</td>
        <td style="text-align: justify">Notwithstanding any of the foregoing, the resignation, discharge, appointment, transfers, assignments and other agreements provided for herein will not be effective unless this Third Supplemental Warrant Indenture
          has been executed by all of the parties hereto, whether upon the original instrument, by facsimile or in counterparts, or any combination thereof, and unless all preconditions to such resignation, discharge, appointment, transfers, assignments
          and other agreements as may be set forth in the Indenture have been fulfilled.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(e)</td>
        <td style="text-align: justify">Notwithstanding anything in the Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued following the Arrangement Effective Date without the prior written consent of Tilray.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>2.3</b></td>
        <td style="text-align: justify"><b>Specific Amendments</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: justify">Effective as of the Arrangement Effective Date, the following specific amendments are made to the following provisions of the Indenture:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(a)</td>
        <td>The recitals of the Indenture are hereby amended to delete in its entirety the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">"<b>AND WHEREAS </b>pursuant to this Indenture, each Warrant shall, subject to adjustment, entitle the holder thereof to acquire one (1) Common Share (each,
    a "<b>Warrant Share</b>") upon payment of the Exercise Price prior to the Expiry Time upon the terms and conditions herein set forth;"</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in">and to instead replace it with the following:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">"<b>AND WHEREAS </b>pursuant to this Indenture, each Warrant shall, subject to adjustment, entitle the holder thereof to acquire 0.000550839<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> of a Common Share (each whole Common Share, a "<b>Warrant Share</b>") upon payment of the Exercise Price prior to the Expiry Time upon the terms and conditions herein set
    forth;"</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(b)</td>
        <td>Section 1.1 of the Indenture is amended by:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in; text-align: left">(1)</td>
        <td style="text-align: justify">Deleting the definition of &#8220;Acceleration Right&#8221; and replacing it with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#8220;<b>Acceleration Right</b>&#8221; means the right of Tilray Brands, Inc. to accelerate the Expiry Date to a date that is fifteen (15) days following delivery of the
    Acceleration Notice if, at any time after the Effective Date, the closing sale price of the Common Shares exceeds $363.08 per Common Share for a period of ten (10) consecutive Trading Days on the Exchange.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> NTD: Previous adjusted exchange ratio of 0.001265714
    (following the 14:1 consolidation) multiplied by the Tilray exchange ratio of 0.4352</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: center">- 4 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(2)</td>
        <td style="text-align: justify; padding-right: 1.55in">
          <div>Adding the following definition of "<b>Arrangement Effective Date</b>": </div>
          <div> <br>
          </div>
          <div>"<b>Arrangement Effective Date</b>" means June 22, 2023.</div>
        </td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(3)</td>
        <td style="text-align: justify">Deleting the definition of "<b>Common Shares</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Common Shares</b>" means, subject to Article 4, fully paid and non-assessable shares of common stock in the capital of Tilray Brands, Inc. as presently
    constituted.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(4)</td>
        <td>Deleting the definition of "<b>Exercise Price</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Exercise Price</b>" at any time means the price at which &#8206;0.000550839&#8206; of a Warrant Share may be purchased by the exercise of a whole Warrant, which at the
    Arrangement Effective Date is $0.10, payable in immediately available Canadian funds, subject to adjustment in accordance with the provisions of Section 4.1.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(5)</td>
        <td>Adding the following definition of <b>&#8220;Plan of Arrangement&#8221;:</b></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify"><b>&#8220;Plan of Arrangement&#8221; </b>means the plan of arrangement attached hereto as Exhibit A, as amended, modified or supplemented from time to time in accordance
    with the terms thereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(6)</td>
        <td>Adding the following definition of "<b>Tilray</b>":</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in">"<b>Tilray</b>" means Tilray Brands, Inc., a company existing under the laws of Delaware.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(7)</td>
        <td>Adding the following definition of <b>&#8220;Tilray&#8217;s Transfer Agent</b>&#8221;: <br>
          <br>
          &#8220;<b>Tilray&#8217;s Transfer Agent</b>&#8221; means Pacific Stock Transfer Company and Odyssey Trust Company.</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in">(8)</td>
        <td>Deleting the definition of "<b>Warrants</b>" and replacing it with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">"<b>Warrants</b>" means the Common Share purchase warrants created by and authorized by and issuable under this Indenture, to be issued and countersigned
    hereunder as a Warrant Certificate and/or Uncertificated Warrant held through the Book Entry Registration System on a no-certificate issued basis, entitling the holder or holders thereof to purchase up to 49,199 Warrant Shares (subject to adjustment as
    herein provided) at the Exercise Price prior to the Expiry Time and, where the context so requires, also means the warrants issued and Authenticated hereunder, whether by way of Warrant Certificate or Uncertificated Warrant;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">(c)</td>
        <td style="text-align: justify">Section 2.2(1) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the applicable conditions for exercise set out in Article 3 having been satisfied and subject to adjustment in accordance with Section 4.1, each
    whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire &#8206;0.000550839&#8206; of a Warrant Share upon payment of the Exercise Price (being an effective Exercise Price of
    $181.54 per Common Share).</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: center">- 5 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">(d)</td>
        <td style="text-align: justify">Section 2.2(2) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No fractional Warrants shall be issued or otherwise provided for hereunder and Warrants may only be exercised in a sufficient number to acquire whole numbers
    of Warrant Shares. Any fractional Warrant Shares that Tilray may otherwise be required to issue upon exercise of Warrants pursuant to Section 3.1 shall be rounded down to the nearest whole number and no consideration shall be paid for any such
    fractional Warrant Shares. Any fractional Warrants shall be rounded down to the nearest whole number and no consideration shall be paid for any such fractional Warrant.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(e)</td>
        <td>Section 2.2(5) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If at any time after the Arrangement Effective Date, the closing sale price of the Common Shares exceeds $363.08 per Common Share for a period of ten (10)
    consecutive Trading Days on the Exchange, the Corporation shall be entitled, at the sole option of the Corporation, to exercise the Acceleration Right by delivering an Acceleration Notice to the Registered Warrantholders and the Warrant Agent. An
    Acceleration Notice shall be delivered to each Registered Warrantholder in the manner set out in Section 10.2.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(f)</td>
        <td style="text-align: justify">Section 2.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(g)</td>
        <td style="text-align: justify">Section 2.9(2) of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(h)</td>
        <td style="text-align: justify">Section 3.1 of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions hereof, each Registered Warrantholder may exercise the right conferred on such holder to subscribe for and purchase &#8206;0.000550839&#8206;
    of a Warrant Share for each Warrant after the Arrangement Effective Date and prior to the Expiry Time and in accordance with the conditions herein.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(i)</td>
        <td>Section 3.2(4) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A beneficial owner of Uncertificated Warrants evidenced by a security entitlement in respect of Warrants in the Book Entry Registration System who desires to
    exercise their Warrants must do so by causing a Book Entry Participant to deliver to the Depository on behalf of the entitlement holder, notice of the owner&#8217;s intention to exercise Warrants in a manner acceptable to the Depository. Forthwith upon
    receipt by the Depository of such notice, as well as payment for the aggregate Exercise Price, the Depository shall deliver to the Warrant Agent and Tilray&#8217;s Transfer Agent confirmation of its intention to exercise Warrants (a &#8220;<b>Confirmation</b>&#8221;) in
    a manner acceptable to the Warrant Agent and Tilray&#8217;s Transfer Agent, including by electronic means through a Book Entry Registration System. An electronic exercise of the Warrants initiated by the Book Entry Participant through a Book Entry
    Registration System, including CDSX, shall constitute a representation to the Corporation, Tilray, Tilray&#8217;s Transfer Agent and the Warrant Agent that the beneficial owner at the time of exercise of such Warrants either: (a) (i) is not in the United
    States, (ii) is not a U.S. Person and is not exercising such Warrants on behalf of a U.S. Person or a person in the United States, and (iii) did not execute or deliver the notice of the owner&#8217;s intention to exercise such Warrants in the United States;
    or (b) the exercise of such Warrant and issuance of the Warrant Shares does not require registration in the United States. If the Book Entry Participant is not able to make or deliver the foregoing representations by initiating the electronic exercise
    of the Warrants, then such Warrants shall be withdrawn from the Book Entry Registration System by the Book Entry Participant and an individually registered Warrant Certificate shall be issued by the Warrant Agent to such beneficial owner or Book Entry
    Participant and the exercise procedures set forth in Section 3.2(1) and Section 3.2(2) shall be followed.</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(j)</td>
        <td>Section 3.2(5) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Payment representing the aggregate Exercise Price must be provided to the appropriate office of the Book Entry Participant in a manner acceptable to it. A
    notice in form acceptable to the Book Entry Participant and payment from such beneficial holder should be provided to the Book Entry Participant sufficiently in advance so as to permit the Book Entry Participant to deliver notice and payment to the
    Depository and for the Depository in turn to deliver notice and payment to the Warrant Agent prior to the Expiry Time. The Depository will initiate the exercise by way of the Confirmation and forward the aggregate Exercise Price electronically to the
    Warrant Agent and Tilray&#8217;s Transfer Agent will execute the exercise by issuing to the Depository through the Book Entry Registration System the Warrant Shares to which the exercising Warrantholder is entitled pursuant to the exercise. Any expense
    associated with the exercise process will be for the account of the entitlement holder exercising the Warrants or the Book Entry Participant exercising the Warrants on its behalf.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(k)</td>
        <td>Section 3.4 of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If any of the Warrant Shares subscribed for are to be issued to a person or persons other than the Registered Warrantholder, the Registered Warrantholder
    shall execute the form of transfer and will comply with such reasonable requirements as the Warrant Agent may stipulate and will pay to the Corporation or the Warrant Agent on behalf of the Corporation, all applicable transfer or similar taxes and
    Tilray will not be required to issue or deliver certificates evidencing Warrant Shares unless or until such Warrantholder shall have paid to the Corporation, or the Warrant Agent on behalf of the Corporation, the amount of such tax or shall have
    established to the satisfaction of the Corporation and the Warrant Agent that such tax has been paid or that no tax is due.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(l)</td>
        <td>Section 3.7(2) of the Indenture is deleted and replaced with the following:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notwithstanding anything herein contained including any adjustment provided for in Section 4.1, Tilray shall not be required, upon the exercise of any
    Warrants, to issue fractions of Warrant Shares. Warrants may only be exercised in a sufficient number to acquire whole numbers of Warrant Shares. Any fractional Warrant Shares that Tilray may otherwise be required to issue upon exercise of Warrants
    pursuant to Section 3.1 shall be rounded down to the nearest whole number and the holder of such Warrants shall not be entitled to any compensation in respect of any fractional Warrant Shares which is not issued.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(m)</td>
        <td style="text-align: justify">Section 4.1(a) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(n)</td>
        <td style="text-align: justify">Section 4.1(b) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(o)</td>
        <td style="text-align: justify">Section 4.1(c) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(p)</td>
        <td style="text-align: justify">Section 4.1(d) of the indenture is amended so that the first four references to "the Corporation" therein refer to "Tilray", the reference to "the Corporation, its successor, or such purchasing body corporate"
          therein shall refer to "the Corporation, Tilray, its successor, or such purchasing body corporate", the reference to "the Corporation and the Warrant Agent" therein shall refer to "the Corporation, Tilray and the Warrant Agent", and the reference
          to "the Corporation, any successor to the Corporation or such purchasing body corporate" therein shall refer to "the Corporation, Tilray, any successor to Tilray, or such purchasing body corporate".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(q)</td>
        <td style="text-align: justify">Section 4.1(e) of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 7 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(r)</td>
        <td style="text-align: justify">Section 4.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(s)</td>
        <td style="text-align: justify">Section 4.4 of the Indenture is amended so that the first reference to "the Corporation" therein shall refer to "the Corporation and Tilray" and the second reference to "the Corporation, the Warrant Agent, all
          holders and all other persons" therein shall refer to "the Corporation, Tilray, the Warrant Agent, all holders and all other persons".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(t)</td>
        <td style="text-align: justify">Section 4.5 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(u)</td>
        <td style="text-align: justify">Section 4.6 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(v)</td>
        <td style="text-align: justify">Section 4.7 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(w)</td>
        <td style="text-align: justify">Section 4.8 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(x)</td>
        <td style="text-align: justify">Section 4.9 of the Indenture is amended so that the references to "the Corporation" therein refer to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(y)</td>
        <td style="text-align: justify">Section 4.10 of the Indenture is amended so that references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0in"></td>
        <td style="width: 0.5in">(z)</td>
        <td style="text-align: justify">Section 5.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(aa)</td>
        <td style="text-align: justify">Section 5.5 of the Indenture is amended so that the last reference to "the Corporation" therein refers to "Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(bb)</td>
        <td style="text-align: justify">Section 5.6 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(cc)</td>
        <td style="text-align: justify">Section 6.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(dd)</td>
        <td style="text-align: justify">Section 6.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(ee)</td>
        <td style="text-align: justify">Section 8.1 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(ff)</td>
        <td style="text-align: justify">Section 8.2 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as the case may be".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(gg)</td>
        <td style="text-align: justify">Section 9.1 of the indenture is amended so that the reference to "The Corporation and the Warrant Agent" therein shall refer to "The Corporation, Tilray and the Warrant Agent".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(hh)</td>
        <td style="text-align: justify">Section 9.3 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">- 8 -</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(ii)</td>
        <td>Section 9.7 of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation and Tilray".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(jj)</td>
        <td>Section 10.1(1) of the Indenture is amended so that the references to "the Corporation" therein refer to "the Corporation or Tilray, as applicable".</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in">(kk)</td>
        <td style="padding-right: 1.3in">Section 10.1(1)(a) of the Indenture is deleted and replaced with the following: "If to the Corporation or Tilray:</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Tilray Brands, Inc.<br>
    655 Madison Avenue<br>
    19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<br>
    New York, New York<br>
    10065<br>
    <br>
  </p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Mitchell Gendel<br>
    Email: <u>mitchell.gendel@tilray.com</u></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">With a copy (which will not constitute notice) to:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">DLA Piper (Canada) LLP<br>
    Suite 6000, 1 First Canadian Place<br>
    PO Box 367, 100 King Street West<br>
    Toronto, ON<br>
    M5X 1E2</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">Attention: Russel Drew</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">Email: russel.drew@dlapiper.com</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">If to Tilray&#8217;s Transfer Agent:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Pacific Stock Transfer Company</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">6725 Via Austi Pkwy, Suite 300</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Las Vegas, Nevada 89119</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Maria Torres</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Email: MTorres@pacificstocktransfer.com</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">and to:</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Odyssey Trust Company</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">United Kingdom Building</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">350 &#8211; 409 Granville Street</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Vancouver BC V6C 1T2</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Attention: Paul Keyes</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Email: PKeyes@OdysseyTrust.com</p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>ARTICLE 3</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>MISCELLANEOUS</b></p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.1</b></td>
        <td style="text-align: justify"><b>Acceptance of Trust</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Warrant Agent accepts the trusts in this Third Supplemental Warrant Indenture and agrees to carry out and discharge the same upon the terms and conditions set out in this Third
    Supplemental Warrant Indenture and in accordance with the Indenture.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.2</b></td>
        <td style="text-align: justify"><b>Confirmation of Indenture</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Indenture as amended and supplemented by this Third Supplemental Warrant Indenture, is hereby confirmed and approved.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.3</b></td>
        <td style="text-align: justify"><b>Governing Law</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of British Columbia and the federal laws of
    Canada applicable therein and shall be binding upon the parties hereto and their respective successors and assigns.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left"><b>3.4</b></td>
        <td style="text-align: justify"><b>Counterparts</b></td>
      </tr>

  </table>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Third Supplemental Warrant Indenture may be executed in counterparts, each of which so executed shall be deemed to be an original, and each of such counterparts
    when taken together shall constitute one and the same instrument and notwithstanding their date of execution they shall be deemed to be dated as of the date hereof. Delivery of an executed copy of this Third Supplemental Warrant Indenture by electronic
    facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Indenture as of the date hereof.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>[<i>Signature page follows</i>]</b></p>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" class="BRPFPageBreakArea">
    <div style="TEXT-ALIGN: center" class="BRPFPageNumberArea"></div>
    <div style="PAGE-BREAK-AFTER: always" class="BRPFPageBreak">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in"><b>IN WITNESS WHEREOF </b>the parties hereto have executed this Third Supplemental Warrant Indenture under the hands of their proper signatories in that behalf.</p>
  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 4%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="width: 46%; border-bottom: Black 1pt solid">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Mitchell Gendel<br>
          </p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>COMPUTERSHARE TRUST COMPANY OF CANADA</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="border-bottom: Black 1pt solid">/s/ Brian Howarth<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Brian Howarth</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="border-bottom: 1pt solid #000000;" rowspan="1">/s/ Alan Zhang<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td rowspan="1">&#160;</td>
        <td rowspan="1">&#160;</td>
        <td rowspan="1">
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Alan Zhang</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Associate Trust Officer<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>HEXO CORP.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Per:</font></td>
        <td style="border-bottom: Black 1pt solid">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Rob Godfrey</p>
          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.12
<SEQUENCE>5
<FILENAME>ny20009174x12_ex4-12.htm
<DESCRIPTION>EXHIBIT 4.12
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="margin: 0; text-align: right"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit 4.12</b></font></p>
  <p style="margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="margin: 0"></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS SUPPLEMENTAL WARRANT INDENTURE</b> is made as of June 22, 2023.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMONG:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HEXO CORP.</b>, a corporation incorporated under the laws of Ontario
      (hereinafter called &#8220;<b>HEXO</b>&#8221;),</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b><font style="font-weight: normal">, a corporation
        incorporated under the laws of Delaware (hereinafter called &#8220;</font><b>Tilray</b><font style="font-weight: normal">&#8221;),</font></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TSX TRUST COMPANY</b>, a trust company existing under the laws of Ontario&#8206;
      (hereinafter called the &#8220;<b>Warrant Agent</b>&#8221;)</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>RECITALS</u></b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEXO and the Warrant Agent executed a warrant indenture dated as of August 24, 2021 (the &#8220;<b>Warrant Indenture</b>&#8221;), a copy of which is
            included in Schedule &#8220;A&#8221; hereto, providing for the issue, and governing the terms of, certain common share purchase warrants (the &#8220;<b>Warrants</b>&#8221;).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On the date hereof (the &#8220;</font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arrangement
              Effective Date</b><font style="font-weight: normal">&#8221;), Tilray acquired all of HEXO&#8217;s issued and outstanding common shares by way of a plan of arrangement (the &#8220;</font><b>Plan of Arrangement</b><font style="font-weight: normal">&#8221;) under the <i>Business



                Corporations Act</i> (Ontario) (the &#8220;</font><b>Arrangement</b><font style="font-weight: normal">&#8221;).</font></font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Section 5.1 of the Plan of Arrangement, each holder of a Warrant, to the extent such Warrant has not expired by 12:01a.m.
            (Toronto time) on the Arrangement Effective Date (the &#8220;<b>Effective Time</b>&#8221;) and the holder of such Warrant has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights, be
            entitled to be issued and receive and shall accept, for the same aggregate consideration, upon such exercise, in lieu of the number of common shares in the capital of HEXO (&#8220;<b>HEXO Shares</b>&#8221;) to which such holder was theretofore entitled
            upon exercise of such Warrants, the kind and aggregate number of shares of capital stock of Tilray (&#8220;<b>Tilray Shares</b>&#8221; or &#8220;<b>Common Shares</b>&#8221;) that such holder would have been entitled to be issued and receive if, immediately prior to
            the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Plan of Arrangement will trigger an adjustment under Article 4 (and, more specifically, Section 4.1(d)) of the Warrant Indenture, and as
            such, the Warrant Agent, relying on advice of Counsel, has determined it appropriate to give effect to or evidence the provisions of Section 4.1(d) of the Warrant Indenture by way of this Supplemental Warrant Indenture in order to provide for
            the application of the provisions of the Warrant Indenture with respect to the rights and interests of the Registered Warrantholders on and after the Arrangement Effective Date, and pursuant to Section 5.2 of the Plan of Arrangement.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Section 8.1 of the Warrant Indenture, subject to the prior approval of the TSX, HEXO and the Warrant Agent may execute and deliver
            indentures supplemental to the Warrant Indenture setting forth any adjustments resulting from the application of the provisions of Article 4 (Adjustments);</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The foregoing recitals are made as representations of HEXO and Tilray, and not by the Warrant Agent.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Warrant Agent has agreed to enter into this Supplemental Warrant Indenture and to hold all rights, interests and
            benefits contained herein for and on behalf of those persons who are holders of Warrants issued pursuant to the Warrant Indenture as modified by this Supplemental Warrant Indenture from time to time.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW THEREFORE THIS INDENTURE WITNESSES</b> that for good and valuable
      consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed and declared as follows:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture is supplemental to the Warrant Indenture and the Warrant Indenture shall henceforth be read in conjunction
            with this Supplemental Warrant Indenture and all the provisions of the Warrant Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of
            the Warrant Indenture and of this Supplemental Warrant Indenture were contained in one instrument and the expressions used herein shall have the same meaning as is ascribed to the corresponding expressions in the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On and after the date hereof, each reference to the Warrant Indenture, as amended by this Supplemental Warrant Indenture, &#8220;this Warrant
            Indenture&#8221;, &#8220;this indenture&#8221;, &#8220;herein&#8221;, &#8220;hereby&#8221;, and similar references, and each reference to the Warrant Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Warrant Indenture as
            amended hereby. Except as specifically amended by the Supplemental Warrant Indenture, all other terms and conditions of the Warrant Indenture shall remain in full force and unchanged.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All terms which are defined in the Warrant Indenture and are used but not defined in this Supplemental Warrant Indenture shall have the
            meanings ascribed to them in the Warrant Indenture as such meanings may be amended or supplemented with respect to the Warrants by this Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the
            Warrant Indenture and the meaning given to the same term in this Supplemental Warrant Indenture, the meaning given to the term in this Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray hereby covenants, acknowledges and agrees that, as and from the date hereof, it shall be bound by the terms of the Warrant Indenture
            and shall cause HEXO to comply with its obligations under the Warrant Indenture. In particular but without limitation, in accordance with the Plan of Arrangement and Section 5.1(a) thereof, and subject to the terms of the Warrant Indenture, to
            the extent a Holder of Warrants has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights thereafter, be entitled to be issued and receive and shall accept for the same aggregate
            consideration, upon such exercise, in lieu of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants, the kind and aggregate number of Common Shares that such holder would have been entitled to be
            issued and receive if, immediately prior to the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In furtherance of Tilray&#8217;s covenant in Section (d) of this Supplemental Warrant Indenture above, Tilray hereby covenants, acknowledges and
            agrees that, as and from the Arrangement Effective Date, Tilray shall make available or cause to be made available the Common Shares in accordance with and subject to the terms of the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the avoidance of doubt, from and after the Arrangement Effective Date, the Exercise Price payable in accordance with Section 3.2 of the
            Warrant Indenture shall be payable to Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Arrangement Effective Date, the following amendments to the Warrant Indenture shall take effect:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition for &#8220;Common Shares&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Common Shares</b>&#8221; means 0.4352 of a fully paid and non-assessable share of common
      stock in the capital of Tilray as such shares of common stock are presently constituted (provided that in no event shall any fractional share of common stock be issued and where the aggregate number of shares of common stock to be issued to a Holder
      would result in such a fractional share being issuable, then the number of such shares of common stock to be issued to such Holder shall be rounded down to the closest whole number without any additional compensation or cost), provided that in the
      event of any adjustment pursuant to Article 4 of the Warrant Indenture, &#8220;<b>Common Shares</b>&#8221; shall thereafter mean the shares or other securities or property resulting from such adjustment, and &#8220;<b>Common Share</b>&#8221; means any one of them.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References to the Corporation in the following sections of the Warrant Indenture shall be to Tilray: <u>Section 1.1</u> &#8220;Auditors&#8221;, &#8220;Common
            Shares&#8221;, &#8220;Convertible Security&#8221;, &#8220;Counsel&#8221;, &#8220;Dividends&#8221; and &#8220;Equity Shares&#8221;, &#8220;VWAP&#8221;, &#8220;Warrantholders&#8217; Request&#8221;; <u>Section 2.11</u> (Transfer and Ownership of Warrants); <u>Article 3</u> (Exercise of Warrants), provided that the words &#8220;in
            accordance with the following wire transfer instructions&#8221; and the wire instructions in Section 3.2(b) shall be removed and replaced with the words &#8220;as directed in writing by Tilray&#8221;; <u>Article 4</u> (Adjustment of Number of Common Shares and
            Exercise Price) provided that references to the Corporation in Section 4.10 (Protection of Warrant Agent) shall be to Tilray and HEXO; and <u>Section 6.2</u> (Suits by the Corporation).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;or Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 2.3</u> (Warrantholder not a Shareholder), <u>2.6</u>
            (Book Entry Only Warrants), <u>2.8</u> (Register of Warrants), <u>2.12</u> (Cancellation of Surrendered Warrants), <u>3.6</u> (Effect of Exercise of Warrant Certificates), <u>5.1</u> (Optional Purchases by the Corporation), <u>5.2(e)</u>
            (General Covenants), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>6.4</u> (Waiver of Default), <u>9.3</u> (Evidence, Experts and Advisers), <u>9.7</u> (Protection of Warrant Agent), <u>10.1</u> (Notice to the Corporation and
            the Warrant Agent) and <u>10.9</u> (Force Majeure).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;and Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 5.2</u> (General Covenants) other than
            Subsection 5.2(e), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>5.5</u> (Enforceability of Warrants), <u>7.9</u> (Corporation and Warrant Agent may be represented), and <u>7.10</u> (Powers Exercisable by Extraordinary
            Resolution); <u>Article 8</u> (Supplemental Indentures); <u>Sections 9.1</u> (Indenture Legislation), <u>9.7</u> (Protection of Warrant Agent) and <u>9.14</u> (Compliance with Privacy Code).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.2 (k) to (o) (General Covenants) are deleted and replaced in their entirety with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) it will engage in cannabis-related activities in Canada in accordance with the <i>Cannabis


        Act</i> (Canada) and all other applicable laws in Canada;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) to the extent it invests or engages (directly or indirectly) in any business or
      activity that is focused on serving the cannabis market in jurisdictions other than Canada, it will do so in accordance with all applicable laws in the relevant jurisdiction;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) it does not and will not specifically target or derive (or reasonably expect to
      derive) revenues or funds from any of the activities described in Section 5.2(l) above, unless and until such time that any such activities become legal under all applicable laws in the relevant jurisdiction; and</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;(n) it will provide the Warrant Agent with reasonable prior notice if it &#8206;decides to
      engage in any of the activities described in (m) above, and &#8206;the Corporation and Tilray agree that the Warrant Agent may, in its &#8206;sole discretion, immediately terminate any contract for services &#8206;between the Corporation and/or Tilray and the Warrant
      Agent (as &#8206;applicable) upon receipt of any information relating to the &#8206;Corporation&#8217;s or Tilray&#8217;s marijuana-related business activities, or as &#8206;otherwise permitted under any such contract for service.&#8206;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices to the Corporation or Tilray pursuant to Section 10.1(1) shall be delivered to HEXO c/o Tilray at:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray Brands, Inc.<br>
      655 Madison Avenue<br>
      19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<br>
      New York, New York<br>
      10065</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Mitchell Gendel</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>mitchell.gendel@tilray.com</u></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (which will not constitute notice) to:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DLA Piper (Canada) LLP<br>
      Suite 6000, 1 First Canadian Place<br>
      PO Box 367, 100 King Street West<br>
      Toronto, ON<br>
      M5X 1E2</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Russel Drew<br>
      Email: russel.drew@dlapiper.com</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray shall not have any responsibility or liability for any matter for which the liability of the Corporation does not have liability or
            responsibility under the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Section 5.2(e) of the Warrant Indenture, Tilray represents and warrants that the shares of common stock in the capital of
            Tilray are listed on the NASDAQ under the trading symbol &#8220;TLRY&#8221; and Tilray has filed a registration statement in respect of its shares of common stock with the SEC.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything in the Warrant Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued
            following the Arrangement Effective Date without the prior written consent of Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of Ontario and shall be
            binding upon the parties hereto and their respective successors and assigns.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture may be simultaneously executed (including by electronic signature) in several counterparts, each of which
            when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution shall be deemed to bear the date set out at the top of the first page of
            this Supplement Indenture. Delivery of an executed copy of this Supplemental Warrant Indenture by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution
            and delivery of this Supplemental Warrant Indenture as of the date hereof, acceptance of which shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURE PAGE TO FOLLOW]</b>&#160;</font></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF the parties hereto have executed this Supplemental Warrant Indenture as of
      the date first above written.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 3%; font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="width: 47%; border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Mitchell Gendel</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;"><b>TSX TRUST COMPANY</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Dalisha Dyal<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Dalisha Dyal</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Corporate Trust Officer<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Donald Crawford<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Donald Crawford</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Senior Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;"><b>HEXO CORP.</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Rob Godfrey</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>6
<FILENAME>ny20009174x12_ex4-14.htm
<DESCRIPTION>EXHIBIT 4.14
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="margin: 0; text-align: right"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit 4.14</b></font></p>
  <p style="margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="margin: 0"></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS SUPPLEMENTAL WARRANT INDENTURE</b> is made as of June 22, 2023.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMONG:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HEXO CORP.</b>, a corporation incorporated under the laws of Ontario (hereinafter called
      &#8220;<b>HEXO</b>&#8221;),</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b><font style="font-weight: normal">, a corporation incorporated
        under the laws of Delaware (hereinafter called &#8220;</font><b>Tilray</b><font style="font-weight: normal">&#8221;),</font></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160; <br>
    </font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TSX TRUST COMPANY</b>, a trust company existing under the laws of Ontario&#8206; (hereinafter
      called the &#8220;<b>Warrant Agent</b>&#8221;)</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>RECITALS</u></b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEXO and the Warrant Agent executed a common share purchase warrant indenture, dated as of June 5, 2020 (the &#8220;<b>Warrant Indenture</b>&#8221;), a
            copy of which is included in Schedule &#8220;A&#8221; hereto, providing for the issue, and governing the terms of, certain common share purchase warrants (the &#8220;<b>Warrants</b>&#8221;).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On the date hereof (the &#8220;</font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arrangement
              Effective Date</b><font style="font-weight: normal">&#8221;), Tilray acquired all of HEXO&#8217;s issued and outstanding common shares by way of a plan of arrangement (the &#8220;</font><b>Plan of Arrangement</b><font style="font-weight: normal">&#8221;) under the <i>Business



                Corporations Act</i> (Ontario) (the &#8220;</font><b>Arrangement</b><font style="font-weight: normal">&#8221;).</font></font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Section 5.1 of the Plan of Arrangement, each holder of a Warrant, to the extent such Warrant has not expired by 12:01a.m.
            (Toronto time) on the Arrangement Effective Date (the &#8220;<b>Effective Time</b>&#8221;) and the holder of such Warrant has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights, be
            entitled to be issued and receive and shall accept, for the same aggregate consideration, upon such exercise, in lieu of the number of common shares in the capital of HEXO (&#8220;<b>HEXO Shares</b>&#8221;) to which such holder was theretofore entitled
            upon exercise of such Warrants, the kind and aggregate number of shares of capital stock of Tilray (&#8220;<b>Tilray Shares</b>&#8221; or &#8220;<b>Common Shares</b>&#8221;) that such holder would have been entitled to be issued and receive if, immediately prior to
            the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Plan of Arrangement will trigger an adjustment under Article 4 (and, more specifically, Section 4.1(d)) of the Warrant Indenture, and as
            such, the Warrant Agent, relying on advice of Counsel, has determined it appropriate to give effect to or evidence the provisions of Section 4.1(d) of the Warrant Indenture by way of this Supplemental Warrant Indenture in order to provide for
            the application of the provisions of the Warrant Indenture with respect to the rights and interests of the Registered Warrantholders on and after the Arrangement Effective Date, and pursuant to Section 5.2 of the Plan of Arrangement.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Section 8.1 of the Warrant Indenture, subject to the prior approval of the TSX, HEXO and the Warrant Agent may execute and deliver
            indentures supplemental to the Warrant Indenture setting forth any adjustments resulting from the application of the provisions of Article 4 (Adjustments);</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The foregoing recitals are made as representations of HEXO and Tilray, and not by the Warrant Agent.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Warrant Agent has agreed to enter into this Supplemental Warrant Indenture and to hold all rights, interests and
            benefits contained herein for and on behalf of those persons who are holders of Warrants issued pursuant to the Warrant Indenture as modified by this Supplemental Warrant Indenture from time to time.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW THEREFORE THIS INDENTURE WITNESSES</b> that for good and valuable
      consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed and declared as follows:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture is supplemental to the Warrant Indenture and the Warrant Indenture shall henceforth be read in conjunction
            with this Supplemental Warrant Indenture and all the provisions of the Warrant Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of
            the Warrant Indenture and of this Supplemental Warrant Indenture were contained in one instrument and the expressions used herein shall have the same meaning as is ascribed to the corresponding expressions in the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On and after the date hereof, each reference to the Warrant Indenture, as amended by this Supplemental Warrant Indenture, &#8220;this Warrant
            Indenture&#8221;, &#8220;this indenture&#8221;, &#8220;herein&#8221;, &#8220;hereby&#8221;, and similar references, and each reference to the Warrant Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Warrant Indenture as
            amended hereby. Except as specifically amended by the Supplemental Warrant Indenture, all other terms and conditions of the Warrant Indenture shall remain in full force and unchanged.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All terms which are defined in the Warrant Indenture and are used but not defined in this Supplemental Warrant Indenture shall have the
            meanings ascribed to them in the Warrant Indenture as such meanings may be amended or supplemented with respect to the Warrants by this Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the
            Warrant Indenture and the meaning given to the same term in this Supplemental Warrant Indenture, the meaning given to the term in this Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray hereby covenants, acknowledges and agrees that, as and from the date hereof, it shall be bound by the terms of the Warrant Indenture
            and shall cause HEXO to comply with its obligations under the Warrant Indenture. In particular but without limitation, in accordance with the Plan of Arrangement and Section 5.1(a) thereof, and subject to the terms of the Warrant Indenture, to
            the extent a Holder of Warrants has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights thereafter, be entitled to be issued and receive and shall accept for the same aggregate
            consideration, upon such exercise, in lieu of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants, the kind and aggregate number of Common Shares that such holder would have been entitled to be
            issued and receive if, immediately prior to the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In furtherance of Tilray&#8217;s covenant in Section (d) of this Supplemental Warrant Indenture above, Tilray hereby covenants, acknowledges and
            agrees that, as and from the Arrangement Effective Date, Tilray shall make available or cause to be made available the Common Shares in accordance with and subject to the terms of the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the avoidance of doubt, from and after the Arrangement Effective Date, the Exercise Price payable in accordance with Section 3.2 of the
            Warrant Indenture shall be payable to Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Arrangement Effective Date, the following amendments to the Warrant Indenture shall take effect:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition for &#8220;Common Shares&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Common Shares</b>&#8221; means 0.4352 of a fully paid and non-assessable share of common
      stock in the capital of Tilray as such shares of common stock are presently constituted (provided that in no event shall any fractional share of common stock be issued and where the aggregate number of shares of common stock to be issued to a Holder
      would result in such a fractional share being issuable, then the number of such shares of common stock to be issued to such Holder shall be rounded down to the closest whole number without any additional compensation or cost), provided that in the
      event of any adjustment pursuant to Article 4 of the Warrant Indenture, &#8220;<b>Common Shares</b>&#8221; shall thereafter mean the shares or other securities or property resulting from such adjustment, and &#8220;<b>Common Share</b>&#8221; means any one of them.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition for &#8220;NYSE&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Nasdaq</b>&#8221; means Nasdaq Capital Market;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and all references to NYSE in the Warrant Indenture shall be to Nasdaq.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References to the Corporation in the following sections of the Warrant Indenture shall be to Tilray: <u>Section 1.1</u> &#8220;Auditors&#8221;, &#8220;Common
            Shares&#8221;, &#8220;Convertible Security&#8221;, &#8220;Counsel&#8221;, &#8220;Dividends&#8221; and &#8220;Equity Shares&#8221;, &#8220;VWAP&#8221;, &#8220;Warrantholders&#8217; Request&#8221;; <u>Section 2.11</u> (Transfer and Ownership of Warrants); <u>Article 3</u> (Exercise of Warrants), provided that the words &#8220;in
            accordance with the following wire transfer instructions&#8221; and the wire instructions in Section 3.2(b) shall be removed and replaced with the words &#8220;as directed in writing by Tilray&#8221;; <u>Article 4</u> (Adjustment of Number of Common Shares and
            Exercise Price) provided that references to the Corporation in Section 4.10 (Protection of Warrant Agent) shall be to Tilray and HEXO; and <u>Section 6.2</u> (Suits by the Corporation).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;or Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 2.3</u> (Warrantholder not a Shareholder), <u>2.6</u>
            (Book Entry Only Warrants), <u>2.8</u> (Register of Warrants), <u>2.12</u> (Cancellation of Surrendered Warrants), <u>3.6</u> (Effect of Exercise of Warrant Certificates), <u>5.1</u> (Optional Purchases by the Corporation), <u>5.2(e)</u>
            (General Covenants), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>6.4</u> (Waiver of Default), <u>9.3</u> (Evidence, Experts and Advisers), <u>9.7</u> (Protection of Warrant Agent), <u>10.1</u> (Notice to the Corporation and
            the Warrant Agent) and <u>10.9</u> (Force Majeure).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;and Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 5.2</u> (General Covenants) other than
            Subsection 5.2(e), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>5.5</u> (Enforceability of Warrants), <u>7.9</u> (Corporation and Warrant Agent may be represented), and <u>7.10</u> (Powers Exercisable by Extraordinary
            Resolution); <u>Article 8</u> (Supplemental Indentures); <u>Sections 9.1</u> (Indenture Legislation), <u>9.7</u> (Protection of Warrant Agent) and <u>9.14</u> (Compliance with Privacy Code).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 2.14 (Legends) shall be deleted.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.2 (i) to (m) (General Covenants) are deleted and replaced in their entirety with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) it will engage in cannabis-related activities in Canada in accordance with the <i>Cannabis


        Act</i> (Canada) and all other applicable laws in Canada;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) to the extent it invests or engages (directly or indirectly) in any business or
      activity that is focused on serving the cannabis market in jurisdictions other than Canada, it will do so in accordance with all applicable laws in the relevant jurisdiction;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) it does not and will not specifically target or derive (or reasonably expect to
      derive) revenues or funds from any of the activities described in Section 5.2(l) above, unless and until such time that any such activities become legal under all applicable laws in the relevant jurisdiction; and</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) it will provide the Warrant Agent with reasonable prior notice if it decides to
      engage in any of the activities described in (m) above, and the Corporation and Tilray agree that the Warrant Agent may, in its sole discretion, immediately terminate any contract for services between the Corporation and/or Tilray and the Warrant
      Agent (as applicable) upon receipt of any information relating to the Corporation&#8217;s or Tilray&#8217;s marijuana-related business activities, or as otherwise permitted under any such contract for service.</font></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 72pt"></td>
        <td style="width: 40.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices to the Corporation or Tilray pursuant to Section 10.1(1) shall be delivered to HEXO care of / Tilray, respectively, at:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray Brands, Inc.<br>
      655 Madison Avenue<br>
      19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor<br>
      New York, New York<br>
      10065</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Mitchell Gendel</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>mitchell.gendel@tilray.com</u></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (which will not constitute notice) to:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DLA Piper (Canada) LLP<br>
      Suite 6000, 1 First Canadian Place<br>
      PO Box 367, 100 King Street West<br>
      Toronto, ON<br>
      M5X 1E2</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Russel Drew<br>
      Email: russel.drew@dlapiper.com</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray shall not have any responsibility or liability for any matter for which the liability of the Corporation does not have liability or
            responsibility under the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Section 5.2(e) of the Warrant Indenture, Tilray represents and warrants that the shares of common stock in the capital of
            Tilray are listed on the NASDAQ under the trading symbol &#8220;TLRY&#8221; and Tilray has filed a registration statement in respect of its shares of common stock with the SEC.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything in the Warrant Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued
            following the Arrangement Effective Date without the prior written consent of Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of Ontario and shall be
            binding upon the parties hereto and their respective successors and assigns.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture may be simultaneously executed (including by electronic signature) in several counterparts, each of which
            when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution shall be deemed to bear the date set out at the top of the first page of
            this Supplement Indenture. Delivery of an executed copy of this Supplemental Warrant Indenture by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution
            and delivery of this Supplemental Warrant Indenture as of the date hereof, acceptance of which shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURE PAGE TO FOLLOW]</b>&#160;</font></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF the parties hereto have executed this Supplemental Warrant Indenture as of
      the date first above written.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 3%; font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="width: 47%; border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Mitchell Gendel</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;"><b>TSX TRUST COMPANY</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Dalisha Dyal<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Dalisha Dyal</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Corporate Trust Officer<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Donald Crawford<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Donald Crawford</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Senior Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-family: 'Times New Roman'; font-size: 10pt;"><b>HEXO CORP.</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>
        <td style="padding-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Rob Godfrey</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="margin: 0">&#160;</p>
  <p style="margin: 0"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.16
<SEQUENCE>7
<FILENAME>ny20009174x12_ex4-16.htm
<DESCRIPTION>EXHIBIT 4.16
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="margin: 0; text-align: right"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit 4.16</b></font></p>
  <p style="margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS SUPPLEMENTAL WARRANT INDENTURE</b> is made as of June 22, 2023.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMONG:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HEXO CORP.</b>, a corporation incorporated under the laws of Ontario (hereinafter called
      &#8220;<b>HEXO</b>&#8221;),</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b><font style="font-weight: normal">, a corporation incorporated
        under the laws of Delaware (hereinafter called &#8220;</font><b>Tilray</b><font style="font-weight: normal">&#8221;),</font></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TSX TRUST COMPANY</b>, a trust company existing under the laws of Ontario&#8206; (hereinafter
      called the &#8220;<b>Warrant Agent</b>&#8221;)</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>RECITALS</u></b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">HEXO and the Warrant Agent executed a warrant indenture, dated as of May 21, 2020 (the &#8220;<b>Warrant Indenture</b>&#8221;), a
            copy of which is included in Schedule &#8220;A&#8221; hereto, providing for the issue, and governing the terms, of certain common share purchase warrants (the &#8220;<b>Warrants</b>&#8221;).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On the date hereof (the &#8220;</font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arrangement
              Effective Date</b><font style="font-weight: normal">&#8221;), Tilray acquired all of HEXO&#8217;s issued and outstanding common shares by way of a plan of arrangement (the &#8220;</font><b>Plan of Arrangement</b><font style="font-weight: normal">&#8221;) under the <i>Business



                Corporations Act</i> (Ontario) (the &#8220;</font><b>Arrangement</b><font style="font-weight: normal">&#8221;).</font></font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.1 of the Plan of Arrangement, each holder of a Warrant, to the extent such Warrant has not expired by 12:01a.m. (Toronto time) on
            the Arrangement Effective Date (the &#8220;<b>Effective Time</b>&#8221;) and the holder of such Warrant has not exercised its rights of acquisition thereunder prior to the Effective <font style="font-weight: normal">Time</font>, shall, upon the exercise
            of such rights, be entitled to be issued and receive and shall accept, for the same aggregate consideration, upon such exercise, in lieu of the number of common shares in the capital of HEXO (&#8220;<b>HEXO Shares</b>&#8221;) to which such holder was
            theretofore entitled upon exercise of such Warrants, the kind and aggregate number of shares of capital stock of Tilray (&#8220;<b>Tilray Shares</b>&#8221; or &#8220;<b>Common Shares</b>&#8221;) that such holder would have been entitled to be issued and receive if,
            immediately prior to the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Plan of Arrangement will trigger an adjustment under Article 4 (and, more specifically, Section 4.1(d)) of the Warrant Indenture, and as
            such, the Warrant Agent, relying on advice of Counsel, has determined it appropriate to give effect to or evidence the provisions of Section 4.1(d) of the Warrant Indenture by way of this Supplemental Warrant Indenture in order to provide for
            the application of the provisions of the Warrant Indenture with respect to the rights and interests of the Registered Warrantholders on and after the Arrangement Effective Date, and pursuant to Section 5.2 of the Plan of Arrangement.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Section 8.1 of the Warrant Indenture, subject to the prior approval of the TSX, HEXO and the Warrant Agent may execute and deliver
            indentures supplemental to the Warrant Indenture setting forth any adjustments resulting from the application of the provisions of Article 4 (Adjustments);</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The foregoing recitals are made as representations of HEXO and Tilray, and not by the Warrant Agent.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Warrant Agent has agreed to enter into this Supplemental Warrant Indenture and to hold all rights, interests and
            benefits contained herein for and on behalf of those persons who are holders of Warrants issued pursuant to the Warrant Indenture as modified by this Supplemental Warrant Indenture from time to time.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW THEREFORE THIS INDENTURE WITNESSES</b> that for good and valuable
      consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed and declared as follows:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160; <br>
    </font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture is supplemental to the Warrant Indenture and the Warrant Indenture shall henceforth be read in conjunction
            with this Supplemental Warrant Indenture and all the provisions of the Warrant Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of
            the Warrant Indenture and of this Supplemental Warrant Indenture were contained in one instrument and the expressions used herein shall have the same meaning as is ascribed to the corresponding expressions in the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On and after the date hereof, each reference to the Warrant Indenture, as amended by this Supplemental Warrant Indenture, &#8220;this Warrant
            Indenture&#8221;, &#8220;this indenture&#8221;, &#8220;herein&#8221;, &#8220;hereby&#8221;, and similar references, and each reference to the Warrant Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Warrant Indenture as
            amended hereby. Except as specifically amended by the Supplemental Warrant Indenture, all other terms and conditions of the Warrant Indenture shall remain in full force and unchanged.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All terms which are defined in the Warrant Indenture and are used but not defined in this Supplemental Warrant Indenture shall have the
            meanings ascribed to them in the Warrant Indenture as such meanings may be amended or supplemented with respect to the Warrants by this Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the
            Warrant Indenture and the meaning given to the same term in this Supplemental Warrant Indenture, the meaning given to the term in this Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray hereby covenants, acknowledges and agrees that, as and from the date hereof, it shall be bound by the terms of the Warrant Indenture
            and shall cause HEXO to comply with its obligations under the Warrant Indenture. In particular but without limitation, in accordance with the Plan of Arrangement and Section 5.1(a) thereof, and subject to the terms of the Warrant Indenture, to
            the extent a Holder of Warrants has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights thereafter, be entitled to be issued and receive and shall accept for the same aggregate
            consideration, upon such exercise, in lieu of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants, the kind and aggregate number of Common Shares that such holder would have been entitled to be
            issued and receive if, immediately prior to the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In furtherance of Tilray&#8217;s covenant in Section (d) of this Supplemental Warrant Indenture above, Tilray hereby covenants, acknowledges and
            agrees that, as and from the Arrangement Effective Date, Tilray shall make available or cause to be made available the Common Shares in accordance with and subject to the terms of the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the avoidance of doubt, from and after the Arrangement Effective Date, the Exercise Price payable in accordance with Section 3.2 of the
            Warrant Indenture shall be payable to Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Arrangement Effective Date, the following amendments to the Warrant Indenture shall take effect:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition for &#8220;Common Shares&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Common Shares</b>&#8221; means 0.4352 of a fully paid and non-assessable share of common
      stock in the capital of Tilray as such shares of common stock are presently constituted (provided that in no event shall any fractional share of common stock be issued and where the aggregate number of shares of common stock to be issued to a Holder
      would result in such a fractional share being issuable, then the number of such shares of common stock to be issued to such Holder shall be rounded down to the closest whole number without any additional compensation or cost), provided that in the
      event of any adjustment pursuant to Article 4 of the Warrant Indenture, &#8220;<b>Common Shares</b>&#8221; shall thereafter mean the shares or other securities or property resulting from such adjustment, and &#8220;<b>Common Share</b>&#8221; means any one of them.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The definition for &#8220;NYSE&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#8220;<b>Nasdaq</b>&#8221; means Nasdaq Capital Market;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">and all references to NYSE in the Warrant Indenture shall
      be to Nasdaq.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References to the Corporation in the following sections of the Warrant Indenture shall be to Tilray: <u>Section 1.1</u> &#8220;Auditors&#8221;, &#8220;Common
            Shares&#8221;, &#8220;Convertible Security&#8221;, &#8220;Counsel&#8221;, &#8220;Dividends&#8221; and &#8220;Equity Shares&#8221;, &#8220;VWAP&#8221;, &#8220;Warrantholders&#8217; Request&#8221;; <u>Section 2.11</u> (Transfer and Ownership of Warrants); <u>Article 3</u> (Exercise of Warrants), provided that the words &#8220;in
            accordance with the following wire transfer instructions&#8221; and the wire instructions in Section 3.2(b) shall be removed and replaced with the words &#8220;as directed in writing by Tilray&#8221;; <u>Article 4</u> (Adjustment of Number of Common Shares and
            Exercise Price) provided that references to the Corporation in Section 4.10 (Protection of Warrant Agent) shall be to Tilray and HEXO; and <u>Section 6.2</u> (Suits by the Corporation).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;or Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 2.3</u> (Warrantholder not a Shareholder), <u>2.6</u>
            (Book Entry Only Warrants), <u>2.8</u> (Register of Warrants), <u>2.12</u> (Cancellation of Surrendered Warrants), <u>3.6</u> (Effect of Exercise of Warrant Certificates), <u>5.1</u> (Optional Purchases by the Corporation), <u>5.2(e)</u>
            (General Covenants), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>6.4</u> (Waiver of Default), <u>9.3</u> (Evidence, Experts and Advisers), <u>9.7</u> (Protection of Warrant Agent), <u>10.1</u> (Notice to the Corporation and
            the Warrant Agent) and <u>10.9</u> (Force Majeure).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;and Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 5.2</u> (General Covenants) other than
            Subsection 5.2(e), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>5.5</u> (Enforceability of Warrants), <u>7.9</u> (Corporation and Warrant Agent may be represented), and <u>7.10</u> (Powers Exercisable by Extraordinary
            Resolution); <u>Article 8</u> (Supplemental Indentures); <u>Sections 9.1</u> (Indenture Legislation), <u>9.7</u> (Protection of Warrant Agent) and <u>9.14</u> (Compliance with Privacy Code).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.2 (k) to (o) (General Covenants) are deleted and replaced in their entirety with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) it will engage in cannabis-related activities in Canada in accordance with the <i>Cannabis


        Act</i> (Canada) and all other applicable laws in Canada;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) to the extent it invests or engages (directly or indirectly) in any business or
      activity that is focused on serving the cannabis market in jurisdictions other than Canada, it will do so in accordance with all applicable laws in the relevant jurisdiction;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) it does not and will not specifically target or derive (or reasonably expect to
      derive) revenues or funds from any of the activities described in Section 5.2(l) above, unless and until such time that any such activities become legal under all applicable laws in the relevant jurisdiction; and</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8206;(n) it will provide the Warrant Agent with reasonable prior notice if it &#8206;decides to
      engage in any of the activities described in (m) above, and &#8206;the Corporation and Tilray agree that the Warrant Agent may, in its &#8206;sole discretion, immediately terminate any contract for services &#8206;between the Corporation and/or Tilray and the Warrant
      Agent (as &#8206;applicable) upon receipt of any information relating to the &#8206;Corporation&#8217;s or Tilray&#8217;s marijuana-related business activities, or as &#8206;otherwise permitted under any such contract for service.&#8206;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices to the Corporation or Tilray pursuant to Section 10.1(1) shall be delivered to HEXO c/o Tilray at:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray Brands, Inc.</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655 Madison Avenue</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10065&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Mitchell Gendel</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>mitchell.gendel@tilray.com</u></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (which will not constitute notice) to:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DLA Piper (Canada) LLP<br>
      Suite 6000, 1 First Canadian Place<br>
      PO Box 367, 100 King Street West<br>
      Toronto, ON<br>
      M5X 1E2</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Russel Drew<br>
      Email: russel.drew@dlapiper.com</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray shall not have any responsibility or liability for any matter for which the liability of the Corporation does not have liability or
            responsibility under the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Section 5.2(e) of the Warrant Indenture, Tilray represents and warrants that the shares of common stock in the capital of
            Tilray are listed on the NASDAQ under the trading symbol &#8220;TLRY&#8221; and Tilray has filed a registration statement in respect of its shares of common stock with the SEC.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything in the Warrant Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued
            following the Arrangement Effective Date without the prior written consent of Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of Ontario and shall be
            binding upon the parties hereto and their respective successors and assigns.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture may be simultaneously executed (including by electronic signature) in several counterparts, each of which
            when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution shall be deemed to bear the date set out at the top of the first page of
            this Supplement Indenture. Delivery of an executed copy of this Supplemental Warrant Indenture by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution
            and delivery of this Supplemental Warrant Indenture as of the date hereof, acceptance of which shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURE PAGE TO FOLLOW]</b>&#160;</font></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF the parties hereto have executed this Supplemental Warrant Indenture as of
      the date first above written.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 3%; font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="width: 47%; border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Mitchell Gendel</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';"><b>TSX TRUST COMPANY</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Dalisha Dyal<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Dalisha Dyal</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Corporate Trust Officer<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Donald Crawford<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Donald Crawford</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Senior Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';"><b>HEXO CORP.</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Rob Godfrey</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="margin: 0">&#160;</p>
  <p style="margin: 0"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.18
<SEQUENCE>8
<FILENAME>ny20009174x12_ex4-18.htm
<DESCRIPTION>EXHIBIT 4.18
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="margin: 0; text-align: right"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit 4.18</b></font></p>
  <p style="margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="margin: 0"></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS SUPPLEMENTAL WARRANT INDENTURE</b> is made as of June 22, 2023.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMONG:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>HEXO CORP.</b>, a corporation incorporated under the laws of Ontario (hereinafter called
      &#8220;<b>HEXO</b>&#8221;),</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b><font style="font-weight: normal">, a corporation incorporated
        under the laws of Delaware (hereinafter called &#8220;</font><b>Tilray</b><font style="font-weight: normal">&#8221;),</font></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TSX TRUST COMPANY</b>, a trust company existing under the laws of Ontario&#8206; (hereinafter
      called the &#8220;<b>Warrant Agent</b>&#8221;)</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 1in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>RECITALS</u></b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS:</b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEXO and the Warrant Agent executed a warrant indenture, dated as of April 13, 2020 (the &#8220;<b>Warrant Indenture</b>&#8221;), a copy of which is
            included in Schedule &#8220;A&#8221; hereto, providing for the issue, and governing the terms, of certain common share purchase warrants (the &#8220;<b>Warrants</b>&#8221;).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On the date hereof (the &#8220;</font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arrangement
              Effective Date</b><font style="font-weight: normal">&#8221;), Tilray acquired all of HEXO&#8217;s issued and outstanding common shares by way of a plan of arrangement (the &#8220;</font><b>Plan of Arrangement</b><font style="font-weight: normal">&#8221;) under the <i>Business



                Corporations Act</i> (Ontario) (the &#8220;</font><b>Arrangement</b><font style="font-weight: normal">&#8221;).</font></font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Section 5.1 of the Plan of Arrangement, each holder of a Warrant, to the extent such Warrant has not expired by 12:01a.m.
            (Toronto time) on the Arrangement Effective Date (the &#8220;<b>Effective Time</b>&#8221;) and the holder of such Warrant has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights, be
            entitled to be issued and receive and shall accept, for the same aggregate consideration, upon such exercise, in lieu of the number of common shares in the capital of HEXO (&#8220;<b>HEXO Shares</b>&#8221;) to which such holder was theretofore entitled
            upon exercise of such Warrants, the kind and aggregate number of shares of capital stock of Tilray (&#8220;<b>Tilray Shares</b>&#8221; or &#8220;<b>Common Shares</b>&#8221;) that such holder would have been entitled to be issued and receive if, immediately prior to
            the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Plan of Arrangement will trigger an adjustment under Article 4 (and, more specifically, Section 4.1(d)) of the Warrant Indenture, and as
            such, the Warrant Agent, relying on advice of Counsel, has determined it appropriate to give effect to or evidence the provisions of Section 4.1(d) of the Warrant Indenture by way of this Supplemental Warrant Indenture in order to provide for
            the application of the provisions of the Warrant Indenture with respect to the rights and interests of the Registered Warrantholders on and after the Arrangement Effective Date, and pursuant to Section 5.2 of the Plan of Arrangement.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#8206;Under Section 8.1 of the Warrant Indenture, subject to the prior approval of the TSX, &#8206;HEXO and the Warrant Agent may
            execute and deliver indentures supplemental to the &#8206;Warrant Indenture setting forth any adjustments resulting from the application of the &#8206;provisions of Article 4 (Adjustments);&#8206;</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The foregoing recitals are made as representations of HEXO and Tilray, and not by the Warrant Agent.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Warrant Agent has agreed to enter into this Supplemental Warrant Indenture and to hold all rights, interests and
            benefits contained herein for and on behalf of those persons who are holders of Warrants issued pursuant to the Warrant Indenture as modified by this Supplemental Warrant Indenture from time to time.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW THEREFORE THIS INDENTURE WITNESSES</b> that for good and valuable
      consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed and declared as follows:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture is supplemental to the Warrant Indenture and the Warrant Indenture shall henceforth be read in conjunction
            with this Supplemental Warrant Indenture and all the provisions of the Warrant Indenture, except only insofar as the same may be inconsistent with the express provisions hereof, shall apply and have the same effect as if all the provisions of
            the Warrant Indenture and of this Supplemental Warrant Indenture were contained in one instrument and the expressions used herein shall have the same meaning as is ascribed to the corresponding expressions in the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On and after the date hereof, each reference to the Warrant Indenture, as amended by this Supplemental Warrant Indenture, &#8220;this Warrant
            Indenture&#8221;, &#8220;this indenture&#8221;, &#8220;herein&#8221;, &#8220;hereby&#8221;, and similar references, and each reference to the Warrant Indenture in any other agreement, certificate, document or instrument relating thereto, shall mean and refer to the Warrant Indenture as
            amended hereby. Except as specifically amended by the Supplemental Warrant Indenture, all other terms and conditions of the Warrant Indenture shall remain in full force and unchanged.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All terms which are defined in the Warrant Indenture and are used but not defined in this Supplemental Warrant Indenture shall have the
            meanings ascribed to them in the Warrant Indenture as such meanings may be amended or supplemented with respect to the Warrants by this Supplemental Warrant Indenture. In the event of any inconsistency between the meaning given to a term in the
            Warrant Indenture and the meaning given to the same term in this Supplemental Warrant Indenture, the meaning given to the term in this Supplemental Warrant Indenture shall prevail to the extent of the inconsistency.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray hereby covenants, acknowledges and agrees that, as and from the date hereof, it shall be bound by the terms of the Warrant Indenture
            and shall cause HEXO to comply with its obligations under the Warrant Indenture. In particular but without limitation, in accordance with the Plan of Arrangement and Section 5.1(a) thereof, and subject to the terms of the Warrant Indenture, to
            the extent a Holder of Warrants has not exercised its rights of acquisition thereunder prior to the Effective Time, shall, upon the exercise of such rights thereafter, be entitled to be issued and receive and shall accept for the same aggregate
            consideration, upon such exercise, in lieu of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants, the kind and aggregate number of Common Shares that such holder would have been entitled to be
            issued and receive if, immediately prior to the Effective Time, such holder had been the registered holder of the number of HEXO Shares to which such holder was theretofore entitled upon exercise of such Warrants.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In furtherance of Tilray&#8217;s covenant in Section (d) of this Supplemental Warrant Indenture above, Tilray hereby covenants, acknowledges and
            agrees that, as and from the Arrangement Effective Date, Tilray shall make available or cause to be made available the Common Shares in accordance with and subject to the terms of the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the avoidance of doubt, from and after the Arrangement Effective Date, the Exercise Price payable in accordance with Section 3.2 of the
            Warrant Indenture shall be payable to Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the Arrangement Effective Date, the following amendments to the Warrant Indentures shall take effect:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition for &#8220;Common Shares&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>Common Shares</b>&#8221; means 0.4352 of a fully paid and non-assessable share of common
      stock in the capital of Tilray as such shares of common stock are presently constituted (provided that in no event shall any fractional share of common stock be issued and where the aggregate number of shares of common stock to be issued to a Holder
      would result in such a fractional share being issuable, then the number of such shares of common stock to be issued to such Holder shall be rounded down to the closest whole number without any additional compensation or cost), provided that in the
      event of any adjustment pursuant to Article 4 of the Warrant Indenture, &#8220;<b>Common Shares</b>&#8221; shall thereafter mean the shares or other securities or property resulting from such adjustment, and &#8220;<b>Common Share</b>&#8221; means any one of them.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The definition for &#8220;NYSE&#8221; in Section 1.1 of the Warrant Indenture shall be deleted and replaced with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#8220;<b>Nasdaq</b>&#8221; means Nasdaq Capital Market;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">and all references to NYSE in the Warrant Indenture shall
      be to Nasdaq.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References to the Corporation in the following sections of the Warrant Indenture shall be to Tilray: <u>Section 1.1</u> &#8220;Auditors&#8221;, &#8220;Common
            Shares&#8221;, &#8220;Convertible Security&#8221;, &#8220;Counsel&#8221;, &#8220;Dividends&#8221; and &#8220;Equity Shares&#8221;, &#8220;VWAP&#8221;, &#8220;Warrantholders&#8217; Request&#8221;; <u>Section 2.11</u> (Transfer and Ownership of Warrants); <u>Article 3</u> (Exercise of Warrants), provided that the words &#8220;in
            accordance with the following wire transfer instructions&#8221; and the wire instructions in Section 3.2(b) shall be removed and replaced with the words &#8220;as directed in writing by Tilray&#8221;; <u>Article 4</u> (Adjustment of Number of Common Shares and
            Exercise Price) provided that references to the Corporation in Section 4.10 (Protection of Warrant Agent) shall be to Tilray and HEXO; and <u>Section 6.2</u> (Suits by the Corporation).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;or Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 2.3</u> (Warrantholder not a Shareholder), <u>2.6</u>
            (Book Entry Only Warrants), <u>2.8</u> (Register of Warrants), <u>2.12</u> (Cancellation of Surrendered Warrants), <u>3.6</u> (Effect of Exercise of Warrant Certificates), <u>5.1</u> (Optional Purchases by the Corporation), <u>5.2(e)</u>
            (General Covenants), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>6.4</u> (Waiver of Default), <u>9.3</u> (Evidence, Experts and Advisers), <u>9.7</u> (Protection of Warrant Agent), <u>10.1</u> (Notice to the Corporation and
            the Warrant Agent) and <u>10.9</u> (Force Majeure).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference to &#8220;and Tilray&#8221; shall be added after each reference to the &#8220;Corporation&#8221; in <u>Sections 5.2</u> (General Covenants) other than
            Subsection 5.2(e), <u>5.4</u> (Performance of Covenants by Warrant Agent), <u>5.5</u> (Enforceability of Warrants), <u>7.9</u> (Corporation and Warrant Agent may be represented), and <u>7.10</u> (Powers Exercisable by Extraordinary
            Resolution); <u>Article 8</u> (Supplemental Indentures); <u>Sections 9.1</u> (Indenture Legislation), <u>9.7</u> (Protection of Warrant Agent) and <u>9.14</u> (Compliance with Privacy Code).</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.2 (k) to (o) (General Covenants) are deleted and replaced in their entirety with the following:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) it will engage in cannabis-related activities in Canada in accordance with the <i>Cannabis


        Act</i> (Canada) and all other applicable laws in Canada;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) to the extent it invests or engages (directly or indirectly) in any business or
      activity that is focused on serving the cannabis market in jurisdictions other than Canada, it will do so in accordance with all applicable laws in the relevant jurisdiction;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) it does not and will not specifically target or derive (or reasonably expect to
      derive) revenues or funds from any of the activities described in Section 5.2(l) above, unless and until such time that any such activities become legal under all applicable laws in the relevant jurisdiction; and</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) it will provide the Warrant Agent with reasonable prior notice if it decides to
      engage in any of the activities described in (m) above, and the Corporation and Tilray agree that the Warrant Agent may, in its sole discretion, immediately terminate any contract for services between the Corporation and/or Tilray and the Warrant
      Agent (as applicable) upon receipt of any information relating to the Corporation&#8217;s or Tilray&#8217;s marijuana-related business activities, or as otherwise permitted under any such contract for service.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 1in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices to the Corporation or Tilray pursuant to Section 10.1(1) shall be delivered to HEXO c/o Tilray at:</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray Brands, Inc.</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655 Madison Avenue</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10065&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;Mitchell Gendel</font><br>
    <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>mitchell.gendel@tilray.com</u></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (which will not constitute notice) to:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DLA Piper (Canada) LLP<br>
      Suite 6000, 1 First Canadian Place<br>
      PO Box 367, 100 King Street West<br>
      Toronto, ON<br>
      M5X 1E2</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Russel Drew<br>
      Email: russel.drew@dlapiper.com</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray shall not have any responsibility or liability for any matter for which the liability of the Corporation does not have liability or
            responsibility under the Warrant Indenture.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Section 5.2(e) of the Warrant Indenture, Tilray represents and warrants that the shares of common stock in the capital of
            Tilray are listed on the NASDAQ under the trading symbol &#8220;TLRY&#8221; and Tilray has filed a registration statement in respect of its shares of common stock with the SEC.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything in the Warrant Indenture, HEXO, Tilray and the Warrant Agent hereby confirm that no Warrants shall be issued
            following the Arrangement Effective Date without the prior written consent of Tilray.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture shall be governed by and be construed in accordance with the laws of the Province of Ontario and shall be
            binding upon the parties hereto and their respective successors and assigns.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</font></td>
        <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Supplemental Warrant Indenture may be simultaneously executed (including by electronic signature) in several counterparts, each of which
            when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution shall be deemed to bear the date set out at the top of the first page of
            this Supplement Indenture. Delivery of an executed copy of this Supplemental Warrant Indenture by electronic facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution
            and delivery of this Supplemental Warrant Indenture as of the date hereof, acceptance of which shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.</font></td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-bottom: 0pt; font: 8pt Arial, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[SIGNATURE PAGE TO FOLLOW]</b>&#160;</font></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF the parties hereto have executed this Supplemental Warrant Indenture as of
      the date first above written.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TILRAY BRANDS, INC.</b></font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 3%; font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="width: 47%; border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Mitchell Gendel<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Mitchell Gendel</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Global General Counsel<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';"><b>TSX TRUST COMPANY</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Dalisha Dyal<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Dalisha Dyal</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Corporate Trust Officer<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Donald Crawford<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Donald Crawford</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Senior Manager, Corporate Trust<br>
          </p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2" style="font-size: 10pt; font-family: 'Times New Roman';"><b>HEXO CORP.</b></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">Per:</td>
        <td style="border-bottom: 1pt solid Black; padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">/s/ Rob Godfrey<br>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</td>
        <td style="padding-left: 5pt; font-size: 10pt; font-family: 'Times New Roman';">
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Name: Rob Godfrey</p>
          <p style="font-style: normal; font-weight: normal; line-height: normal; font-size-adjust: none; font-stretch: normal; font-feature-settings: normal; font-language-override: normal; font-kerning: auto; font-synthesis: weight style; font-variant: normal; margin: 0pt 0px;">Title:&#160;&#160; Director<br>
          </p>
        </td>
      </tr>

  </table>
  <p style="margin: 0">&#160;</p>
  <p style="margin: 0"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>9
<FILENAME>ny20009174x12_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="margin: 0"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0"></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit 5.1 </b></font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"> <img src="ny20009174x12_ex5-1img01.jpg"></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2023</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tilray Brands, Inc.&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265 Talbot Street West&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><br>
  </p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leamington, Ontario, Canada</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies and Gentlemen:</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are acting as counsel to Tilray Brands, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;),


      in connection with the offering of up to 1,471,295 shares of its common stock, par value $0.0001 per share (&#8220;<b>Common Stock</b>&#8221;), issuable upon the exercise of warrants (the &#8220;<b>Warrants</b>&#8221;) to purchase shares of Common Stock (the &#8220;<b>Shares</b>&#8221;)



      that were assumed by the Company pursuant to an arrangement agreement, dated as of April 10, 2023, as amended on June 1, 2023 (as amended, the &#8220;<b>Arrangement Agreement</b>&#8221;), by and between the Company and HEXO Corp. a corporation existing under the
      laws of the Province of Ontario, as described in the Prospectus (as defined below), pursuant to a Registration Statement on Form S-3 (Registration Statement No. 333-267788) (the &#8220;<b>Registration Statement</b>&#8221;), filed with the Securities and Exchange
      Commission (the &#8220;<b>Commission</b>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<b>Act</b>&#8221;), the prospectus included in the Registration Statement (the &#8220;<b>Base Prospectus</b>&#8221;), and the prospectus supplement dated June 22, 2023, filed with
      the Commission pursuant to Rule 424(b) of the Rules and Regulations of the Act (the &#8220;<b>Prospectus Supplement</b>&#8221; and together with the Base Prospectus, the &#8220;<b>Prospectus</b>&#8221;). The Registration Statement was filed with the Commission and became
      automatically effective on October 7, 2022.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As counsel for the Company, we have examined originals or copies, certified or otherwise
      identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary for the purposes of rendering this opinion and we are familiar with the proceedings taken and
      proposed to be taken by the Company in relation to the registration of the issuance and sale of the Shares. In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the
      conformity with the originals of all documents submitted to us as copies. This opinion letter is given, and all statements herein are made, in the context of the foregoing.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This opinion letter is based as to matters of laws of the State of Delaware. We express no
      opinion herein as to any other laws, statutes, ordinances, rules, or regulations. As used herein, the term &#8220;laws of the State of Delaware&#8221; includes the Delaware laws and rules, regulations and orders thereunder that are currently in effect, all
      applicable provisions of the Delaware Constitution and reported judicial decisions interpreting these laws.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to our opinion expressed below, we have assumed that at or prior to the time of
      issuance of the Shares, the Registration Statement will not have been modified, withdrawn or deregistered and that there will not have occurred any change in law affecting the validity of the issuance of the Shares.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon, subject to and limited by the foregoing, we are of the opinion that the Shares,
      when issued and delivered upon exercise and payment of the exercise price of the applicable Warrants, and in accordance with the terms of the applicable Warrants, will be validly issued, fully paid and nonassessable.&#160;&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>
  <div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="TEXT-ALIGN: center">&#160;</div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr noshade="noshade" style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
  </div>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This opinion letter has been prepared for use in connection with the Prospectus Supplement.
      The foregoing opinion is rendered as of the date hereof. We assume no obligation to update or supplement this opinion if any laws change after the date hereof or if any facts or circumstances come to our attention after the date hereof that might
      change this opinion.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Company&#8217;s Current
      Report on Form 8-K to be filed with the Commission on or about June 22, 2023, which will be incorporated by reference in the Registration Statement, and the reference to us under the caption &#8220;Legal Matters&#8221; in the Prospectus Supplement, which is a
      part of the Registration Statement. In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the Commission thereunder.</font></p>
  <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" border="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 60%;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="width: 40%; font-size: 8pt;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="font-size: 8pt; width: 60%;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="font-size: 8pt; width: 40%;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="font-size: 8pt; width: 60%;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></td>
        <td style="font-size: 8pt; width: 40%;"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ DLA Piper LLP (US) </font></td>
      </tr>

  </table>
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <p style="margin-top: 0; margin-bottom: 0"></p>
  <!-- Field: Rule-Page -->
  <div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
  <p style="margin: 0"></p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>ny20009174x12_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div style="font-size: 10pt; text-align: right;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <font style="font-size: 10pt;"><br>
    </font></div>
  <div>
    <div style="text-align: center; font-size: 10pt;"><img width="209" height="64" src="ny20009174x12_ex99-1img1.jpg"></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">TILRAY BRANDS COMPLETES ACCRETIVE ACQUISITION OF HEXO CORP. </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">LEADING THE NEXT EVOLUTION OF CANADIAN CANNABIS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">Creates Canada&#8217;s Largest Cannabis Company by Revenue and Increases Tilray&#8217;s #1 Leading Cannabis Share by 44% with
      ~13% Pro Forma Market Share</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">Accelerates Realization of Operating and Cost Synergies in Excess of US$27 Million</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">Solidifies Tilray&#8217;s Position as the Leader in Cannabis Operations, Brands and Innovation in the World&#8217;s Largest
      Federally Legal Cannabis Market and Strengthens Value Creation for Shareholders and Consumers</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;">
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">LEAMINGTON, Ontario, June 22, 2023 &#8211; Tilray Brands, Inc. (&#8220;Tilray Brands&#8221;, &#8220;Tilray&#8221; or the &#8220;Company&#8221;) (Nasdaq | TSX: TLRY), a leading global
        cannabis-lifestyle and consumer packaged goods company, today announced the completion of its previously announced acquisition of <font style="font-family: 'Times New Roman',Times,serif;">HEXO Corp. (&#8220;HEXO&#8221;)</font>, (Nasdaq | TSX: HEXO)<font style="font-family: 'Times New Roman',Times,serif;"> by way of plan of arrangement (the &#8220;Arrangement&#8221;).</font></div>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The HEXO acquisition provides several key strategic benefits, including:</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z649ed0dbac5a46bbbc2c8934728e2a5f">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Creates Largest Canadian Cannabis
                  LP by Revenue</font><font style="font-size: 10pt;"><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">, Strengthening Tilray&#8217;s #1 Market Share Position.</font> Tilray
                  expands its leading cannabis market share position in Canada with pro-forma cannabis market share increasing by 467 basis points to ~13% for the quarter ended May 31, 2023, including the #1 position in almost all markets.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; margin-left: 36pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">From a category perspective, Tilray becomes #1 in Flower (40% market share with an extensive combined genetics
      library to fuel product innovation and growth), Oils, and Concentrates, and #2 in Pre-Rolls (29% market share), #4 in Vape, and Top 10 in all other categories.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1de77fd2214b4ccb90fdc1e968866849">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Establishes Unrivaled Portfolio of
                  High-Growth Brands</font><font style="font-size: 10pt;">. Tilray amplifies its market-leading offering and substantially expands its base of consumers and patients with a portfolio consisting of the highest growth consumer and medical
                  brands in the Canadian cannabis market across the premium, mainstream, and value segments.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; margin-left: 36pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Tilray&#8217;s newly combined brand portfolio now includes Canada&#8217;s top-selling brands such as Good Supply, RIFF, Broken
      Coast, Solei, Canaca, HEXO, Redecan, Original Stash, and Bake Sale, among others.</div>
    <div style="text-align: justify; margin-left: 36pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
    </div>
    <div style="color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">
      <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 2px; width: 10%; color: #000000; text-align: left;"></div>
    <div style="color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"> <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Based on pro forma net cannabis revenue.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za73b95ce27a349f6b7b9e8b70d364ac7">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Enhances Tilray&#8217;s Position in
                  Growing Premium Pre-Roll Segment.</font><font style="font-size: 10pt;"> HEXO&#8217;s state-of-the-art production process provides significant opportunities for Tilray to meet growing consumer demand for premium pre-roll and cone-style cannabis
                  products, representing a significant margin opportunity in a category which is expected to surpass flower on a revenue basis.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c3f2933bb134025969c2bc14853d13f">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Fortifies Commercial Network
                  Through Collective Sales, Marketing and Distribution Force. </font><font style="font-size: 10pt;">Tilray and HEXO will optimize their sales, marketing, and distribution networks to strengthen Tilray&#8217;s commercial footprint and hasten
                  market share growth.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf96ed6d706e40bba164f0061ea9b4f4">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; color: #0A0A0A; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Enables Accelerated Cost Savings
                  and Earnings Growth. </font><font style="font-size: 10pt;">With this acquisition, Tilray expects to achieve additional cost savings in excess of US$27M on an annualized pre-tax basis, driven by synergies across production, sales,
                  marketing, distribution, and corporate savings, with potential incremental upside resulting from consolidating packaging, procurement, freight, and logistics. This work builds on Tilray&#8217;s substantial progress optimizing its operations
                  including improving distribution capabilities while also achieving significant reductions in costs related to transportation, waste, and other factors, and growing cannabis potencies to 25% on average.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z451c0b04d29d4231b065cc89f9cf1fa5">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-size: 10pt;">
              <div style="text-align: left; margin-left: 18pt; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(10, 10, 10);">Scaled Platform Empowers
                  Tilray to Stay Ahead in Rapidly Consolidating Market.</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">The combined organization is expected to result in increased economies of scale to succeed in today&#8217;s increasingly competitive and rapidly consolidating cannabis market.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 10pt;">
      <div><br>
      </div>
    </div>
    <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Irwin D. Simon, Tilray Brands&#8217; Chairman and CEO, said, &#8220;Acquiring HEXO boosts Tilray&#8217;s competitive positioning in the largest,
      federally legalized cannabis market in the world and, we believe, marks the next evolution of Canadian cannabis. Having already established ourselves as the clear leader in Canada through an unparalleled portfolio of consumer and medical brands,
      continuous product innovation, and the lowest-cost production as well as industry-leading extraction capabilities, this transaction affirms and builds on our enviable standing by bringing HEXO&#8217;s leading cannabis brands into our state-of-the-art
      operations. Together, we expect to deliver revenue growth, margin contribution, and value creation for shareholders.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Blair MacNeil, President, Tilray Canada, added, &#8220;We are relentlessly focused on growing market share strategically and winning in
      Canada and will leverage this acquisition to substantially expand our consumer base, serve new segments and additional occasions. To best take advantage of this opportunity, we are revamping our sales approach to drive education and awareness as we
      integrate HEXO&#8217;s production to generate even greater value from our leading operational processes. Taken together, we intend to capitalize on the commercial and financial benefits that are inherent in combining HEXO with Tilray. These include
      accelerating the optimization of our operations, sales, and marketing efforts that are already underway. We look forward to our future with great excitement.&#8221;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Effective on closing, Tilray&#8217;s Canadian leadership team, led by Blair MacNeil, President, Tilray Canada, and Carl Merton, Chief
      Financial Officer, Tilray Brands, Inc., will provide a strong foundation for the combined Company to accelerate growth and capitalize on the strategic financial, operational, and commercial benefits.</div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Advisors</div>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Canaccord acted as financial advisor, and DLA Piper acted as external legal counsel to Tilray Brands.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Early Warning Disclosure</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">Prior to the Arrangement, Tilray Brands held a senior
        secured convertible note of HEXO with an outstanding principal balance of $173.7 million, which was convertible into approximately 48% of the outstanding shares of common stock of HEXO (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(10, 10, 10);">HEXO Common Shares</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">&#8221;), on a non-diluted basis. On completion of the
        Arrangement, Tilray Brands holds 100% of the outstanding HEXO shares, including 100% of the outstanding HEXO Common Shares and 100% of the outstanding Series 1 Preferred Shares of HEXO. The HEXO Common Shares were acquired by Tilray Brands in
        exchange for the issuance of 0.4352 of a share of Tilray common stock (each whole share, a &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(10, 10, 10);">Tilray Share</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">&#8221;) for each whole HEXO Common Share held. Tilray Brands also issued 19,551,282 Tilray Shares in consideration for the acquisition of the 25,000,000 issued
        and outstanding Series 1 Preferred Shares of HEXO. As a result of the Arrangement, HEXO is a wholly-owned subsidiary of Tilray Brands. As such, it is expected that the HEXO Common Shares will be delisted from the TSX and Nasdaq promptly. An early
        warning report will be filed by Tilray Brands on SEDAR at www.sedar.com in accordance with applicable securities laws. </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">A copy of the early warning report filed by
        Tilray Brands will be available under TIlray&#8217;s profile on SEDAR at </font><u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">www.sedar.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"> or by contacting Tilray (844) 845.7291</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);"> or </font><u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">legal@tilray.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div style="text-align: left; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">About Tilray Brands</div>
    </div>
    <div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with
        operations in Canada, the United States, Europe, Australia, and Latin America that is changing people&#8217;s lives for the better &#8211; one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live
        their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative,
        high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray Brands&#8217; unprecedented production platform supports over 20 brands in
        over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);">For more information on Tilray Brands, visit </font><u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">www.Tilray.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(10, 10, 10);"> and follow @Tilray</font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Concerning Forward-Looking Statements</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; color: rgb(10, 10, 10); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking
        statements (together, &#8220;forward-looking statements&#8221;) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are
        intended to be subject to the &#8220;safe harbor&#8221; created by those sections and other applicable laws. Forward-looking statements can be identified by words such as &#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;enable,&#8221; &#8220;potential,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221;
        &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors,
        estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs,
        projections, outlook, analyses or current expectations concerning, among other things: anticipated accretion, Tilray shareholder value and profitability related to the HEXO acquisition; expected revenue growth, production efficiencies,
        sustainability efforts, strengthened market positioning, market share, operational scale and potential cost saving and brand portfolio synergies resulting from the HEXO acquisition; expectations regarding consolidation in the cannabis industry; and
        the Company&#8217;s ability to commercialize new and innovative products.. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not
        presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these
        risks and other factors, see the most recently filed Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray Brands made with the SEC and available on EDGAR. The forward-looking statements included in this communication
        are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities
        laws.</div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(0, 0, 0);">Media:</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">Berrin Noorata</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><br>
      </font><u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">news@tilray.com</font></u></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; color: rgb(0, 0, 0);">Investors</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">Raphael Gross</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0);">203-682-8253</font><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"><br>
      </font><u><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Raphael.Gross@icrinc.com</font></u></div>
    <font style="font-size: 10pt;"><br>
    </font>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 10pt;"><br>
    </font>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>tlry-20230622.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<xs:schema targetNamespace="http://tilray.com/20230622" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:tlry="http://tilray.com/20230622" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20230622_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20230622_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://tilray.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>tlry-20230622_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>tlry-20230622_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://tilray.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="tlry-20230622.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tilray.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ny20009174x12_ex5-1img01.jpg
<TEXT>
begin 644 ny20009174x12_ex5-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 5P"6 P$1  (1 0,1 ?_$ *D  0 " @,!
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MFMVX,!D\#E9L9DHO+N83X<0ZGW70^*MX5;:+X6Q4H]F4S8UY53<9=&=FU?\
M=.'_ *VW_P P5IM_E2]S,Z?YT/ZE^)M\OC\=4<^B'- * 4 H!0"@% :73#[U
M_M'YZOZ['S1]Q!#///'! AEGE8)%&.)9F.@7Y:Q.2C%M]D9A!R?BO4VKV!LZ
MVVMMV&Q0=5W(!+?3<-6F8<1K]5>2U2=O9E=-R?Z"_:6JJ*U%=_4DU<YV"@%
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M H!0"@% :73?BO\ :/SU?UV/FC[EQ_MRME:?.W/BJV\7KZVJ YV76*]Y9O\
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..!0"@% * 4 H!0"@/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ny20009174x12_ex99-1img1.jpg
<TEXT>
begin 644 ny20009174x12_ex99-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 6*"?0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBDH 6BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK+= $-UK;!R,UPRBX[G0G<6BBBI&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA%>+65I'?!Z!1116184444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M04444@&2G"5YQXTUXZ<WWL5Z/*,IBO'_ (F:=)-EE!XK>BKLSGW,5?'';?\
MK4B^-L#[_P"M>2W!D@N2A)XIPFD(ZFO<IX=2B<4IV9ZQ_P )MS]_]:0^-LG[
M_P"M>4>;)ZFCS9/4T_JJN+VK/6#XWXQYGZT@\;8_Y:?K7E'FR>IH\Z3U-5]5
M1+J'JX\;8/W_ -:#XVR<^9^M>4>;)ZFCS9,=32^JI,?M#U<^.,C'F?K1_P )
MOA?]9^M>3B23/4T/+)MZFB6%5A^T/=_"WBO[9=;=_?UKU&SF\Z(-FOEGP;J3
M6M\"S=Z^D/"]V+JQ5LYXKR<71Y&==*5SH****X#<**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I&.%)I:HZA="WA8D]J:5W83=CB_$WB46,K+NQ
MCWKAV\<9D(\SOZUD>/M5+Z@ZAN]>>B63>3DU[.%PZ:U.*=34]8/CC QYGZTJ
M^-\?\M/UKR??(3G)H,D@[FNIX9&3JGK/_";_ /33]:0^-L_Q_K7DXED]33O,
MD ZFG]50E4U/5_\ A-^,>9^M \;X_C_6O)_-D]31YLGJ:7U5#]HSU?\ X3;G
M._\ 6AO&V?X_UKRCS9/4T>;)CJ:/JR#VC/4Y/'.%QYGZUK:'XK-U,@W9R?6O
M$"TCMC)KTCP'I,MPT;X)P:X\12C%&\)7/H+39/-M$?U%7:HZ7$8K*-3V%7J\
MA[G7'8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.75'=1GT.SHIJ.'4$4ZO..D**** "BBB@ HHHH **** "BBB@ HHHH ****
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M^R<>E>N"O(?@\<VGX5Z_7R^(_B,]6E\(4445@:A1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*G&R%HHHKF-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#FT_"O7ATKY7$_Q&>M0^$6BBBN<V"BBB@ HHHH **** "BBB@ HHHH ****
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M+8&:^@O#&J)<6BY;)Q7@8RE:5T>E2G?0ZBBD!R,TM>>;A1110 4444 %%%%
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MTM\,ZK-_O&FGTKZK#KW3RJVX YH)[4H%*5XS71'<QOJ,IW;-"C-(>N*J6X,
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M\HP,4ZBBO'.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110!R7CL?\ $I;Z5\UZP/\
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M 8P*T*^:J2O(]2"L@HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH ****
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MTS0)_-M <]J\S$QZG?0D;5%%%<9UA1110 4444 %%%% !1110 4444 %%%%
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MZ**\4[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?X(OO-TR(9[5X6.IMZG?AV=O12#D4M>0=H4444 %%%% !1110 4444 %%%%
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MRH-+4,#[HU^E35YC5CT$[H****0PHHHH **** "BBB@ HHHH **** "BBB@
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M>KR/X0'_ $3\*]<KY3$?Q&>O2^$****P- HHHH **** "BBB@ HHHH ****
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M=Q";64H>.:^BP56\3S:\7<C Q2$<YI^1BFD\5Z<=3C>X=:;WQ2KP:/XLU5]
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M4 %%%% !1110 4444 %%%% !1110!B^)_P#D#R_2OF'Q+_Q^2?[QKZ>\3_\
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M8XHN(3K32:<>*"O&:-Q]1JMBG>]- IPYXH8"9S1G/%*1BF]*"QP..*5N!FD
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M0Z4M-C.8U/M3J^?/1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4CCZDG&VFCWI%-*W%.^H-"#[U*],[T[.:8(.U(*!UI3Q20EHQC';S7JWPVU
M1HJEJ\HE^[74>$-0-O<QKG&37#BZ=T=5+<^H;*3S+=6]15FLG0)O-TR)L]16
MM7S,U:3/36P4445(PHHHH **** ,S5K1;F!@PSQ7SMXYTLPZF[*O -?3$J;D
M(]J\C\?:2&264+^E=^#J6E8YJ\;GA^?FQZ5,IXJLZE+IP>QJ3=7T=*5XGGU%
M9CGI?X::.:.]58SN"T#[U!XIM6M1(>XYI3]VA>13&/-2WJ,5>E"_>IH-/Z"J
M%U!_O4K?=IF<T9XH&.6FRM@4"HY-SD!:QJNRN5"-V=%X7TYKF_B;;D9KZ4\/
MZ>EO8Q$+@XKRGX<:,)8(Y&7D5[9:Q^7;JOH*^?QU3F9Z-&%B>BBBO..H****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'I7C5VOD7[IZ&O4P]9,YIP:W%88-)TI2=U-->AS71SH<!D9H')I%/%+TYK,
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M?-59\TCTHJR"BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOWJDQGFHQUJ53A:^GIK0\N6X'D8J,CFGJ?FH(RV:O80 8I",C-.;I0/NT"&
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M]A :.U"\F@_>Q0%B-JZ7P1G^WH?]ZN<D%=-X' _MR'ZBN'&? SIH;GU#8_\
M'E%_NBK%5['_ (\HO]T58KYA[GJA1112 **** "BBB@ HHHH **** "BBB@
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M*3'.:!Q%S112]J0A!S3MW:D I,<U70+ 3BEA;RI-]+MW4UUPN*SJ:HUBSO\
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MT;= #7S&,5IGIT2>BBBN,Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI.AYC%)PN*1#2-310 _'.:1SS3^U1&I0#P>*=G J,4IYIDI:D<G6O:OA8/\
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M?L^U2V*][TVX66U4YZBOF\;2<97/3HLOT445P'0%%%% !1110 4444 %%%%
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M#>W,<I&>:]C\U='LT)XXKTIR]RR.9/WM2]::!'"@&T5/)HD;KC KG7\9(O\
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M[<A^M<.,^!G10>I]0V/_ !Y1?[HJQ5>Q_P"/*+_=%6*^8>YZB"BBBD 4444
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M4.0, -7KGPPN/,B SVJL0^:%S6#U/4Z6DI:\TW04444#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO=G$1
MJQ56]/[DU4=R9['F_B<YFK#3[M;7B0YF_&L9?N5ZU+8\VH@/6C/%.09%-/WL
M5ON<Z8H/%(.M!XI13&(>M*>E+0O)H :*!UIS#!IIXI( /6CI2BBAA83M0*4=
M:5QBD#T&YH/% Z4O6JMH E/0Y'--Q3"V& %3+1#2U-'2(3)?KQQFO3].@$42
M\=JXGP]:;I5?%>@PKM0?2O+Q$M;'H8>-E<DHHHKE.H**** "BBB@ HHHH **
M** "BBB@ HHHH **** $-8OB&Y\BP9LXXK:;IFN(\;7HBTR0 ]JSJ.R,JCLC
MQGQA?FYN&YSS7*Q@DU=O[@W%PV?6H0@"UYDI79XU26I&I*7*$=C7L?@+5-[1
MQ%J\>*_Q>E==X#U$IJRH3P#6M*6IOAY69](HVY ?:I*HZ?,)85(/:KU>A%W5
MSU8NZN%%%%44%%%% !1110 4444 %%%% !1110 4444 %1SKNB8>HJ2D(R,4
M(#QWXAZ6/LLD@7FO$=IBD(/K7TYXWL!-IK\=J^<M;MS:W1&,<U[N"JW1P5X:
ME4_=S4><FI!S&*CQS7L1V.*PY>:#3P,"FXI]2&]1O-.[4X+36X.*;U'N-')H
M[TX"@BH6XK@>E,IZ\TA'S512 4AIS<4N/ES0@ZD8S3^U"#-'\6*&)C#UI<TY
MQBDQQ0QW(HN+Z/\ WJ^B? ;YLH1["OG:/_C]C_WJ^@O +_Z-"/85Y6,6C.VC
MT/4%^Z*6D7[HI:^>/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** (Y?N'Z5X!\5/\ C_/UKZ DY4_2OG_XK\:B?K79@_C.>OL>8K]ZGGK3
M!UIXY%?3T](GE3W!NE Z4#DT=#BJZD@.M(:4\4X#*TT-$>:?VI .:7OBJ2$R
M-JZ7P03_ &]#]:YQQ72^"!_Q/8?K7#C%:#.F@]3ZALO^/*+_ '15D56L?^/*
M+_=%6:^6>YZJ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH Q?$_\ R!Y?
MI7S)XB_X_)/]XU]-^)_^0/+]*^9/$7_'Y)_O&O3R[XCEQ.QC)]RE'O38SVIS
M\5])T/+&]Z<?:D[9I5YJ00=J04=\4'B@0G>E-+CY<T#D4(HADKVCX5_\>@KQ
MAQS7M/PM&+1:\W&/0ZZ)[+!_JQ4E1P?ZH5)7SKW/16P4444AA5#5TWV$B^U7
MZ@NTWP,*<=Q/8^;?'MKY,CMCO7$0?ZNO6/B=9;(F8"O)HOE&*^EP;]T\RLB0
M'FD_BI0*<1QFN_<Y5N(_3BHZD7FFX^:J&)3AUI6&*,8&:3'T$;VIM/7YA3,?
M-36B$QPZ4@^]1TIV,#-)ZH2&N!FE*@K32<FG YH<=!W(BM*B<TXCFGXP*S<;
MCN1N@S3=E2]12+R:KDL@4A @VTS9S4I.#BAA@5/+J-,CV4%:D ^6A1DU7*%R
M/;Q0JU(1SBAA@5+CJ)[$17FC;4F/EI4%5R"3(BG%0!<SK]:O,HQ58C$Z_6HG
M%-&L'J>N_#P8GB_"O=(O]4OTKPOX>?Z^+\*]TB_U2_2OFL:K3/2HN\3E/'G_
M ""'^E?->L?\?#?6OI7QW_R"6^E?-FLC_26^M=V6_"<^*W,]>E.HQA:<HRN:
M]J+.'H(>E,[T\<G%(P^:J$@7WI#3CP*4#*T(5M2.I!]VFJ.:7OBB3N,@?_7)
M]:^A_AO_ ,@F/Z"OGF;B5/K7T1\-1G1XS["O(Q^QVX<]*3[HI:1?NBEKP&>@
M%%%% !1110 4444 %%%% !1110 5A>(K,75JP(SQ6[4%S$)8R/:J@[2N3)71
M\L>-M/:WU-MJ\9KGHSQ@UZWX_P!'!GDDV]*\CD^2X9?0U]+@JET>97B.:DS3
M\97-,'6O1.="]J3)IPZXH<8HV&QHZTYA0!Q2K\U!'4C'6I<#%1MP:4-4M7'U
M(@QBEW"O5?AYJQ0*K-7ESIE<UM>'-2:TNHU!QEJX<7"\3IIRU/JBSG#VBOGM
M7D7Q-U$QS,H/6N^T?45;1(W+?PUXW\2[WS+W />O'PU)\]SKG.ZL>?N3)<LQ
M[FG/UI%'&ZG#FOHH+W3SIO40_=H7I3L48J[&5QHZTO>EQ013ZCOJ#=.*!]VD
M')I>AQ4VU+0PD@TUOF&*D<<4ELOF7 7UI5'9#CN=_P##?3_.N,L.]?0.F0B&
MV50.U>4_#73MC!B*]AC38N*^;QL[RL>I0C97'T445P&X4444 %%%% !1110
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M<:*/>CO2^U:,$A":53VH9<#-"CO2V 4\<TW/-/\ O<5&1@T)A8&.:Z7P0?\
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MK+T>W\JSBX_A%:E?+UI<T[GIP5D%%%%9%A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<3XVL/M4#'&<"NVK)UFV\^V?C/%:T9<LTR*BO$^4-=A
M^SZJRXZ&J^=PKI/&=@8]6D;'>N70XXKZ7#2NCRZRL29[49Q1CO2 9KL1DM@[
MYI"<FE[XI",&@&+G(Q2@X%)CC-(: Z"[N:&&5)IH&33^V*36@EN:7AB[-K?
MYQS7TCX-N_M-@K9SQ7R[;-Y$P;WKZ!^'%_OTY1GM7BXZ'NGH4'J>ET4U#E0:
M=7B':%%%% "'I7%>.?\ D$3?2NU/2N*\<\Z1-]*Z,/\ &95?A/FBZ.;R7_>-
M-SQBGW0Q>2_[QIFWC-?44OA1Y4T .*4=<TBC-+WQ6Q* G-(3VI2,4E - IQ3
ML=Z:!3\Y&*3W$-)XIUD?]('UIC# I]D/WX^M3-:&D+'T5\,O^0:/I7H5>>_#
M+_D&CZ5Z%7RF)_BL]6E\".<\6+_Q)YS_ +)KYB#9\02C_;KZD\4)NT6?_=-?
M+<Z^3K\I_P!NNK!NZ9C521]#>!_^0&/I7!_%4X@-=SX#??H0^E<)\5_]52I:
M564U>*.!TBP,]MNQ576;0V[+D=Z[+P98?:;-1C.:B\=Z/]DB5]N*]&=56L<\
M879O_#NV5DB>O99SML"/]FO"?A_JPCEB@SWKW&9]VF[O5*\K$:S1T+2)\[>/
M#_Q-I#[UV7P?.2:X7QO+OUV1/>O0OA) 8QG%74_AD0^(]B'2EHHKSSK"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *HZG_Q[FKU4=4_X]C51W)EL>9:[S+^-9B_=K5UKB4Y]:RUZ5ZU
M'8\NIN%*O6D(S16[W,A['-,- /% ZTP 4M(>M*>E "#K3V.5IF,4#K20K!VH
M%&.:#1?48M(:.U %"W D'W*:K;:*8X)Z52T"P,VXUT?AVV\Q@<5S4(+2A:[_
M ,+VNU<D5QXB=D=-&.IU%FFR$"K-,48&*?7EO<]&.P4444AA1110 4444 %%
M%% !1110 4444 %%%% !1139'"+DT <GXNU$6D# G&17SSKDYGU5WSP37JWQ
M,U';PK5XY*WFREC7G8B6IY6*E[UAV>*,TT=*09S7$><]Q^:BF'RYIQZTLG*5
M465%G:>!]1\AT0MWKW[2I?-LD;U%?+FAW+07L0SCYJ^CO#%X)=.B&><5WT)'
MJX61TE%%%=IWA1110 4444 %%%% !1110 4444 %%%% !1110 =JX/QIIOVB
M"1MN>*[RLK6K99K&7(YVUK1GR3N9U%='R?JD!@U.0'L:K,V372^+]/:"_F?&
M!DURD9S7U&&ES1N>;61-U%*#@4U:&KH9SH5#S3CR<U&*D'2C88CGBE!^6F'.
M:!FJ <O!I,_-13:2&R1N11GY<4T>](U!/4<AQ2'KFFC-/[4,&(>:7MBD% ZT
MA$2#%W']:]Y\ ?ZN+Z"O"!_Q]Q_6O>/ '^JA^@KS<9K!G?0Z'K"?<'TI:1?N
MBEKYP] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9)]TU
M\_\ Q7;_ (F)^M>_S?<-?/GQ6/\ Q,?QKKPB]\YZ^QYIWJ9#\N*A')IX!%?4
M4_A/,EN.Q@YI.]./2FU:>@D.8Y%(#A:04&C<745#S2-R<TT4_M0*Y&U=1X'/
M_$\A^M<NPKI?!&?[>A^M<.-^!G30^(^H['_CRB_W15FJUC_QY1?[HJR*^89Z
MB"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH Q/%'_ "!Y?I7S'XA_X_)?
M]XU].^)_^0/+]*^8_$7_ !^2?[QKU,N^(Y,2C&C'>G.<TJ?<IAKZ2*T/-8_/
MRXIG2@=:4\U+"^H9I#244QMCNU.4X%,'6E-%Q7U(I3SFO:OA7S:"O%)>E>U_
M"@8M!GTKR<8]#JHGLL/^K%25'#_JQ4E?/O<]);!1112&%%%% $4\8DC8$=J\
M/\?>'FDNI)E7BO=#TKF_$FEI<V4AVY)%;T*G)*YC6C='RM<PFVE8'L:1) RU
MU'B?098YG(4XSZ5R7E-"^&KZ'#U>9'#.F3BF]\TTR"G@Y6NRYS25F(3S4G\%
M18.:E'2J3%L,'% ZYI6Y-&.*&(1SFD[4E**(EH>IP*8P[TO>G'E:&[ 1CK4A
M.14>,4HHW!"]!0IP:0T@HL*UF/;DTTT[M3<4X]@N*.E)C% IS<TVK"3LQ*#S
M1VH'%)Z(IL=GY<4BG%)WI6%2V2'\6:C?F9?K4G:H@/WR_6HF]"X/4]<^'O\
MKXJ]SB_U2_2O"OA]_P ?,5>ZQ?ZI?I7S&,=YGJT7[IROCK_D$M]*^;=:_P"/
MEOK7TGXY&=);Z5\V:V,7)^M>AEOPG/BMS.49%2#@8IL8XI6ZU[".)@.#2,>:
M7M3#5HE,D/(I.@I$-*PR:0,1>#3_ 'IIZ4H/RU+U!:H@FYE3ZU]$?#4XT>/Z
M"OG9_P#7+]:^A_AO_P @F/Z"O+Q^QVX<],7[HI:1/NBEKP&>@%%%% !1110
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M7$^.3C2)OH:[8]*XGQW_ ,@>;Z&NC#_&95?A/FJZ;-Y)_O&DS\M,GR+V7/\
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M,<5.)]V-BZ:N[G7T445YYTA1110 4444 %%%% !1110 4444 %%%% !1110
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M4KC425:4'YJCSBDR0:.:PK$SXIUGCSA]:@9N*DL"3<#ZUG.?NFL8GT9\,O\
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M-MR UZM)WB>W1E>(ZBBBM#4**** "BBB@ HHHH **** "BBB@ HHHH ****
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M6S_J_P!*!X%;/^K_ $JOK<;![,\Q%NPYQ2^2V.E>HGP,V/\ 5_I2?\(,V/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*** "BBB@ HHHH **** "BBB@ HI,TM !129%&X4 +12;A1N% "T4FX4;A0
MM%)N%&X4 +12;A1N% "T4FX4;A0 M%)N%&X4 +12;A1D4 +129I: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,T;A0*XM%)N
M%&X4#%HI-PHW"@!:*3<*-PH 6BDW"EH **** "BBB@ HHHH **** "BBB@ H
MHHH ***3<* %HI-PHW"@!:*3<*-PH 6BDW"EH **** "BBB@ HHHH **** "
MBBB@ HHHH ***3- "T4FX4;A0 M%)N%&X4 +12;A1N% "T4F:6@ HHHH **3
M<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-P
MH 6BDW"C(- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%(6 IAE0=Z )*3<*A-PGK59[Q WWJI1;)<D7]PHW"LQ[Y!_$*!?)M^
M\*KV;%SHTMPI=PK+6_3^]3UO4+?>%#IL7M$:5%5EN4/\0J03(>]0T4I)DM%-
M$BGO3J104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 %%%% !1110 4444 %%%% !4$LH0]:E<X6N&\2^)5TZ?:6Q5PBY,ER2.O\
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M?WJ0ZD-V-U>5CQBH_CI#XP7=]^A85W)=4]5.I#^]3O[1&W[U>5'Q@I_CI?\
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MB"D9!FM%21C[05;R;^\:/M<V<[C3=M.VC%/V28G.P&[F_O&E^US8^\::%%
MW4O9(.=CA=S ?>-)]KFS]XT.HI"HQ0Z2#V@INIC_ !&E-W-C[QI$48I"HS25
M)#YQRWDV/O&FFZF_O&DVC-2,@*T_9(.>S(Q=S?WC3_MD^.&--"#%.11GFE[%
M JCN2)?SKU=JU;#5I489<_G6*Z\\4@<ITJ9458OVAZ3IGB'RRNY_UKM-,\5Q
M< N/SKP3[;*@X)JW9:S<(_+&N"K1N:PEU/INQ\1Q384,.?>N@@N!* 17SMH7
MB&03IN>O7=#\00O&H+CI7G5L/RJYU0J7.THJK!>), 5-6JXFFC>X4444@"BB
MB@ HHHH ***1CM&: $=MHK$U+68[0$,PJ;4-4BMT.YL5Y+XQ\0YD?RWKIHT7
M-F4YV-?7_%4;(P5Q^=>5:WK$DTY*N<?6LJ^UB>65AN-4O,:3EC7MX>@D<,Y=
M1TUW-)_$:B5W[DU*BCO05&ZNU4E<Q=30;EJ-N:>0,4\ ;:T]FK$<UR,(*0K4
MB^]-;[U'*A\PB(*:R\U**1NE1R:D<Q" >U!9N@-3(!1M&ZFJ29:D0K-*AX8U
MHZ;J4T4X)<X^M4V0'I3#\G(J'11HIGK_ (9\3+$%#O\ K7J.D:W'=JJA@:^5
M;74YH9%PQ'->I>"?$)%P@D>O'QM#JCKI3L>\#I2U1L;^.ZB!4YXJ]7D--'6@
MHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (Y^
M86^E>;Z]'B=S7I,G,9'M7"^)(-J,V*ZL,[,YL1L<<K<U(?NYJ",Y8U9QE:]*
M^AYK5F-7D5&>M//RG%*5XS3B(8*4T4G4U8PIR'-)CBFD[:EZ(+"C+3!1WKN/
M#%IL8-BN.T^+S;M?K7IND6HBB4X[5Q8B6ECLP\=3848%+117G'>%%%% !111
M0 4444 %%%% !1110 4444 %%%% !39&VH33JIZE+Y5H[>@I/83V/-_B5J'E
MVI"M7ATKF>;<?6O0O'NI?:-Z9S@UY]$O&:\VM,\>O/4D/ %)VIQYI *Y=SB;
MN-6GYHQBB@3W&L:4&EQFDQ28=!:9GFGT;>],$)0>E%+C-"$MQH.:6EQBC'%2
MQM#2>:4\#-+MS1C/%,I I^6HVY-2@8XI'7 S3OJ">IH^'[YH-4B7/&:^C_#U
MV)K.+G/ KY?L3Y=XK^AKW/P'JOVC9&6Z5W8>>MCT\++4],HI <BEKO/2"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K!\1V8FTZ7CM6]5:^B\ZV9/454
M':5Q25T?*_B:R,%W(=N.:YY&XKU7XC:0+9&D"]:\J48.*^EPE121Y=:-F/'6
MG=LTH6D/7%=YS;@.:0GM2D8I.M"U&EJ'2D[T]1FDQ\V*J(V(3D5)I@\R]"^]
M,D&!5WPY%YNIJ/>N?$/0TIGOGPY@\JV'':O1*X[P9;^3;+QVKL:^6Q#O49ZE
M+X0HHHK T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (Y?
MN'Z5X#\5#_IY^M>_R_<-?/WQ6.-0/UKLP?QG-7/+@?GJ8'FHP/FS4@'>OIX?
M">;-ZCF'RTRI!SQ36'S5:)%3FD<<T_&T48R*8$0IW:D YHSSBDQ,0TH-!%.Q
M\N:+C0E-IZC-(1SBJB# <TAZTIXIQ'RYJ5N)#,TIY%-[T]>:L:&@<4=3BG-Q
M28XS6=A#67F@Q#%&<FI1R*EQ&G8K[=O-6;74I+5P5)%,*U&\/>LYTE)&L:FI
MZ=X2\2NTL:LYZ^M>Y:7>)<6L9# DBODO3-0-G<)@XP:]Q\!>(3>LD9?.*\+&
M4;:G?2F>J44U6##BG5YITA7">/?^/9OI7=UPGCW_ (]F^E;X;^(B*GPGSGK?
M_(0;ZU5'2K>M?\A)OK5<C %?4T7H>55W$!H-.Q\M(*V6IFA*>O(I .:#Q28,
M:W6@&G,/ES2*,TUH(0T"G#EL4,,&@JX+UI'ZT[H,TG44+5DMC!3QTIH'-+T.
M*&(0G-(.M2%>*3%%PN(>*.HIQ&:3H*745Q%'-(PYH!P:?CY<U8UN0F/-(8]H
MS4R\FE89XK-PYC6,A+749+5QM)ZUZ7X,\2NUS&C.<?6O,&@YS6AI-^;&X5@<
M8KS\1031O"J?6&FW:SPJ0P/%:->9^ ]=^VQ*&;/%>DQMN7->!5ARR.^$KH?1
M116184444 %%%% !1110 4444 %%%% !5'49A%;/D]JO5R/B_4/LMNW.,BM*
M4>:5B9NR/"O'5^9-8D0'C-<BHP<UI^))_M&JN^<\UGHN17T^'CRP/+JRNQ>U
M-%*?2BNM;&,4+2&GD?+FFJ,U3>@,.@S2KR*"*!P*B^A"9&_/%7]$N3!J4(!_
MBJDPHLVVWT;>AK"O"\3:G(^IO"UV)=.A&>U=..E>9>!=1\V.*//:O35^Z*^9
MQ$>6=CU:3NA:***YS0**** "BBB@ HHHH **** . \=?ZI_I7SMK _XF3_6O
MHKQS_JG^E?.VK<ZHX]Z]_ KW$<%?<KJ.*7/.*<!@4A&*]6.QP/<1J;4BC(IF
M/FJP'*,K4#YC;(JRO2F2ID5E./,BX2U.P\&ZZ]O<11[B!FOHK1[Q+BQC.X$D
M5\EZ;<&VND;.,&O=? >O&Z*1%LXKPL;0MJCT*,^AZG1358,HQ3J\HZPHHHH
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MDS*&YQ7S5=3-->2Y/\1KV,!#0XZ\A(\".E%(O%*U>Y':QYTMP'WJ5S3*7FK
M.HIP&*1!S2O[4K ]112-UH[4E**%$4GB@?<--HJ[:#2L7M&N#;78;..:^BO
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MBBBN8U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HHHH **** "BBB@ HHHH **** &2?=/TKY^^*X_XF)^M?0,IPA^E?/\
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MV>*W^HKR+P-KOF0QH6ZUZO!('A4^HKYRO3<9'HTY71-10**P- HHHH ****
M#M7D/Q.'SM7KQZ5X_P#$]L.:Z\%_%1C7^ \2G'^DM]:0\&EG/^D&@#(KZ:*T
M/*EN!&%S0.12,>U(#6J(8X<FB$?Z6GUI.G-$!_TI/K6578N&Y[?\.Q^\2O7A
MT%>0?#H_O$KU\?=%?,8O^(>K0^$4]*X[QI_R"9OH:[$]*X_QI_R")_\ =-1A
M_C*J_"?,-YQJ4O\ O&GX^7-17A_XF4W^\:<K=J^KI/W#R:B]X5>31GG%!XIF
M><U:U()<4TT YH;I2)>Y'"W^G1?[PKZB\"#_ (D4/^Z*^6X/^/\ B_WA7U+X
M$_Y ,/\ NBO$S$[Z".M%+2"EKQCT$%%%% !1110!7FMQ)U%9ESHT<P.5%;=(
M:I3:$TCSS6O"<30NP09QZ5X[XDT=K1WVIW]*^F[J 31%<=:\[\4^&A)&S;*]
M#"U[.S.2I3ZGS_@J.>M.3GK5[7K0V=\8P,<U0/RKFO<I2N<4H6%8\XI#Q3 <
M\T_K6[1DQ0,T'B@=<42"A($,=<+NKO/ &IFVE5=V.:X1N4Q6CHEZ;6ZC&<?-
M7'B(71T4W8^K='G\^R5L]16C7*^$+OSM*B.>U=4.E?-58\LF>G!W05P7C6^,
M$,BYZBN]/2O(_B3=&)V7-:897F*I\)XGJ[^9J<C>]1(.*+@^9=L?>E)VBOIZ
M'PGE5'=C2><4F*/>E[5O8E #FG "F+UI6;%*YF]QLHZ8KN/"&C?:WC++G/M7
M'VD?GR@=>:]U\ Z,/L:2;:\S%U>5:G91A<Z32_#44,"':.GI6]!IZQ= *NPH
M$C"^E/KP74;9Z"BD,2,**DHHK-LI*PA&15&YL5F!R*OT4U)K8&KG&:MX9BFB
M8E1T]*\5\6:,;2:3:O ]J^F)HPZ$8ZBO-_&GAX26TDFVN["UVI:F%2%SY]A!
M!(-./!JUJEN;.=AC'-4@VY<U]%2G<X)JQ*O-+BHU;%/8_+FMV8-#2><5%.OR
MYIV<FDD.Y<5G/8J&C._\ ZB8'C3/>OH;3)/,LHV]17RGX;O/(U&%<_Q5]/>'
MIQ)ID)S_  U\YCHZW/3HRT-JB@45YQTA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %(>E+10!RGB*#>&.*\]GXN&7WKU75X=\+G':O+KY-E
MZWUKTL._=L<%>.HP#%+29S17:MCE%"Y.:23D8IX.%J O\U2Q):FMI$.Z=3CO
M7I>GQ;(%X[5Q/A^T\S:^*] MUVQ*/:O-Q$M3T:$26BBBN0Z0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *S-:F\K3Y6ST%:1Z5QOB[5!#9RQY[5$W9&=
M1VB>*^+=0^U74B9S@URT0P,5;U&4RZA*<]6J #FO+JRNSQJT[L7;BEIQZ4S/
M-8,Y6+C-&.,4HH--!T&@8I:0&EI"#&:,<8I<XHSS1L4)C%&WO3C2;NU "%<T
M4X4AHW$]A****8@VY-*1D49Q1FD7< ,4$49HS183$V\YIQ&10.E)G%-!<CC_
M '<P:O6OAWJ.9%7=7DS],UU_@:_^S7(R>]=-&5F=F'G9GT9 _F(#4]96BW N
M+16SVK5KT8GL0=U<****LH**** "BBB@ HHHH **** "BBB@ HHHH *CE7<A
M%244(#Q_XG:=O@) KP^5/)E*5]-^-[#[5;-@9XKYRU^W-MJ97&.:]W U/=.&
MO$I$<4[;\N:.H%+NXQ7M1>ES@ZC0,FF3<+BI1\M12?-43>@XK4Z[P1:>=.IQ
MWKZ.T&/R].1?:O$/AI8^:0<5[U81^7;*M?/9A--V/1PZU+5%%%>8=84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,E&4/TKP#XJ#&
MH'ZU[_(<*?I7@/Q5YU _6NO"?&<]?8\O!PU2XSS4/\53*W%?4T_A/+EN)C--
M(YQ3@>:",G-%P88P*9GG-/8Y%1GK1+8([GJ_PH8-=_C7NZ*-HXKP7X3\7GXU
M[U']T5\OC?XAZ=#8=M'I1M'I2T5QG2)@48%+10 F!1@4M% ";1Z4;1Z4M% $
M,\2O&PQU%>6^.M%S;.X6O5S7+>,H ^FMQVKHP]1QFC*I&Z/E^^B^SS%?>HD^
M85J>)H?*NSQWK*B.!7T]!W1YE30<1@TN,#-*>3FD=OEKI>QB-(S0* >*!UJ4
MM1K<GT7C6HO]ZOIOPF^;.+_=%?,>C_\ (9B_WJ^F?"/_ !Z1?2O%S$]*AL=A
M7!>/ES;-]*[VN%\>?\>S?2O+PW\1'14^$^<M9&-0/UJ #BK.MC_B8L?>JN>*
M^HI;'F3L.*\9IJC-/SD8I!Q6S, ]J:XP*4'YJ<_*TFM!QT9>\,C_ (FJ_6OI
M'P?_ ,>R_2OF_P ,<ZJH]Z^DO" Q;+]*\/'_  G?0W.KHHHKQCM"BBB@ HHH
MH **** "BBB@#C_&5F+BV;CM7S?XC@\C5&7WKZFUV/?;OQVKYF\:KLUMQ[U[
M.7RTL<5?<Q ,BE[XI$/%.QSFO;1P/<:RXI0,<T,<TH/&*N6PAK\BI=+/EW@;
MWJ)N*(&V2@^]<]=>X:TW9GT9\.IO-M1SVKT*O+?A5+YEI^%>I5\K6^-GJP^$
M****R+"BBB@ HHHH **** "N2\87WV6V;G'%=6[;5S7EGQ*U$1VY /:NC#1O
M-&55^Z>+>)KC[3JC-GO6:B8%.NW\ZY+^]+NXKZ2DN5'F5&+C'-'WJ"W%(AQ7
M2F9B8YQ0PQ3OXLTUS6CD(%'-(ZDU=TRV-W.(P,UH:GI+68Y&*Y?:+FL6EU,)
M1VI^,"F]'Q3F:M4[HF0T<&GXW<TSK3U^452!BD<4:<_E:I$?1J-U0QG;=J_H
M:RK+W2Z;U/I;P9?^=:Q)GM7=#I7B_P .=4$DJ1[NE>RQON4&OE\5"TSTZ+5A
M]%%%<QL%%%% !1110 4444 <#XY7,3_2OG76/^0HX]Z^C/'!_<O]*^<]8'_$
MT<^]>]@?@1Y];XF1*<"E([TT#-//(Q7L'&R/K2]>*7I2#K22U($(P:<!@9I#
MR:4GBFV4@(R*:IP:>I^6F'K32 <3DU'*G0BE!YIY^85%17*3L=7X0UC[-=11
M[N]?0NAWPN;:/GM7RAI\YMM01\X ->Z^"?$"S(B;N@KQ<91NKG=2D>K4M5[>
M7S8]U3 YKQFCL0ZBBBD,**** #M7C_Q/7+FO8.U>0?$YL.:[,%_%1C7^ \1G
M'^D$4O3BB<_Z23[TAYKZ>.QY4@8<9I%7/-.)RN*%.!6A(G7BD@&+M/K2@\T0
MG_2T^M8U?A*@M3V[X=+B2.O7A]T5Y'\.V^>.O7!T%?+XO^(>M1^$4]*X[QH?
M^)3,/8UV!Z5QWC0?\2J8^QI8?XRI['S%>#_B93?[QI0.]%WSJ4W^\:=G Q7U
M-/X$>34^(3[U,QS3UXI#US6B,VPZ4\C*TP\T[/RXHZ"1##_Q_1?[PKZD\"?\
M@&'_ '17RW#_ ,?T7^\*^I/ G_(!A_W17A9@>A0.M%+117CG<%%%% !1110
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M6X3C^*OJ+P_%LT^$_P"R*\',9'HX<VZX3Q[_ ,>[?2N[KAO'?_'LWTKSL/\
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M?'>OIO28]EA$/]D5XK\/-'\Q(Y2O2O<K1-ENB^@KYS'3O(]2A&R)ZX3QZ?\
M1F^E=W7">/1_HS?2N;#_ ,1&M3X3YSUL_P#$Q;ZU O(J?6A_Q,F'O4.-H%?4
M4/A/*J[B$T@.*<1\N:8!709(<>10!\IH')Q2O\HHGJAFIX6_Y"R_6OI'PI_Q
M[+]*^;/#!_XFBGWKZ1\(G-LOTKPL>O=._#[G54445XQVA1110 4444 %%%%
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M>:V>YDMQ.U(>AIQZTTCBB:T+18T60Q:BK>]?1?@*Y,UNOTKYNLODN0WO7O\
M\,9=]N/I7BX^/N'90?O'IQZ5Y%\2H-[L<5Z[VKSOQU:>;'(V.U>5AG^\.NK\
M)\Z3?+>,/>G.<4[4E\O4Y![TF-PKZ>D[Q/*J+4CS3QTI@'-2@5ON8L:O)H/!
MQ2D;>:!SS18H:SF+#"NR\,^(9("B;C7&E=_%2V\QMI 0>E<=:ES&\)61]%Z%
MKBRHNY_UKKH+^)ESN'YU\W:=XJ:V"C?T]ZZ>T\;ML'[S]:\BMA[['5&H>Y"[
MC/1A^=/$Z'N*\DL/&!E/+_K6[:^(M[ ;_P!:Y7AY(V]JCT 2*>].!!KF8-65
M@/FK6M[Q74?-6<J312J)F@:45$)5/>GAU]:SL6G<=129!I:0PHHHH **** "
MDI:*!-""EHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,8C4>U.I!TI:\,]$**** "BBDI7 6BBBF 4444 %%%% !1110 4444 %%%%
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MQ7GU:#3T.J%1,Z^BLVSU!;@9!K14Y%8.+6YHG<6BBBI&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M(: .2\1V
MQD+-BN!EC)N"H]:]9U2W$ELYQVKSA;1FU-ACC-==*I96.2K"[N=5X6M0( 2*
MZY!A<5CZ)!Y4(&*VA6%5WD;4HV04445F:A1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH **** "BBB@!DGW3]*^?_BO_P A$_6O?Y?N'Z5X!\5/^/\
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M"1^M0G[HQ4VL_P#(0;ZU"G3FOJ:"]T\JJP[4)2=Z#Q6S,4(W6G)]VD/W:5.
M:392-+PV=NJ*?>OH;PM>*ENN3VKYST=_*O@WO7K&B:TL40&_M7FXJESQL=E&
M=CUO[>GK1]O3UKS[_A(4_P">GZT?\)"G_/3]:\KZJ=/MCT#^T$]:/[03UKSL
M^(5S]_\ 6@>(5S_K/UI_5"O:GHAU!/6@:@GK7GC^(5V_?_6A?$*[?O\ ZT?5
M"?;'H?\ :">M']H)GK7GB^(5S]_]:0^(5W??_6CZH#K6/09-3C09)K(U/Q#"
MENPW#IZUQ5_XB'E\/^M</K/B.4A@'_6M:>#UN2ZV@OCG6/M98(V>:X:(Y&33
MI[R2ZD.\U&.*]BC3Y3CJRN2.13%ZT=:*[+&%Q[TO\-1YI5/-#V #P*;:QF2X
M ]Z?)TJUH47G7ZKCO7-6E[IK#<]S^%MN8K49':O4*X?P):_9[8<8XKN*^6KN
M\V>I37NA1116)H%%%% !1110 UVVKFO,OB5J(2T(4]J]%OY/+M6;T%>%?$?4
MO-1E#5V82GS2N85I65CS.\D\Z<L>>::G J&,ECDU,W KZ2FK1/,D]1>](QH[
M4PYK4BY+GY:CS1SBF$TV[(:W-+P_!]HU)5QGFOHSP78?9;=?EQQ7A7@:S,NM
M1DCC-?3.F6JP6R8':OG\PJZV.^A'6YH4445Y)VF1KUN+BS9<9XKYQ\?6)M[_
M (&.:^G[B,21D&O"/B?I_P#I98+WKT,%4L^4YJRZGERD>6!0*BY64J>U2&OH
MZ3T//DM1V:;WI*<.E:[D;BMTI+1O+NU;T- ]Z8WRG<*RJ*Z"+LSW3X=ZEYKH
MA;I7K:-N7-?.GPTU K>@,>]?05C*)8 0<U\SC*?+.YZE"7NV+=%(*6N(W044
M44#"BBB@#@?'/^I?Z5\Z:K_R%7^M?1?CK_5/]*^<]7_Y"C_6O?P&L$<%?=B=
MJ0]*13Q2=Z]9'!U 4J_>IK=:=VH3U$12_?&*]'^&+9U)0?6O.&Y->A_#'/\
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M[U]%:#>?:+=.>U>C0EH>QA9:6-RBBBNH[ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3%+10 4444
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MM*)858=Q7@5:?*SNI3YB>N"\?#_1C]*[VN#\??\ 'LWTIX?^(BJOPGSMK/\
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M0_[HKY>MS_IT7^\*^H? O_("A^E>#F!WT#KZ*!THKR#O"BBB@ HHHH ****
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M.\.ZDMQ91#.>*^=QE*TKH]&BSHJ***X#H"BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8YH#<>#2&B@]*2 0'-/SQ3 ,4ZCJ&PTG%.!II&32CI38"FFYIW:F8YHZ!N2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(4445D6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2$YK!G\3PQ@Y8?G7/ZKXPA,9 <?G6E.A)O4B<TB;Q!XJ6V5X]]>/>)M;-Z6
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M@Q330<TZDVXIL%L%(32T8S20(/X<T@.:=CC%)C%"*>PW/-!-.VTA%/J(5_\
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M;F=CT:,+(M4445YYTA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QSA2:<>E0W#;
M8'/M28FS@?'>I@:?)&#VKP2:0R3N3ZUZ5XZU+,LL>ZO+T.9"?>O.KRNSRL3.
M^A,#BE)S2$<4@%<5CSK #SBE/%(HYI7'-4D.PM)0#Q2TR1*7=24TCFI&A^<4
M9R:1N12"CH-CS3,TZF$<TT+<>M!I*#TI(!,YI_:HP,4^CJ&PA.* :1AF@4V
M\TS-.IF.: W) >*::*#R*$  YIW:F*,4M+J&PA.#3EIA&33ATIL!33<TO:F@
M<T= ) >*:3BBD89H0;B@]Z7.::!Q0!3 ,\TX4PCFG5+T#87O2FFTM""X ]J&
MXIH^]2N,U0]Q .<TV0;N:D/W:0#Y31<I:'0>"[S[-JBDGO7T1HEZ+J!2#GBO
ME[2YC;W@;..:]]\!7OGV@R<\5WX>1Z>%GK8[RBD!R*6NT]$**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH CE.$/TKP'XIG-^?K7OLWW#]*\ ^*9Q?GZUVX/
MXSEKGF7\52@X&*B4_-3^]?30^$\V6XH&#F@\G-*>E)T%4A,4_,*,X&*1#S0W
M6GL @X-!&>:4TX?=Q0F)(C S3NV*0<&CO1S!8.E ZYI6YH[4K@*6II.:;2@<
MTVDD%A1P*0'YJ4\TWO0K A[')IP;BHC1F@8]FIHZTE-SBDK!8G'2H99<"@2C
MI4B6;W!P :QJ3L7"&HEK";F0*!UKT_P-X;9)UD*=:P/#7AJ5YHV*G&?2O<O#
MFE+;0I\N#BO*Q.(LK([:=/4V]+MA! %QVK1I%4*,"EKQI.[N=B5D%<-X[/\
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M@\U9U.<SZBQ)ZFHV &,5Y=1ZGC57J/'2FT$_+0IR*Q.<48%!P149)S0":!I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "8HQ2T4 )M%&T4M% ";11M%+10 F
MT4;12T4 )M%&T4M% ";11M%+10 FT4;12T4 )M%&T4M% ";11BEHH"P4444
M%%%% !1110 4444 %%%% ";11M%+10 FT4;12T4 )M%&T4M% ";12XHHH **
M** "BBB@ HHHH **** "BBB@ I,"EHH 3:*-HI:* $VBC:*6B@!-HHVBEHH
M3:*,"EHH 0@&C:*6B@!NT4NT4M% ";11M%+10 FT4;12T4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4F,TM% #=HI=HI:* $VBC:*6B@!-HH
MVBEHH 3:*6BB@ I-HI:* $VBC:*6B@!-HHVBEHH 3:* H%+10 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *8T:MU%/HH Q]2L$EB(VBO.M=\,-,Y(2O6V0,.:JS6,4@.5%93I
MJ1A.BF?.VI>%Y(@3L-<Q<V#0$C%?1>MZ-')$=J"O--9\-NSMM3]*Y94CCE1/
M,MVP\T\29K;O?#DZ$G:?RK,?3I(3\P-8.!S2A8BS4BGBHF&WK31)S631@[ED
MG%1'KFAGR*0'BI)8IYH![4"D[T,5B0=*8?O9IXIII(!1S3L]J:@I!PU'4=AY
M.*;NYH?GI3,&F%B3K32>:5#Q3&'-%@L3*XQBFMZU&,YI['BE85A1S33S0& 6
MF+( :I(?*29VKBF!MIH9MQXIPA:3I3Y2U$C\WYJL(OF\"IH-'FE(P#70:;X;
MFR"5/Y5K&G<VC3N95GH;W+C"GFNNTKPC(I4E#72Z#X?V.FY/TKT.UTN%(U^0
M=*ZH4CLA0.<T/1! JY7I780VZ(HXIT=NB#@5,!BNF,>4ZX4U$  .E+115FH4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRDJ$'K2MC%0D,#T-.*N5Z&CE!1#?@T\L-M5_+DST-.\N4C[IIJ)7)J3*PQ2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRT_9,M4&<#!X(5AGR_TJ_#X)53_J_P!*]%AM%0=*LB%1VK2-,UA1.*M/"JQ
M?)^E;%MH@B(^6NA6-1VI^T>E;Q@CH5-%*WM!&!Q5T  =*6BK2L6DD%%%%,84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 )BD* TZB@!GE+Z4GE+Z"I** L1>0GH*/LZ>@
MJ6B@+$7D)Z"E\E/05)10%B/RE]!3A&H[4ZB@+";:,4M%%@"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140529019169200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 22, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 22,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tilray Brands, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001731348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4310622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">265 Talbot Street West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Leamington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ON<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">N8H 5L4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">845-7291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLRY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ny20009174x12_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tlry-20230622.xsd" xlink:type="simple"/>
    <context id="c20230622to20230622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001731348</identifier>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-06-22</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230622to20230622"
      id="Fact_ebbcf9f95c5b48bcb762bd0e3ca8206b">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230622to20230622"
      id="Fact_5414f07889a342d89b02e41e41ebad99">0001731348</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230622to20230622"
      id="Fact_3ce1a4f16d594c87a5bbfb438f6f52b5">ON</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230622to20230622"
      id="Fact_8f0f3b4cd4c24449a64a6d136b3aae77">N8H 5L4</dei:EntityAddressPostalZipCode>
    <dei:DocumentType
      contextRef="c20230622to20230622"
      id="Fact_69926e009d6a4281a6cfdeba4d77ad0b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230622to20230622"
      id="Fact_3c1ae370cd5e42f6a738b9c95c447ae6">2023-06-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230622to20230622"
      id="Fact_f8c51d7124cf45cea14d1735f7f0130c">Tilray Brands, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230622to20230622"
      id="Fact_8b8ac2966ebe4421b21d205fd31219e1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230622to20230622"
      id="Fact_3ff9e5b0329b430ab6822529d5502c19">001-38594</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230622to20230622"
      id="Fact_6c5b7d4b89d44bd7bef1102667bf2e09">82-4310622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230622to20230622"
      id="Fact_521ff4e7a462457dab150ec61d04ebf5">265 Talbot Street West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230622to20230622"
      id="Fact_7af743a6e813422f8b8171e3211dd952">Leamington</dei:EntityAddressCityOrTown>
    <dei:CityAreaCode
      contextRef="c20230622to20230622"
      id="Fact_73730a95e07f489cbe7ca7a9b02577f1">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230622to20230622"
      id="Fact_4cfc877fcb3e46b9bf58c93f40accb76">845-7291</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230622to20230622"
      id="Fact_f5973f640cef471581dcb9e64dc3d2b3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230622to20230622"
      id="Fact_27b27134518b4f979814da0999971daa">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230622to20230622"
      id="Fact_04b8b9de113848248d445f1293c087b6">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230622to20230622"
      id="Fact_1dbd010ca59443daa60ae01de4cd2946">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230622to20230622"
      id="Fact_07d73e947dc84f2198abd7c1f4b951e7">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230622to20230622"
      id="Fact_facb318aeb77429fad7fc46ad015feaf">TLRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230622to20230622"
      id="Fact_05d11a1e617d4f31bd3c4acffdada45c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230622to20230622"
      id="Fact_dfb81aea7d1540a0a27511be6e1e1bf4">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>18
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M4$L! A0#%     @ 0XC65I:$:9+M    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 0XC65IE<G",0!@  G"<
M !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !#B-96Z:H6T5<$  "=$   &               @($,"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 0XC65I^@&_"Q @  X@P
M  T              ( !F0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !#
MB-96EXJ[',     3 @  "P              @ %U#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " !#B-96'#AEZC\!   \ @  #P              @ %>$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 0XC65B0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ 0XC65F60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20009174x12_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tilray.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode, dei:EntityAddressStateOrProvince -  ny20009174x12_8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="ny20009174x12_8k.htm">ny20009174x12_8k.htm</File>
    <File>ny20009174x12_ex4-1.htm</File>
    <File>ny20009174x12_ex4-12.htm</File>
    <File>ny20009174x12_ex4-14.htm</File>
    <File>ny20009174x12_ex4-16.htm</File>
    <File>ny20009174x12_ex4-18.htm</File>
    <File>ny20009174x12_ex4-4.htm</File>
    <File>ny20009174x12_ex4-8.htm</File>
    <File>ny20009174x12_ex5-1.htm</File>
    <File>ny20009174x12_ex99-1.htm</File>
    <File>tlry-20230622.xsd</File>
    <File>tlry-20230622_lab.xml</File>
    <File>tlry-20230622_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ny20009174x12_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ny20009174x12_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tlry-20230622_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlry-20230622_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tlry-20230622.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tlry",
   "nsuri": "http://tilray.com/20230622",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20009174x12_8k.htm",
      "contextRef": "c20230622to20230622",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://tilray.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20009174x12_8k.htm",
      "contextRef": "c20230622to20230622",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001140361-23-030980-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-030980-xbrl.zip
M4$L#!!0    ( $.(UE:^A\]?X"<  )A? 0 4    ;GDR,# P.3$W-'@Q,E\X
M:RYH=&WM/6M3V\B6W[=J_T,O=W87MFRCIRV1A"J&D!EV$I("LC-[O]QJ22VL
M.[+DD>0 ^^OWG&Z]'T: '1OBS%1B6RVIS_O9W6^GR<PG=S,_B(_NK,CWWNU-
MDV1^='AX>WL[PE]&871SJ$B2>N@%<4(#F^VEXWTO^'/)<+QLT3@??M<8?ZOR
MT;)IFH?\:CXT]MH&PF/EPS\^?;RRIVQ&A_7YX.N=XL;R;,:'XF(VU(M#39$G
MRX 5([(;XBC)![LTMOA ^!$&*VK^U+NN!\J(/8"0_?'SY<=B>-(^OAAZF$0T
MB-TPFM'$"P-\FS24E*&LE!XRC)E=>1!\']V$WY8^1]:'DC%4Y>PYBWAX0^F\
M"61ZH0*HPVIHSMX(%RH#[7 1)-%]^^#T8O6&112QP.ZZ([U:G4P2#9/[.8O;
MD0F7#_$RWJ,,);4,<Q)U<H!Y"%>S@0'U[+A]2OQ293ZQ9[</A0O5@<D\ZA@)
M5RI#V9T];1^*5ZH89&X'\IA;&9CX)<(DGA_1^Y$=SO@8::QD'-8ML:@Z]H[_
M]5\(>3MEU.&?X'/B)3X[?GLH_DU__+?AD'ST;!;$S"%)>$1^CD+J1)YSP\@'
M+P Q]JA/KD)_@?P9#\AY8(_$O?S/^]!>S%B0$#MB-(%G+&(ON"D_Y<OE9]?S
M&5'4D3Z21[JL*Z7[3\/Y?>3=3!,"<]?)D""4Y=N'PVRJ,Y90@C /V5\+[]N[
MO=,P2.#5PVO@HCUBBV_O]A)VEQQR')!#N/?M88H$^&B%SCV)DWN?O=MS8?S0
MI3//OS\B_WGMS5A,+M@MN0QG-/C/ >&_#$C,(L]]0_CHV/L_=D1D:9Z\(?B6
M(?6]F^"(^,R%7^S0#Z,C\C>)_WE#+&K_>1.!+#G#[)++_[Q!XKQUO&_$<][M
MO;_Z\L%#7?"KYS@LV,OFYWCQW*<PMR ,&-SRUKL[0DA8)#[RT?PC#+@ (D2>
M30(ZPUN9=W0"5'&0,A]\>K/'W_2!VLD_F&79KNF:NJU;FF'9UF2L6([$5)L:
MBC2V4D3>)9?(KW;&=$E8L)]05^_V0,4=N=X=<P"-/MB38_[/V\/*E+IG>!8
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M%3HQ57Q+=&)%H8(]2ECTALQH=.,%0]2O1X0NDC#_*1)OX;\)/<]!*J 37S(
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M9C -AZCF8")+ T/3NURLS5,HB$&3I L_6@\F:3W$HL"$%V3'^(6IA\-/]J2
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M<8RX0(6BN!H:!;DK$A8GH"Y24N:U50R9\GZ!DU2HT#.\9'R\@R=;&ID&/@?
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ML] G)S/J?7U/;D(_N\;5:O_VGFR$_R]_TEO:^U]_@1DDTO*_'K7V7]87O]B
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M"L2J[]F2&X &$9G1,.)A05X-!.O,$M[WKTGZ8OT 2;H DSA =D60RZ59NU)
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MKY7UO;UC?<[>NY@3,3(4L!MH\H3-0\Z>4DP@E_95J.2"]S[$CH?*->8G4C'
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M!*)O- 9!WA]_'O1 SJ$<(T>/IKX">$5MN*3-_9F?* $YQL:KLX%F&8 &Z7Y
M40\* Y#Q83"9CKM*PL.?P\E9?]P ?=G[B#)48 8>O>C^CO*TP9&#E595E/,-
M DT%N+W@.D9V@(?UB$G@(W\ ES7L?E*8)W^A<_"V>J-F V>97()N'7%ER!_J
M3L0(_W79G^R^G>1( 2FAQD&4MJQ,BG/"=Z5IX>G!]'<QL5C\0V<_;O"I"UQ>
MG/=//W"]+J:XG/2)1 ]NPN?N^67QZY<!_ H3"<#X&OKC"6P/+.$+V"<?SB[/
MR00H49@?)>1^')V?PNABY,8J<C_"BKK &",8#M8W&.)+DZG:DDF_=SD&3=^?
M%(M2-@LJ]%4FPUG0, $\#SAZN^3S8'2>4Q+2V7CPX>.46R;PG%BZ7 NL#*%M
MY$C"Y9[VN^?"0%B=[2?2VC_N]H;5J &:!5630&J_JJ(&2X!K42F:J.>!HL0'
ME',;1M]8"OJQL 7P)B(Y%M[<PZ_BX5?TE8P#6]./Z#$JV3&[6L[$+3ZG97-A
M774?BTL;:,+POB.P:=('6BD[7T^QBSFS ;X==F9U%QKWV1,"XD.[H.)%/;_-
MLBOW_D!$K3R%ZHI[@I<7((RD:YC+9.Y@@;P23A:^_F4 GH_XIBQP+X<H;W'L
MR^$ 9YR 'H#A2S-U>U.I0<^D08MB&%32*3Q>5O&"?"HO*K7-%>/*"LZ[7[C;
MA?J!SZH<LPHD3?[5BEX E%Q<CD&[3]#4X9JO&!C@^S#N]X70QI=/^L/^&4AX
M&'X'0P6_&0ESHC!Q/H*_O3(-*./?I6Y!R,\0G0TRX2I!:,O3JD)4>@+1/AJ>
M_PX:_ECYL:5)&^3H!,R<R^ED<-K?L#.HL7KP_&D7]2?7-6,, CF:A2N$O;V4
M*FQ2WMWUO1&*;\C+SL\'Q6C="_C8X[1U/NJ!/N,;A0\78P.2CWK'\+:T.E>&
MP!F!)#]=<#C.QJ-/53/M;KA P6,<@MLJ1_JQ6!Z(*F&0\7<;:%AW/W<'YP@G
MIZXCHWBR>\>CL!#TYLG)B-/!I,^=^S6<EK @B'.-<F'*TV.Q?FY%".N [S*L
M I?)R>9T!&\@XZ$--ACW'X();G7\?C\L:DV<E&!)2 BP/X@\ 2;IGHP^]U7X
M1S#B^3F&:R['P\'D(PRT3HFYV%'Q&&%T8\3E8C 41I+:_TMP=\X%_?5&'X;<
ML@18AZ?(H%6C6 69$& >\<%I)I<G^'@/T=,%\PH6"U(!P)B< 2+0@]D G[)Z
M5:CIM'\.)NSX=R%(5JP]8%>^#3V@7C"/+Z<YQW\8C4[S=Y5>!> F_>GT7,24
ME%\A-G:"@;7)=-3[S]S'F!2\P(]N'*:Y5Z<;ZG3#5G_\8C29OBT'6I58V*I7
M#Y('GA&-8-K%A'K_7(8):XCKP/G=WDCYW#9FWUGBA:F\1SP.L+IV/H?')M?@
M$>!];S\["C=2XIU]I7]./(%_!TZ7*LWVR6*9I$N\3!!\W=5[[[D7C!].&7P-
MA'9\.-C;^UL"F<.HWVD9NNN:EMW1.S;M:)39CJ4'AL?L^V\)W% R\MQ5*=5A
M#?N'%>ZH*RY[.%L \P$A#N,F^9^__,EI6];[_]V]ZNC' %P&-(@3\NM28I6\
MW']^_67Y6S%1^=\7G'3W_VSX(+]"P%7X35XRCK<A9S-Y?3>Y!ODM5!]J.Y1-
MN79<Q&GVMKQ[!#8%1KKBMZ,VB-8$)FN;MN7P^[KQPN^$"S%/:,PTB[VO*MSG
MT05&H_#G:3A+Z"TY2? "5= 5D0?N?KIT_\$\+ARICP$<<>EXBO>J?@LQ1X=[
M+0=;OY:U'$ISV2R^.3Y^2NG9_C#\XT9]R3KU_<'-HV7+LX3#MZO4@N)65>L/
ME:!?@,=1_Z;/$MX'P7LY&5R0_]D4WI:*%^OG3:-!,")IMH[OE^@6^GOEB'44
M)_/\H6\4CU%F;V&%_)[V=,OO(%M6?U+FJ85>XHQE8,B]E>9)\>0Z_O@W(9<J
M[X3?RK_)0-JD('_F^&[$P X!![883SBXUV'&^'=\&3<)76QR71%%AFTWB/KG
M6,[A,P\-Q3".\NA]%&9A#F?I=SE4_KL?IHL9O<5O0*XS\J\DG(/5F0%N !VS
MF&82;F0YQ^G8[ZO_V9JPN)<D_O<9+H/<'WE2R]I:UNZ)K!U,!L-:U-:B]O&B
M]H!+[)\WE_OP,B>RMJR?H'!C-:"'R9H!ST&)E,WO/'>V<VU#0Y$DNFW?Z&S)
M2,(\%GYC?N,0ZPS44+M%NT2"@__)0U":32W7<UV[16W+MGSJ62W;MBVJM3N.
MT7:>*SZVFA\IQ\L*W596AU4]NNW8E5Q;GF?"/,V;50U<HO4[39"J_%I3T14H
M5H[JPKR;CNJ^%"@5ZTS14DFD'A0!OPYI_K1*;1DX$D&OU3K6,.7!I5*AM@R.
MR2!]M)R[XI,*</& UV*9>-<T9>1&E;D]"XSI*G@PK]49@JUQ37HTBJ@+\&+G
ME^83YU/=8\#<69TR73!/U+M1-_[&&CQ7!M.*$")(<I%!RW-F E$I*RK^\@Q;
M$=\3%(8@ Y+GXB" %T=^B!"D(-HRU!FP2@Q)AN)M&?>3&"9A'O?S>6J%\D1*
M=Y&$,W&N1G?($5B)WG7Q: .FOF(8YR18.2@*X<(D!60M%XL9CVG2V=8I)FR1
M,;[_.C],HA,*)' E3ZB(;7CT%N @*[CGQP!(:6\X'GKQ?+$$M G*$R=M>^+H
M)6( Z(+Z%(\WY"'2[A6/U>)@*4,T[[;<ORW!N,W/S8BEK@#4D"%F!+ZQ.:C[
M:(2(T5;)D<K#II6UB?SM;$9BOK=8F)DL<75I=:5X/"7RPMF,)K<BW)W%2,N2
MRA(6L 1Y'@/00A \E8.+\/3ZWL:%V,!:T^A6<@6H=^(RH'\FCI MFG.LA8L3
M>#_F/Q\_D=W[WQ<A8  -B34)$Y5YR+">9Z93("AUNN)A20.!D_7,P1'/8]R
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M]AIFJ:- ^H?L5OKQ&">^\_>-XW_\K?%FY_#H%71F495^RDW@U?P,5D4'@E8
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M'(R<#IH4;.BV.(6E,\A9#_%8:M9+IM. $ G<=[XUR!7*,,+QC9-#H#";9W@
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MI..7?" #M/SFN/=;1^TE=K&@2!U9.#:J)ORMFN,8;\$DL$!&MU@NQ[)RHB0
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MC&)O[8QB+E@MGV@&29YH#:@F1PX&YD<U(I"\!@(#$7D.P5BCWQ=.).\$.P>
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M:/ T2D(M8#>A5/,%FOZ@-*-(8WP\5A$P%>220.D#Y!^". E^!58C;D!<H%Z
M@Y%_09,N#=T6I[!P!CE#(1Y*S3K)>!P0(H'[SK8&N4+90CB^\6<(%&:S# ]
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MENIQ8,0F1@,TB&=O03<B!H>NXJ@'N+&AG"R]?SXW&W/<&0FJD<C6L8\(_A^
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MK<(I_]LR3$V#06VMCSBE586N=_C=CV[3\)<71+"&,29+!^E@S@]NCIN9? &
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MW-QOO#M\-59S($#?>\)W#U@W\47MDEN;<+WOC%[_I?*I\[Y7,>M1T]3B<'S
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M1T+<2@]86 _874T/.!=]+U!L[3N6_&T43,3),S/4Q9TK63(MH?"!!!TEZ/]
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M+16N9'_?>[[7W'E)COF<!$-'*&=4^TE=[Z1][&PKMX>3T+S=B/*_87[8FY9
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MR5FE#9MF-D2XC@6;NNIX#R2J E8RS!Y-"<T58JA*^/=0*61AY,$*<0M(0F8
M*F9JCZT@?(^]4V/^"?\-[P25DYKJ(QP&(BN8A2JM1XQF:/J2!1-])119NZH9
MGEZQI[C N&3=+G7YXBE[HI>14X3])CM7S6S&J@]!!@**Y=$+B\([U^Y90:#/
M'>JUH]OO##W@.2H\KXIKJ9[0N(^L(:T3#H<)]FRC;3E\1!P#G@%5PTT<U99\
M%'E!NDK3I2RWZ0PR9#I8NZ0=Y;2D K@\+%?<E$/A?X^]DUOXDM-.1_S.)$\
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MAZ8'1@GHBMJ>!85,(H,$65'TM7@W]CG51$%K57!(C'RKLI"OC0954E;.R0V
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MY!-)"VV<,)=%!U8D[$M@QD18@+SFIED;L%XO0^Q1"@O6S1!@N$5Q7I35)S1
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M=N7LY38WLF=K!T_QQB.7<KH5M;(E/'[:_15+H3!N3LDAD:A;?YS1AVJCB&J
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M^(KVA_\!4$L! A0#%     @ 0XC65KZ'SU_@)P  F%\! !0
M ( !     &YY,C P,#DQ-S1X,3)?.&LN:'1M4$L! A0#%     @ 0XC65B$&
M4^6J30  #,L" !<              ( !$B@  &YY,C P,#DQ-S1X,3)?97@T
M+3$N:'1M4$L! A0#%     @ 0XC65H,XMM*)&@  9<L  !@
M ( !\74  &YY,C P,#DQ-S1X,3)?97@T+3$R+FAT;5!+ 0(4 Q0    ( $.(
MUE;Y:S>M!AL  %W3   8              "  ;"0  !N>3(P,# Y,3<T>#$R
M7V5X-"TQ-"YH=&U02P$"% ,4    " !#B-96B^T@[Q,;  #_T0  &
M        @ 'LJP  ;GDR,# P.3$W-'@Q,E]E>#0M,38N:'1M4$L! A0#%
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M>2TR,#(S,#8R,E]L86(N>&UL4$L! A0#%     @ 0XC65CIF7-?9!0  [3X
M !4              ( !>5L! '1L<GDM,C R,S V,C)?<')E+GAM;%!+!08
1    #0 - 'D#  "%80$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
